{
  "entities": [
    {
      "id": "E1",
      "type": "Condition",
      "name": "cocaine addiction",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "5e4e759866a368650b92c7c1c6812eae"
      ],
      "confidence": 0.9,
      "evidence": "cocaine addiction",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Condition",
      "name": "methamphetamine addiction",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "5e4e759866a368650b92c7c1c6812eae"
      ],
      "confidence": 0.9,
      "evidence": "methamphetamine addiction",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Condition",
      "name": "alcohol addiction",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "5e4e759866a368650b92c7c1c6812eae"
      ],
      "confidence": 0.85,
      "evidence": "alcohol addictions",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Condition",
      "name": "obesity",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "5e4e759866a368650b92c7c1c6812eae"
      ],
      "confidence": 0.85,
      "evidence": "obesity",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Condition",
      "name": "attention deficit disorder",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "5e4e759866a368650b92c7c1c6812eae"
      ],
      "confidence": 0.85,
      "evidence": "attention deficit disorder",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Condition",
      "name": "depression",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "5e4e759866a368650b92c7c1c6812eae"
      ],
      "confidence": 0.85,
      "evidence": "depression",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Target",
      "name": "mesolimbic dopamine neurons",
      "attributes": {
        "target_type": "neuron"
      },
      "source_chunk_ids": [
        "5e4e759866a368650b92c7c1c6812eae"
      ],
      "confidence": 0.8,
      "evidence": "mesolimbic dopamine (DA) neurons",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Target",
      "name": "serotonin neurons",
      "attributes": {
        "target_type": "neuron"
      },
      "source_chunk_ids": [
        "5e4e759866a368650b92c7c1c6812eae"
      ],
      "confidence": 0.8,
      "evidence": "serotonin (5-HT) neurons",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Target",
      "name": "5-HT2C receptors",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "5e4e759866a368650b92c7c1c6812eae"
      ],
      "confidence": 0.85,
      "evidence": "5-HT2C receptors",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Effect",
      "name": "inhibitory influence over mesolimbic DA neurons",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "5e4e759866a368650b92c7c1c6812eae"
      ],
      "confidence": 0.75,
      "evidence": "inhibitory influence over mesolimbic DA neurons",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Effect",
      "name": "dampen DA-mediated stimulant effects",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "5e4e759866a368650b92c7c1c6812eae"
      ],
      "confidence": 0.75,
      "evidence": "dampen DA-mediated stimulant effects",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Compound",
      "name": "PAL-287",
      "attributes": {},
      "source_chunk_ids": [
        "5e4e759866a368650b92c7c1c6812eae"
      ],
      "confidence": 0.9,
      "evidence": "PAL-287",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Effect",
      "name": "suppresses cocaine self-administration",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "5e4e759866a368650b92c7c1c6812eae"
      ],
      "confidence": 0.8,
      "evidence": "suppresses cocaine self-administration",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Effect",
      "name": "lacks positive reinforcing properties",
      "attributes": {
        "level": "behavioral",
        "valence": "neutral"
      },
      "source_chunk_ids": [
        "5e4e759866a368650b92c7c1c6812eae"
      ],
      "confidence": 0.8,
      "evidence": "lacks positive reinforcing properties",
      "verified": true
    },
    {
      "id": "E15",
      "type": "TraditionalUse",
      "name": "agonist therapy",
      "attributes": {},
      "source_chunk_ids": [
        "5e4e759866a368650b92c7c1c6812eae"
      ],
      "confidence": 0.7,
      "evidence": "agonist therapy",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "dopamine",
      "attributes": {
        "target_type": "neurotransmitter"
      },
      "source_chunk_ids": [
        "5268763697f5f696c251e9886636a663"
      ],
      "confidence": 0.9,
      "evidence": "dopamine (DA)",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "serotonin",
      "attributes": {
        "target_type": "neurotransmitter"
      },
      "source_chunk_ids": [
        "5268763697f5f696c251e9886636a663"
      ],
      "confidence": 0.9,
      "evidence": "serotonin (5-HT)",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Condition",
      "name": "stimulant addiction",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "5268763697f5f696c251e9886636a663"
      ],
      "confidence": 0.85,
      "evidence": "stimulant addiction",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Condition",
      "name": "alcohol addiction",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "5268763697f5f696c251e9886636a663"
      ],
      "confidence": 0.85,
      "evidence": "alcohol addiction",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Study",
      "name": "Rea et al., 1998",
      "attributes": {
        "year": 1998
      },
      "source_chunk_ids": [
        "5268763697f5f696c251e9886636a663"
      ],
      "confidence": 0.8,
      "evidence": "Rea et al., 1998",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Study",
      "name": "Wojnicki et al., 1999",
      "attributes": {
        "year": 1999
      },
      "source_chunk_ids": [
        "5268763697f5f696c251e9886636a663"
      ],
      "confidence": 0.8,
      "evidence": "Wojnicki et al., 1999",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Study",
      "name": "Baumann et al., 2000",
      "attributes": {
        "year": 2000
      },
      "source_chunk_ids": [
        "5268763697f5f696c251e9886636a663"
      ],
      "confidence": 0.8,
      "evidence": "Baumann et al., 2000",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Study",
      "name": "Baumann et al., 2001",
      "attributes": {
        "year": 2001
      },
      "source_chunk_ids": [
        "5268763697f5f696c251e9886636a663"
      ],
      "confidence": 0.8,
      "evidence": "Baumann et al., 2001",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Study",
      "name": "Rothman et al.",
      "attributes": {},
      "source_chunk_ids": [
        "5268763697f5f696c251e9886636a663"
      ],
      "confidence": 0.7,
      "evidence": "Rothman and",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Evidence",
      "name": "laboratory data",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "5268763697f5f696c251e9886636a663"
      ],
      "confidence": 0.75,
      "evidence": "data from our laboratory",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Baumann, 2003",
      "attributes": {
        "year": 2003
      },
      "source_chunk_ids": [
        "1d21f261392efbd361304acd60d7267d"
      ],
      "confidence": 0.9,
      "evidence": "Baumann, 2003",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Study",
      "name": "Rothman et al., 2005",
      "attributes": {
        "year": 2005
      },
      "source_chunk_ids": [
        "1d21f261392efbd361304acd60d7267d"
      ],
      "confidence": 0.9,
      "evidence": "Rothman et al., 2005",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Study",
      "name": "Wee et al., 2005",
      "attributes": {
        "year": 2005
      },
      "source_chunk_ids": [
        "1d21f261392efbd361304acd60d7267d"
      ],
      "confidence": 0.9,
      "evidence": "Wee et al., 2005",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Evidence",
      "name": "literature review",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "1d21f261392efbd361304acd60d7267d"
      ],
      "confidence": 0.7,
      "evidence": "integrate our findings with the existing literature",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Condition",
      "name": "addiction disorders",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "1d21f261392efbd361304acd60d7267d"
      ],
      "confidence": 0.9,
      "evidence": "addiction disorders",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Compound",
      "name": "cocaine",
      "attributes": {},
      "source_chunk_ids": [
        "1d21f261392efbd361304acd60d7267d"
      ],
      "confidence": 0.95,
      "evidence": "cocaine",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Compound",
      "name": "amphetamines",
      "attributes": {},
      "source_chunk_ids": [
        "1d21f261392efbd361304acd60d7267d"
      ],
      "confidence": 0.95,
      "evidence": "amphetamines",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Effect",
      "name": "cardiovascular stimulation",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "1d21f261392efbd361304acd60d7267d"
      ],
      "confidence": 0.85,
      "evidence": "cardiovascular stimulation",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Effect",
      "name": "mood elevation",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "1d21f261392efbd361304acd60d7267d"
      ],
      "confidence": 0.85,
      "evidence": "mood elevation",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Effect",
      "name": "decreased need for sleep",
      "attributes": {
        "level": "behavioral",
        "valence": "neutral"
      },
      "source_chunk_ids": [
        "1d21f261392efbd361304acd60d7267d"
      ],
      "confidence": 0.85,
      "evidence": "decreased need for sleep",
      "verified": true
    },
    {
      "id": "E11",
      "type": "AdverseEvent",
      "name": "disordered thoughts",
      "attributes": {},
      "source_chunk_ids": [
        "1d21f261392efbd361304acd60d7267d"
      ],
      "confidence": 0.8,
      "evidence": "disordered thoughts",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "NET",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "ac1a75296f8c89bda21b6071a5d3238a"
      ],
      "confidence": 0.9,
      "evidence": "NE transporters (NET)",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "DAT",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "ac1a75296f8c89bda21b6071a5d3238a"
      ],
      "confidence": 0.9,
      "evidence": "DA transporters (DAT)",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "SERT",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "ac1a75296f8c89bda21b6071a5d3238a"
      ],
      "confidence": 0.9,
      "evidence": "5-HT transporters (SERT)",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "Na+/Cl--dependent transporters",
      "attributes": {
        "target_type": "transporter superfamily"
      },
      "source_chunk_ids": [
        "ac1a75296f8c89bda21b6071a5d3238a"
      ],
      "confidence": 0.85,
      "evidence": "Na+/Cl--dependent transporters",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Study",
      "name": "Uhl and Johnson, 1994",
      "attributes": {
        "year": 1994
      },
      "source_chunk_ids": [
        "ac1a75296f8c89bda21b6071a5d3238a"
      ],
      "confidence": 0.8,
      "evidence": "Uhl and Johnson, 1994",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Study",
      "name": "Torres and Amara, 2007",
      "attributes": {
        "year": 2007
      },
      "source_chunk_ids": [
        "ac1a75296f8c89bda21b6071a5d3238a"
      ],
      "confidence": 0.8,
      "evidence": "Torres and Amara, 2007",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Study",
      "name": "Amara and Sonders, 1998",
      "attributes": {
        "year": 1998
      },
      "source_chunk_ids": [
        "ac1a75296f8c89bda21b6071a5d3238a"
      ],
      "confidence": 0.8,
      "evidence": "Amara and Sonders, 1998",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Study",
      "name": "Iversen, 2006",
      "attributes": {
        "year": 2006
      },
      "source_chunk_ids": [
        "ac1a75296f8c89bda21b6071a5d3238a"
      ],
      "confidence": 0.8,
      "evidence": "Iversen, 2006",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Effect",
      "name": "inactivation of monoamine signalling",
      "attributes": {
        "level": "molecular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "ac1a75296f8c89bda21b6071a5d3238a"
      ],
      "confidence": 0.85,
      "evidence": "inactivation of monoamine signalling",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Effect",
      "name": "profound effects on CNS function",
      "attributes": {
        "level": "systemic",
        "valence": "neutral"
      },
      "source_chunk_ids": [
        "ac1a75296f8c89bda21b6071a5d3238a"
      ],
      "confidence": 0.8,
      "evidence": "profound effects on CNS function",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Compound",
      "name": "amphetamine",
      "attributes": {},
      "source_chunk_ids": [
        "54188172c7a6b92f330b827dccbfbdad"
      ],
      "confidence": 0.95,
      "evidence": "amphetamine",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Compound",
      "name": "methamphetamine",
      "attributes": {},
      "source_chunk_ids": [
        "54188172c7a6b92f330b827dccbfbdad"
      ],
      "confidence": 0.95,
      "evidence": "methamphetamine",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Compound",
      "name": "phentermine",
      "attributes": {},
      "source_chunk_ids": [
        "54188172c7a6b92f330b827dccbfbdad"
      ],
      "confidence": 0.95,
      "evidence": "phentermine",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Compound",
      "name": "chlorphenamine",
      "attributes": {},
      "source_chunk_ids": [
        "54188172c7a6b92f330b827dccbfbdad"
      ],
      "confidence": 0.95,
      "evidence": "chlorphenamine",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Compound",
      "name": "fenfluramine",
      "attributes": {},
      "source_chunk_ids": [
        "54188172c7a6b92f330b827dccbfbdad"
      ],
      "confidence": 0.95,
      "evidence": "fenfluramine",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Compound",
      "name": "m-fluoroamphetamine",
      "attributes": {
        "code": "PAL-353"
      },
      "source_chunk_ids": [
        "54188172c7a6b92f330b827dccbfbdad"
      ],
      "confidence": 0.9,
      "evidence": "m-fluoroamphetamine (PAL-353)",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Compound",
      "name": "p-methylamphetamine",
      "attributes": {
        "code": "PAL-313"
      },
      "source_chunk_ids": [
        "54188172c7a6b92f330b827dccbfbdad"
      ],
      "confidence": 0.9,
      "evidence": "p-methylamphetamine (PAL-313)",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Compound",
      "name": "1-naphthyl-2-aminopropane",
      "attributes": {
        "code": "PAL-287"
      },
      "source_chunk_ids": [
        "54188172c7a6b92f330b827dccbfbdad"
      ],
      "confidence": 0.9,
      "evidence": "1-naphthyl-2-aminopropane (PAL-287)",
      "verified": true
    },
    {
      "id": "E9",
      "type": "CompoundClass",
      "name": "stimulants",
      "attributes": {},
      "source_chunk_ids": [
        "54188172c7a6b92f330b827dccbfbdad"
      ],
      "confidence": 0.85,
      "evidence": "stimulant drugs",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "transporter proteins",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "373e0a0b0e91145a4c78062620948992"
      ],
      "confidence": 0.8,
      "evidence": "bind to transporter proteins",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "vesicular monoamine transporter 2",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "373e0a0b0e91145a4c78062620948992"
      ],
      "confidence": 0.9,
      "evidence": "vesicular monoamine transporter 2 (VMAT2)",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Effect",
      "name": "elevate extracellular transmitter concentrations",
      "attributes": {
        "level": "molecular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "373e0a0b0e91145a4c78062620948992"
      ],
      "confidence": 0.85,
      "evidence": "elevate extracellular transmitter concentrations",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Effect",
      "name": "promote efflux of transmitter",
      "attributes": {
        "level": "molecular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "373e0a0b0e91145a4c78062620948992"
      ],
      "confidence": 0.8,
      "evidence": "promote efflux of transmitter",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Effect",
      "name": "increase cytoplasmic levels of transmitter",
      "attributes": {
        "level": "molecular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "373e0a0b0e91145a4c78062620948992"
      ],
      "confidence": 0.8,
      "evidence": "increase cytoplasmic levels of transmitter",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "disrupt storage of transmitters in vesicles",
      "attributes": {
        "level": "molecular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "373e0a0b0e91145a4c78062620948992"
      ],
      "confidence": 0.85,
      "evidence": "disrupting storage of transmitters in vesicles",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Effect",
      "name": "block the effects of releasers",
      "attributes": {
        "level": "molecular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "373e0a0b0e91145a4c78062620948992"
      ],
      "confidence": 0.8,
      "evidence": "block the effects of releasers",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Compound",
      "name": "cocaine",
      "attributes": {},
      "source_chunk_ids": [
        "99340e432914aeae370104e5f4090e3a"
      ],
      "confidence": 0.95,
      "evidence": "stimulants such as cocaine",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Compound",
      "name": "methamphetamine",
      "attributes": {},
      "source_chunk_ids": [
        "99340e432914aeae370104e5f4090e3a"
      ],
      "confidence": 0.95,
      "evidence": "stimulants such as ... methamphetamine",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Compound",
      "name": "alcohol",
      "attributes": {},
      "source_chunk_ids": [
        "99340e432914aeae370104e5f4090e3a"
      ],
      "confidence": 0.95,
      "evidence": "alcohol-induced increases",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Effect",
      "name": "high or rush",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "99340e432914aeae370104e5f4090e3a"
      ],
      "confidence": 0.9,
      "evidence": "produces a 'high' or 'rush'",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Effect",
      "name": "elevations in extracellular DA levels",
      "attributes": {
        "level": "molecular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "99340e432914aeae370104e5f4090e3a"
      ],
      "confidence": 0.85,
      "evidence": "elevations in extracellular DA levels",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "elevations in extracellular NE",
      "attributes": {
        "level": "molecular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "99340e432914aeae370104e5f4090e3a"
      ],
      "confidence": 0.8,
      "evidence": "elevations in extracellular NE",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Effect",
      "name": "positive reinforcing effects",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "99340e432914aeae370104e5f4090e3a"
      ],
      "confidence": 0.85,
      "evidence": "positive reinforcing effects",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Condition",
      "name": "addiction",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "99340e432914aeae370104e5f4090e3a"
      ],
      "confidence": 0.9,
      "evidence": "lead to serious addiction",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Effect",
      "name": "long-term changes in neurochemistry and brain circuitry",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "99340e432914aeae370104e5f4090e3a"
      ],
      "confidence": 0.85,
      "evidence": "long-term changes in neurochemistry and brain circuitry",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Target",
      "name": "mesolimbic circuits",
      "attributes": {
        "target_type": "pathway"
      },
      "source_chunk_ids": [
        "99340e432914aeae370104e5f4090e3a"
      ],
      "confidence": 0.8,
      "evidence": "mesolimbic circuits",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Target",
      "name": "synaptic plasticity",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "99340e432914aeae370104e5f4090e3a"
      ],
      "confidence": 0.8,
      "evidence": "processes of synaptic plasticity",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Condition",
      "name": "withdrawal from stimulant abuse",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "e75e60fb30c47f351ae165c2a93a3147"
      ],
      "confidence": 0.9,
      "evidence": "withdrawal from stimulant and alcohol abuse",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Condition",
      "name": "withdrawal from alcohol abuse",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "e75e60fb30c47f351ae165c2a93a3147"
      ],
      "confidence": 0.9,
      "evidence": "withdrawal from stimulant and alcohol abuse",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "DA function",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "e75e60fb30c47f351ae165c2a93a3147"
      ],
      "confidence": 0.85,
      "evidence": "deficits in DA and 5-HT function",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "5-HT function",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "e75e60fb30c47f351ae165c2a93a3147"
      ],
      "confidence": 0.85,
      "evidence": "deficits in DA and 5-HT function",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "extracellular DA",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "e75e60fb30c47f351ae165c2a93a3147"
      ],
      "confidence": 0.8,
      "evidence": "decreased levels of extracellular DA",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Target",
      "name": "extracellular 5-HT",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "e75e60fb30c47f351ae165c2a93a3147"
      ],
      "confidence": 0.8,
      "evidence": "decreased levels of extracellular 5-HT",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Target",
      "name": "DA D2 receptors",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "e75e60fb30c47f351ae165c2a93a3147"
      ],
      "confidence": 0.85,
      "evidence": "loss of DA D2 receptors",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Target",
      "name": "neuroendocrine responsiveness to 5-HT releasers",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "e75e60fb30c47f351ae165c2a93a3147"
      ],
      "confidence": 0.75,
      "evidence": "Neuroendocrine responsiveness to 5-HT releasers",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Effect",
      "name": "decreased synaptic levels of DA",
      "attributes": {
        "level": "molecular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "e75e60fb30c47f351ae165c2a93a3147"
      ],
      "confidence": 0.85,
      "evidence": "decreased synaptic levels of DA",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Effect",
      "name": "decreased synaptic levels of 5-HT",
      "attributes": {
        "level": "molecular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "e75e60fb30c47f351ae165c2a93a3147"
      ],
      "confidence": 0.85,
      "evidence": "decreased synaptic levels of 5-HT",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Study",
      "name": "Parsons et al., 1991, 1995",
      "attributes": {
        "year": "1991, 1995"
      },
      "source_chunk_ids": [
        "e75e60fb30c47f351ae165c2a93a3147"
      ],
      "confidence": 0.8,
      "evidence": "Parsons et al., 1991, 1995",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Study",
      "name": "Rossetti et al., 1992",
      "attributes": {
        "year": "1992"
      },
      "source_chunk_ids": [
        "e75e60fb30c47f351ae165c2a93a3147"
      ],
      "confidence": 0.8,
      "evidence": "Rossetti et al., 1992",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Study",
      "name": "Weiss et al., 1996",
      "attributes": {
        "year": "1996"
      },
      "source_chunk_ids": [
        "e75e60fb30c47f351ae165c2a93a3147"
      ],
      "confidence": 0.8,
      "evidence": "Weiss et al., 1996",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Study",
      "name": "Volkow et al., 1997, 2002",
      "attributes": {
        "year": "1997, 2002"
      },
      "source_chunk_ids": [
        "e75e60fb30c47f351ae165c2a93a3147"
      ],
      "confidence": 0.8,
      "evidence": "Volkow et al., 1997, 2002",
      "verified": true
    },
    {
      "id": "E15",
      "type": "Study",
      "name": "Martinez et al., 2007",
      "attributes": {
        "year": "2007"
      },
      "source_chunk_ids": [
        "e75e60fb30c47f351ae165c2a93a3147"
      ],
      "confidence": 0.8,
      "evidence": "Martinez et al., 2007",
      "verified": true
    },
    {
      "id": "E16",
      "type": "Study",
      "name": "Levy et al., 1994",
      "attributes": {
        "year": "1994"
      },
      "source_chunk_ids": [
        "e75e60fb30c47f351ae165c2a93a3147"
      ],
      "confidence": 0.8,
      "evidence": "Levy et al., 1994",
      "verified": true
    },
    {
      "id": "E17",
      "type": "Study",
      "name": "Baumann et al., 1995a",
      "attributes": {
        "year": "1995"
      },
      "source_chunk_ids": [
        "e75e60fb30c47f351ae165c2a93a3147"
      ],
      "confidence": 0.8,
      "evidence": "Baumann et al., 1995a",
      "verified": true
    },
    {
      "id": "E18",
      "type": "Study",
      "name": "Haney et al., 2001",
      "attributes": {
        "year": "2001"
      },
      "source_chunk_ids": [
        "e75e60fb30c47f351ae165c2a93a3147"
      ],
      "confidence": 0.8,
      "evidence": "Haney et al., 2001",
      "verified": true
    },
    {
      "id": "E19",
      "type": "Study",
      "name": "Ghitza et al., 2007",
      "attributes": {
        "year": "2007"
      },
      "source_chunk_ids": [
        "e75e60fb30c47f351ae165c2a93a3147"
      ],
      "confidence": 0.8,
      "evidence": "Ghitza et al., 2007",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Condition",
      "name": "major depression",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "739019506863bb79bcc7d89e6a0fec8c"
      ],
      "confidence": 0.9,
      "evidence": "symptoms resembling major depression",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Condition",
      "name": "suicidal ideation",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "739019506863bb79bcc7d89e6a0fec8c"
      ],
      "confidence": 0.85,
      "evidence": "increased prevalence of suicidal ideation",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Condition",
      "name": "suicide attempts",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "739019506863bb79bcc7d89e6a0fec8c"
      ],
      "confidence": 0.85,
      "evidence": "suicide attempts",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "5-HT dysfunction",
      "attributes": {
        "target_type": "pathway"
      },
      "source_chunk_ids": [
        "739019506863bb79bcc7d89e6a0fec8c"
      ],
      "confidence": 0.8,
      "evidence": "5-HT dysfunction in mediating depression",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Condition",
      "name": "depression",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "739019506863bb79bcc7d89e6a0fec8c"
      ],
      "confidence": 0.9,
      "evidence": "5-HT dysfunction in mediating depression",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Condition",
      "name": "suicide",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "739019506863bb79bcc7d89e6a0fec8c"
      ],
      "confidence": 0.8,
      "evidence": "5-HT dysfunction in mediating suicide",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Target",
      "name": "decreased synaptic 5-HT",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "739019506863bb79bcc7d89e6a0fec8c"
      ],
      "confidence": 0.75,
      "evidence": "decreased synaptic 5-HT in cocaine and alcohol withdrawal",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Condition",
      "name": "cocaine withdrawal",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "739019506863bb79bcc7d89e6a0fec8c"
      ],
      "confidence": 0.8,
      "evidence": "cocaine withdrawal states",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Condition",
      "name": "alcohol withdrawal",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "739019506863bb79bcc7d89e6a0fec8c"
      ],
      "confidence": 0.8,
      "evidence": "alcohol withdrawal states",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Condition",
      "name": "depressed mood",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "739019506863bb79bcc7d89e6a0fec8c"
      ],
      "confidence": 0.85,
      "evidence": "depressed mood",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Condition",
      "name": "obsessive thoughts",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "739019506863bb79bcc7d89e6a0fec8c"
      ],
      "confidence": 0.8,
      "evidence": "obsessive thoughts",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Condition",
      "name": "intense craving",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "739019506863bb79bcc7d89e6a0fec8c"
      ],
      "confidence": 0.8,
      "evidence": "intense craving",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Condition",
      "name": "anhedonia",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "739019506863bb79bcc7d89e6a0fec8c"
      ],
      "confidence": 0.85,
      "evidence": "anhedonia",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Condition",
      "name": "increased impulsivity",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "739019506863bb79bcc7d89e6a0fec8c"
      ],
      "confidence": 0.8,
      "evidence": "increased impulsivity",
      "verified": true
    },
    {
      "id": "E15",
      "type": "Condition",
      "name": "susceptibility to drug-related cues",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "739019506863bb79bcc7d89e6a0fec8c"
      ],
      "confidence": 0.75,
      "evidence": "susceptibility to drug-related cues",
      "verified": true
    },
    {
      "id": "E16",
      "type": "Target",
      "name": "monoamine systems deficits",
      "attributes": {
        "target_type": "pathway"
      },
      "source_chunk_ids": [
        "739019506863bb79bcc7d89e6a0fec8c"
      ],
      "confidence": 0.7,
      "evidence": "deficits in monoamine systems underlie symptoms",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "DA dysfunction",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "27d60c76638cac35174e70812a614f27"
      ],
      "confidence": 0.7,
      "evidence": "drug-induced DA dysfunction",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "5-HT dysfunction",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "27d60c76638cac35174e70812a614f27"
      ],
      "confidence": 0.7,
      "evidence": "drug-induced 5-HT dysfunction",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Condition",
      "name": "withdrawal symptoms",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "27d60c76638cac35174e70812a614f27"
      ],
      "confidence": 0.8,
      "evidence": "withdrawal symptoms",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Condition",
      "name": "drug craving",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "27d60c76638cac35174e70812a614f27"
      ],
      "confidence": 0.8,
      "evidence": "drug craving",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Condition",
      "name": "relapse",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "27d60c76638cac35174e70812a614f27"
      ],
      "confidence": 0.8,
      "evidence": "relapse",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Study",
      "name": "Baumann and Rothman, 1998a, b",
      "attributes": {
        "year": "1998"
      },
      "source_chunk_ids": [
        "27d60c76638cac35174e70812a614f27"
      ],
      "confidence": 0.75,
      "evidence": "Baumann and Rothman, 1998a, b",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Evidence",
      "name": "proposed model",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "27d60c76638cac35174e70812a614f27"
      ],
      "confidence": 0.7,
      "evidence": "proposed a dual deficit model",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "synaptic DA",
      "attributes": {
        "target_type": "neurotransmitter"
      },
      "source_chunk_ids": [
        "a8c8d0c88ed162af1354041ab7d1fdb9"
      ],
      "confidence": 0.8,
      "evidence": "decreased synaptic DA",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "synaptic 5-HT",
      "attributes": {
        "target_type": "neurotransmitter"
      },
      "source_chunk_ids": [
        "a8c8d0c88ed162af1354041ab7d1fdb9"
      ],
      "confidence": 0.8,
      "evidence": "decreased synaptic 5-HT",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Condition",
      "name": "anhedonia",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "a8c8d0c88ed162af1354041ab7d1fdb9"
      ],
      "confidence": 0.9,
      "evidence": "underlies anhedonia",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Condition",
      "name": "psychomotor retardation",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "a8c8d0c88ed162af1354041ab7d1fdb9"
      ],
      "confidence": 0.9,
      "evidence": "psychomotor retardation",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Condition",
      "name": "depressed mood",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "a8c8d0c88ed162af1354041ab7d1fdb9"
      ],
      "confidence": 0.9,
      "evidence": "gives rise to depressed mood",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Condition",
      "name": "obsessive thoughts",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "a8c8d0c88ed162af1354041ab7d1fdb9"
      ],
      "confidence": 0.85,
      "evidence": "obsessive thoughts",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Condition",
      "name": "lack of impulse control",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "a8c8d0c88ed162af1354041ab7d1fdb9"
      ],
      "confidence": 0.85,
      "evidence": "lack of impulse control",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Condition",
      "name": "major depression",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "a8c8d0c88ed162af1354041ab7d1fdb9"
      ],
      "confidence": 0.9,
      "evidence": "major depression",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Condition",
      "name": "stimulant dependence",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "a8c8d0c88ed162af1354041ab7d1fdb9"
      ],
      "confidence": 0.8,
      "evidence": "stimulant dependence",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Condition",
      "name": "alcohol dependence",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "a8c8d0c88ed162af1354041ab7d1fdb9"
      ],
      "confidence": 0.8,
      "evidence": "alcohol dependence",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Glowa et al., 1995",
      "attributes": {
        "design": "preclinical",
        "year": 1995
      },
      "source_chunk_ids": [
        "0cc6a8fb8c98dc1494145ccbd1d3dd98"
      ],
      "confidence": 0.85,
      "evidence": "Glowa et al., 1995",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Study",
      "name": "Negus and Mello, 2003a, b",
      "attributes": {
        "design": "preclinical",
        "year": 2003
      },
      "source_chunk_ids": [
        "0cc6a8fb8c98dc1494145ccbd1d3dd98"
      ],
      "confidence": 0.85,
      "evidence": "Negus and Mello, 2003a, b",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Study",
      "name": "Wojnicki et al., 1999",
      "attributes": {
        "design": "preclinical",
        "year": 1999
      },
      "source_chunk_ids": [
        "0cc6a8fb8c98dc1494145ccbd1d3dd98"
      ],
      "confidence": 0.85,
      "evidence": "Wojnicki et al., 1999",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Study",
      "name": "Rothman et al., 2002",
      "attributes": {
        "design": "review",
        "year": 2002
      },
      "source_chunk_ids": [
        "0cc6a8fb8c98dc1494145ccbd1d3dd98"
      ],
      "confidence": 0.8,
      "evidence": "Rothman et al., 2002",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Study",
      "name": "Grabowski et al., 2004b",
      "attributes": {
        "design": "clinical",
        "year": 2004
      },
      "source_chunk_ids": [
        "0cc6a8fb8c98dc1494145ccbd1d3dd98"
      ],
      "confidence": 0.8,
      "evidence": "Grabowski et al., 2004b",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Study",
      "name": "Lile, 2006",
      "attributes": {
        "design": "review",
        "year": 2006
      },
      "source_chunk_ids": [
        "0cc6a8fb8c98dc1494145ccbd1d3dd98"
      ],
      "confidence": 0.8,
      "evidence": "Lile, 2006",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Evidence",
      "name": "preclinical evidence",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "0cc6a8fb8c98dc1494145ccbd1d3dd98"
      ],
      "confidence": 0.75,
      "evidence": "preclinical results",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Compound",
      "name": "d-amphetamine",
      "attributes": {},
      "source_chunk_ids": [
        "0cc6a8fb8c98dc1494145ccbd1d3dd98"
      ],
      "confidence": 0.9,
      "evidence": "d-amphetamine",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Compound",
      "name": "phentermine",
      "attributes": {},
      "source_chunk_ids": [
        "0cc6a8fb8c98dc1494145ccbd1d3dd98"
      ],
      "confidence": 0.9,
      "evidence": "phentermine",
      "verified": true
    },
    {
      "id": "E10",
      "type": "CompoundClass",
      "name": "DA releasers",
      "attributes": {},
      "source_chunk_ids": [
        "0cc6a8fb8c98dc1494145ccbd1d3dd98"
      ],
      "confidence": 0.85,
      "evidence": "DA releasers",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Condition",
      "name": "cocaine addiction",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "0cc6a8fb8c98dc1494145ccbd1d3dd98"
      ],
      "confidence": 0.9,
      "evidence": "cocaine addiction",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Effect",
      "name": "decreases cocaine self-administration",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "0cc6a8fb8c98dc1494145ccbd1d3dd98"
      ],
      "confidence": 0.8,
      "evidence": "decreases cocaine self-administration",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Effect",
      "name": "suppresses responding for cocaine injections",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "0cc6a8fb8c98dc1494145ccbd1d3dd98"
      ],
      "confidence": 0.8,
      "evidence": "suppresses responding for cocaine injections",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Compound",
      "name": "fenfluramine",
      "attributes": {},
      "source_chunk_ids": [
        "3363929e19d1bdb8822dee231bd8508d"
      ],
      "confidence": 0.95,
      "evidence": "5-HT releaser fenfluramine",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Compound",
      "name": "phentermine",
      "attributes": {},
      "source_chunk_ids": [
        "3363929e19d1bdb8822dee231bd8508d"
      ],
      "confidence": 0.95,
      "evidence": "phentermine plus fenfluramine",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Effect",
      "name": "decreases responding for cocaine",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "3363929e19d1bdb8822dee231bd8508d"
      ],
      "confidence": 0.85,
      "evidence": "decreases responding for cocaine",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Effect",
      "name": "decrease in cocaine self-administration",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "3363929e19d1bdb8822dee231bd8508d"
      ],
      "confidence": 0.85,
      "evidence": "75% decrease in cocaine self-administration",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Study",
      "name": "Negus et al., 2007",
      "attributes": {
        "year": 2007
      },
      "source_chunk_ids": [
        "3363929e19d1bdb8822dee231bd8508d"
      ],
      "confidence": 0.9,
      "evidence": "Negus et al., 2007",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Study",
      "name": "Glowa et al., 1997",
      "attributes": {
        "year": 1997
      },
      "source_chunk_ids": [
        "3363929e19d1bdb8822dee231bd8508d"
      ],
      "confidence": 0.9,
      "evidence": "Glowa et al., 1997",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Evidence",
      "name": "in vivo study",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "3363929e19d1bdb8822dee231bd8508d"
      ],
      "confidence": 0.8,
      "evidence": "in rhesus monkeys",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Condition",
      "name": "Parkinson-like symptoms",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "3afe1d9ef100e1705e32be19daa3ab2e"
      ],
      "confidence": 0.9,
      "evidence": "Parkinson-like Symptoms",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Condition",
      "name": "slow reaction time",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "3afe1d9ef100e1705e32be19daa3ab2e"
      ],
      "confidence": 0.85,
      "evidence": "slow reaction time",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Condition",
      "name": "anergia",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "3afe1d9ef100e1705e32be19daa3ab2e"
      ],
      "confidence": 0.85,
      "evidence": "anergia",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Condition",
      "name": "anhedonia",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "3afe1d9ef100e1705e32be19daa3ab2e"
      ],
      "confidence": 0.9,
      "evidence": "Anhedonia",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Condition",
      "name": "pleasure center dysfunction",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "3afe1d9ef100e1705e32be19daa3ab2e"
      ],
      "confidence": 0.8,
      "evidence": "pleasure center dysfunction",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Condition",
      "name": "OCD-like symptoms",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "3afe1d9ef100e1705e32be19daa3ab2e"
      ],
      "confidence": 0.9,
      "evidence": "OCD-like Symptoms",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Condition",
      "name": "obsessive thoughts",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "3afe1d9ef100e1705e32be19daa3ab2e"
      ],
      "confidence": 0.85,
      "evidence": "obsessive thoughts",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Condition",
      "name": "compulsive behaviors",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "3afe1d9ef100e1705e32be19daa3ab2e"
      ],
      "confidence": 0.85,
      "evidence": "compulsive behaviors",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Condition",
      "name": "impulsivity",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "3afe1d9ef100e1705e32be19daa3ab2e"
      ],
      "confidence": 0.9,
      "evidence": "Impulsivity",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Condition",
      "name": "suicide",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "3afe1d9ef100e1705e32be19daa3ab2e"
      ],
      "confidence": 0.8,
      "evidence": "suicide/aggression",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Condition",
      "name": "aggression",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "3afe1d9ef100e1705e32be19daa3ab2e"
      ],
      "confidence": 0.8,
      "evidence": "suicide/aggression",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Condition",
      "name": "susceptibility to cue triggers",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "3afe1d9ef100e1705e32be19daa3ab2e"
      ],
      "confidence": 0.75,
      "evidence": "susceptibility to cue triggers",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Condition",
      "name": "depression",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "3afe1d9ef100e1705e32be19daa3ab2e"
      ],
      "confidence": 0.95,
      "evidence": "Depression & Craving",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Condition",
      "name": "craving",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "3afe1d9ef100e1705e32be19daa3ab2e"
      ],
      "confidence": 0.9,
      "evidence": "Depression & Craving",
      "verified": true
    },
    {
      "id": "E15",
      "type": "Target",
      "name": "dopamine",
      "attributes": {
        "target_type": "neurotransmitter"
      },
      "source_chunk_ids": [
        "3afe1d9ef100e1705e32be19daa3ab2e"
      ],
      "confidence": 0.9,
      "evidence": "DOPAMINE DEFICIT",
      "verified": true
    },
    {
      "id": "E16",
      "type": "Target",
      "name": "serotonin",
      "attributes": {
        "target_type": "neurotransmitter"
      },
      "source_chunk_ids": [
        "3afe1d9ef100e1705e32be19daa3ab2e"
      ],
      "confidence": 0.9,
      "evidence": "SEROTONIN DEFICIT",
      "verified": true
    },
    {
      "id": "E17",
      "type": "Effect",
      "name": "decreased synaptic dopamine",
      "attributes": {
        "level": "molecular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "3afe1d9ef100e1705e32be19daa3ab2e"
      ],
      "confidence": 0.85,
      "evidence": "decreased synaptic DA",
      "verified": true
    },
    {
      "id": "E18",
      "type": "Effect",
      "name": "altered dopamine transporter function",
      "attributes": {
        "level": "molecular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "3afe1d9ef100e1705e32be19daa3ab2e"
      ],
      "confidence": 0.85,
      "evidence": "altered DA transporter function",
      "verified": true
    },
    {
      "id": "E19",
      "type": "Effect",
      "name": "postsynaptic receptor changes",
      "attributes": {
        "level": "molecular",
        "valence": "neutral"
      },
      "source_chunk_ids": [
        "3afe1d9ef100e1705e32be19daa3ab2e"
      ],
      "confidence": 0.8,
      "evidence": "postsynaptic receptor changes",
      "verified": true
    },
    {
      "id": "E20",
      "type": "Effect",
      "name": "decreased synaptic serotonin",
      "attributes": {
        "level": "molecular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "3afe1d9ef100e1705e32be19daa3ab2e"
      ],
      "confidence": 0.85,
      "evidence": "decreased synaptic 5-HT",
      "verified": true
    },
    {
      "id": "E21",
      "type": "Effect",
      "name": "decreased serotonin cell activity",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "3afe1d9ef100e1705e32be19daa3ab2e"
      ],
      "confidence": 0.85,
      "evidence": "decreased 5-HT cell activity",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "DA",
      "attributes": {
        "target_type": "neurotransmitter"
      },
      "source_chunk_ids": [
        "c993c9c96de91fea924b3244322dd7ae"
      ],
      "confidence": 0.9,
      "evidence": "decreased synaptic availability of DA",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "5-HT",
      "attributes": {
        "target_type": "neurotransmitter"
      },
      "source_chunk_ids": [
        "c993c9c96de91fea924b3244322dd7ae"
      ],
      "confidence": 0.9,
      "evidence": "decreased synaptic availability of 5-HT",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Condition",
      "name": "withdrawal symptoms",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "c993c9c96de91fea924b3244322dd7ae"
      ],
      "confidence": 0.85,
      "evidence": "contributes to withdrawal symptoms",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Condition",
      "name": "drug craving",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "c993c9c96de91fea924b3244322dd7ae"
      ],
      "confidence": 0.85,
      "evidence": "contributes to drug craving",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Condition",
      "name": "relapse",
      "attributes": {
        "condition_type": "behavior"
      },
      "source_chunk_ids": [
        "c993c9c96de91fea924b3244322dd7ae"
      ],
      "confidence": 0.85,
      "evidence": "contributes to relapse",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Condition",
      "name": "anhedonia",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "c993c9c96de91fea924b3244322dd7ae"
      ],
      "confidence": 0.8,
      "evidence": "DA dysfunction underlies anhedonia",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Condition",
      "name": "psychomotor disturbances",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "c993c9c96de91fea924b3244322dd7ae"
      ],
      "confidence": 0.8,
      "evidence": "DA dysfunction underlies psychomotor disturbances",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Condition",
      "name": "depressed mood",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "c993c9c96de91fea924b3244322dd7ae"
      ],
      "confidence": 0.8,
      "evidence": "5-HT dysfunction causes depressed mood",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Condition",
      "name": "obsessive thoughts",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "c993c9c96de91fea924b3244322dd7ae"
      ],
      "confidence": 0.8,
      "evidence": "5-HT dysfunction causes obsessive thoughts",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Condition",
      "name": "lack of impulse control",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "c993c9c96de91fea924b3244322dd7ae"
      ],
      "confidence": 0.8,
      "evidence": "5-HT dysfunction causes lack of impulse control",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Study",
      "name": "Rothman and Baumann (2003)",
      "attributes": {
        "year": 2003
      },
      "source_chunk_ids": [
        "c993c9c96de91fea924b3244322dd7ae"
      ],
      "confidence": 0.9,
      "evidence": "Adapted with permission from Rothman and Baumann (2003)",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Evidence",
      "name": "theoretical model",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "c993c9c96de91fea924b3244322dd7ae"
      ],
      "confidence": 0.7,
      "evidence": "dual deficit model of stimulant addiction",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Compound",
      "name": "D-fenfluramine",
      "attributes": {},
      "source_chunk_ids": [
        "9f3218ad44d746766a5bfa5f02e43312"
      ],
      "confidence": 0.95,
      "evidence": "D-fenfluramine reduces cocaine self-administration",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Condition",
      "name": "cocaine self-administration",
      "attributes": {
        "condition_type": "behavioral"
      },
      "source_chunk_ids": [
        "9f3218ad44d746766a5bfa5f02e43312"
      ],
      "confidence": 0.9,
      "evidence": "cocaine self-administration",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Study",
      "name": "Glatz et al., 2002",
      "attributes": {
        "year": 2002
      },
      "source_chunk_ids": [
        "9f3218ad44d746766a5bfa5f02e43312"
      ],
      "confidence": 0.85,
      "evidence": "Glatz et al., 2002",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Evidence",
      "name": "animal study",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "9f3218ad44d746766a5bfa5f02e43312"
      ],
      "confidence": 0.8,
      "evidence": "in rats",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Compound",
      "name": "5-HT-releasing agents",
      "attributes": {},
      "source_chunk_ids": [
        "9f3218ad44d746766a5bfa5f02e43312"
      ],
      "confidence": 0.9,
      "evidence": "5-HT-releasing agents",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Condition",
      "name": "cue-elicited cocaine-seeking behaviour",
      "attributes": {
        "condition_type": "behavioral"
      },
      "source_chunk_ids": [
        "9f3218ad44d746766a5bfa5f02e43312"
      ],
      "confidence": 0.85,
      "evidence": "cue-elicited cocaine-seeking behaviour",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Study",
      "name": "Burmeister et al., 2003",
      "attributes": {
        "year": 2003
      },
      "source_chunk_ids": [
        "9f3218ad44d746766a5bfa5f02e43312"
      ],
      "confidence": 0.85,
      "evidence": "Burmeister et al., 2003",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Condition",
      "name": "cocaine craving",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "9f3218ad44d746766a5bfa5f02e43312"
      ],
      "confidence": 0.9,
      "evidence": "cocaine craving",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Study",
      "name": "Buydens-Branchev et al., 1998",
      "attributes": {
        "year": 1998
      },
      "source_chunk_ids": [
        "9f3218ad44d746766a5bfa5f02e43312"
      ],
      "confidence": 0.85,
      "evidence": "Buydens-Branchev et al., 1998",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Evidence",
      "name": "clinical study",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "9f3218ad44d746766a5bfa5f02e43312"
      ],
      "confidence": 0.8,
      "evidence": "cocaine-dependent human patients",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Compound",
      "name": "DA and 5-HT releasers",
      "attributes": {},
      "source_chunk_ids": [
        "9f3218ad44d746766a5bfa5f02e43312"
      ],
      "confidence": 0.85,
      "evidence": "DA and 5-HT releasers",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Condition",
      "name": "stimulant self-administration",
      "attributes": {
        "condition_type": "behavioral"
      },
      "source_chunk_ids": [
        "9f3218ad44d746766a5bfa5f02e43312"
      ],
      "confidence": 0.8,
      "evidence": "stimulant self-administration",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Condition",
      "name": "cue-induced relapse",
      "attributes": {
        "condition_type": "behavioral"
      },
      "source_chunk_ids": [
        "9f3218ad44d746766a5bfa5f02e43312"
      ],
      "confidence": 0.8,
      "evidence": "cue-induced relapse",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Condition",
      "name": "alcohol dependence",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "9f3218ad44d746766a5bfa5f02e43312"
      ],
      "confidence": 0.9,
      "evidence": "alcohol dependence",
      "verified": true
    },
    {
      "id": "E15",
      "type": "Study",
      "name": "Yu et al., 1997",
      "attributes": {
        "year": 1997
      },
      "source_chunk_ids": [
        "9f3218ad44d746766a5bfa5f02e43312"
      ],
      "confidence": 0.85,
      "evidence": "Yu et al., 1997",
      "verified": true
    },
    {
      "id": "E16",
      "type": "Study",
      "name": "Halladay et al., 1999, 2006",
      "attributes": {
        "year": "1999, 2006"
      },
      "source_chunk_ids": [
        "9f3218ad44d746766a5bfa5f02e43312"
      ],
      "confidence": 0.85,
      "evidence": "Halladay et al., 1999, 2006",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Evidence",
      "name": "review",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "62675204c6afc820766a5babedc84411"
      ],
      "confidence": 0.8,
      "evidence": "for review, see Grabowski et al., 2004b",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Condition",
      "name": "stimulant abuse",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "62675204c6afc820766a5babedc84411"
      ],
      "confidence": 0.9,
      "evidence": "decrease stimulant abuse",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Condition",
      "name": "nicotine dependence",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "62675204c6afc820766a5babedc84411"
      ],
      "confidence": 0.9,
      "evidence": "nicotine dependence",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Condition",
      "name": "opioid dependence",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "62675204c6afc820766a5babedc84411"
      ],
      "confidence": 0.9,
      "evidence": "opioid dependence",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Condition",
      "name": "cocaine dependence",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "62675204c6afc820766a5babedc84411"
      ],
      "confidence": 0.9,
      "evidence": "cocaine dependence",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Target",
      "name": "mesolimbic DA neurons",
      "attributes": {
        "target_type": "neural pathway"
      },
      "source_chunk_ids": [
        "62675204c6afc820766a5babedc84411"
      ],
      "confidence": 0.85,
      "evidence": "mesolimbic DA neurons",
      "verified": true
    },
    {
      "id": "E7",
      "type": "AdverseEvent",
      "name": "abuse liability",
      "attributes": {
        "severity": "significant"
      },
      "source_chunk_ids": [
        "62675204c6afc820766a5babedc84411"
      ],
      "confidence": 0.8,
      "evidence": "exhibit inherent abuse liability",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "synaptic 5-HT",
      "attributes": {
        "target_type": "neurotransmitter"
      },
      "source_chunk_ids": [
        "d2ed63a86880844af8294b6dd89d65d6"
      ],
      "confidence": 0.9,
      "evidence": "synaptic 5-HT",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Effect",
      "name": "counteract stimulant and reinforcing effects",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "d2ed63a86880844af8294b6dd89d65d6"
      ],
      "confidence": 0.85,
      "evidence": "counteract the stimulant and reinforcing effects",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "synaptic DA",
      "attributes": {
        "target_type": "neurotransmitter"
      },
      "source_chunk_ids": [
        "d2ed63a86880844af8294b6dd89d65d6"
      ],
      "confidence": 0.9,
      "evidence": "synaptic DA",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Compound",
      "name": "L-tryptophan",
      "attributes": {},
      "source_chunk_ids": [
        "d2ed63a86880844af8294b6dd89d65d6"
      ],
      "confidence": 0.95,
      "evidence": "L-tryptophan",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Effect",
      "name": "increases 5-HT synthesis and release",
      "attributes": {
        "level": "molecular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "d2ed63a86880844af8294b6dd89d65d6"
      ],
      "confidence": 0.85,
      "evidence": "increases 5-HT synthesis and release",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Condition",
      "name": "cocaine self-administration",
      "attributes": {
        "condition_type": "behavioral"
      },
      "source_chunk_ids": [
        "d2ed63a86880844af8294b6dd89d65d6"
      ],
      "confidence": 0.8,
      "evidence": "self-administration of cocaine",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Condition",
      "name": "amphetamine self-administration",
      "attributes": {
        "condition_type": "behavioral"
      },
      "source_chunk_ids": [
        "d2ed63a86880844af8294b65d6",
        "d2ed63a86880844af8294b6dd89d65d6"
      ],
      "confidence": 0.8,
      "evidence": "amphetamine in rats",
      "verified": true
    },
    {
      "id": "E8",
      "type": "CompoundClass",
      "name": "5-HT reuptake inhibitors",
      "attributes": {},
      "source_chunk_ids": [
        "d2ed63a86880844af8294b6dd89d65d6"
      ],
      "confidence": 0.85,
      "evidence": "5-HT reuptake inhibitors",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Condition",
      "name": "cocaine self-administration",
      "attributes": {
        "condition_type": "behavioral"
      },
      "source_chunk_ids": [
        "d2ed63a86880844af8294b6dd89d65d6"
      ],
      "confidence": 0.8,
      "evidence": "intravenous cocaine self-administration",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Target",
      "name": "SERT",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "d2ed63a86880844af8294b6dd89d65d6"
      ],
      "confidence": 0.9,
      "evidence": "SERT",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Effect",
      "name": "reduce self-administration behaviour",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "d2ed63a86880844af8294b6dd89d65d6"
      ],
      "confidence": 0.85,
      "evidence": "support less self-administration behaviour",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Effect",
      "name": "anti-stimulant effects",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "d2ed63a86880844af8294b6dd89d65d6"
      ],
      "confidence": 0.85,
      "evidence": "anti-stimulant effects",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "5-HT",
      "attributes": {
        "target_type": "neurotransmitter"
      },
      "source_chunk_ids": [
        "de55bb27b736b486b5727fd154119b0b"
      ],
      "confidence": 0.9,
      "evidence": "5-HT in vivo",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "DA",
      "attributes": {
        "target_type": "neurotransmitter"
      },
      "source_chunk_ids": [
        "de55bb27b736b486b5727fd154119b0b"
      ],
      "confidence": 0.9,
      "evidence": "indirect DA agonists",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Effect",
      "name": "locomotor stimulation",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "de55bb27b736b486b5727fd154119b0b"
      ],
      "confidence": 0.85,
      "evidence": "strong locomotor stimulants",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Effect",
      "name": "self-administration behaviour",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "de55bb27b736b486b5727fd154119b0b"
      ],
      "confidence": 0.85,
      "evidence": "support self-administration behaviour",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Compound",
      "name": "fenfluramine",
      "attributes": {},
      "source_chunk_ids": [
        "de55bb27b736b486b5727fd154119b0b"
      ],
      "confidence": 0.95,
      "evidence": "fenfluramine",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Compound",
      "name": "chlorphentermine",
      "attributes": {},
      "source_chunk_ids": [
        "de55bb27b736b486b5727fd154119b0b"
      ],
      "confidence": 0.95,
      "evidence": "chlorphentermine",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Effect",
      "name": "increased extracellular 5-HT",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "de55bb27b736b486b5727fd154119b0b"
      ],
      "confidence": 0.8,
      "evidence": "increase endogenous extracellular 5-HT",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Effect",
      "name": "increased extracellular DA",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "de55bb27b736b486b5727fd154119b0b"
      ],
      "confidence": 0.8,
      "evidence": "more than extracellular DA",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Effect",
      "name": "minimal motor activity",
      "attributes": {
        "level": "behavioral",
        "valence": "neutral"
      },
      "source_chunk_ids": [
        "de55bb27b736b486b5727fd154119b0b"
      ],
      "confidence": 0.85,
      "evidence": "produce minimal motor activity",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Effect",
      "name": "no self-administration behaviour",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "de55bb27b736b486b5727fd154119b0b"
      ],
      "confidence": 0.85,
      "evidence": "do not support self-administration behaviour",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Effect",
      "name": "anti-stimulant effect",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "de55bb27b736b486b5727fd154119b0b"
      ],
      "confidence": 0.8,
      "evidence": "anti-stimulant effect of 5-HT releasers",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Evidence",
      "name": "conditioned place preference assay",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "de55bb27b736b486b5727fd154119b0b"
      ],
      "confidence": 0.75,
      "evidence": "conditioned place preference (CPP) assay",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Compound",
      "name": "phentermine",
      "attributes": {},
      "source_chunk_ids": [
        "de55bb27b736b486b5727fd154119b0b"
      ],
      "confidence": 0.95,
      "evidence": "phentermine",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Effect",
      "name": "positive CPP",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "de55bb27b736b486b5727fd154119b0b"
      ],
      "confidence": 0.8,
      "evidence": "positive CPP induced by phentermine",
      "verified": true
    },
    {
      "id": "E15",
      "type": "Effect",
      "name": "reduced positive CPP",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "de55bb27b736b486b5727fd154119b0b"
      ],
      "confidence": 0.8,
      "evidence": "greatly reduces the positive CPP",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "5-HT receptor subtypes",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "30f8a86b00b9d3a882a7db7899d606d6"
      ],
      "confidence": 0.85,
      "evidence": "multiple 5-HT receptor subtypes",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "DA function",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "30f8a86b00b9d3a882a7db7899d606d6"
      ],
      "confidence": 0.8,
      "evidence": "modulate DA function",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "mesolimbic DA neurons",
      "attributes": {
        "target_type": "neuron"
      },
      "source_chunk_ids": [
        "30f8a86b00b9d3a882a7db7899d606d6"
      ],
      "confidence": 0.9,
      "evidence": "mesolimbic DA neurons",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "ventral tegmental area",
      "attributes": {
        "target_type": "brain region"
      },
      "source_chunk_ids": [
        "30f8a86b00b9d3a882a7db7899d606d6"
      ],
      "confidence": 0.85,
      "evidence": "midbrain ventral tegmental area (VTA)",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "nucleus accumbens",
      "attributes": {
        "target_type": "brain region"
      },
      "source_chunk_ids": [
        "30f8a86b00b9d3a882a7db7899d606d6"
      ],
      "confidence": 0.9,
      "evidence": "nucleus accumbens",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "anti-stimulant effects",
      "attributes": {
        "level": "systemic",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "30f8a86b00b9d3a882a7db7899d606d6"
      ],
      "confidence": 0.8,
      "evidence": "anti-stimulant effects",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Effect",
      "name": "increases in extracellular 5-HT",
      "attributes": {
        "level": "molecular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "30f8a86b00b9d3a882a7db7899d606d6"
      ],
      "confidence": 0.85,
      "evidence": "increases in extracellular 5-HT",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Effect",
      "name": "stimulant and reinforcing properties",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "30f8a86b00b9d3a882a7db7899d606d6"
      ],
      "confidence": 0.8,
      "evidence": "stimulant and reinforcing properties",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Study",
      "name": "Muller and Huston, 2006",
      "attributes": {
        "year": 2006
      },
      "source_chunk_ids": [
        "30f8a86b00b9d3a882a7db7899d606d6"
      ],
      "confidence": 0.9,
      "evidence": "Muller and Huston, 2006",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Study",
      "name": "Alex and Pehek, 2007",
      "attributes": {
        "year": 2007
      },
      "source_chunk_ids": [
        "30f8a86b00b9d3a882a7db7899d606d6"
      ],
      "confidence": 0.9,
      "evidence": "Alex and Pehek, 2007",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Study",
      "name": "Ungerstedt, 1971",
      "attributes": {
        "year": 1971
      },
      "source_chunk_ids": [
        "30f8a86b00b9d3a882a7db7899d606d6"
      ],
      "confidence": 0.9,
      "evidence": "Ungerstedt, 1971",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Study",
      "name": "Moore and Bloom, 1978",
      "attributes": {
        "year": 1978
      },
      "source_chunk_ids": [
        "30f8a86b00b9d3a882a7db7899d606d6"
      ],
      "confidence": 0.9,
      "evidence": "Moore and Bloom, 1978",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Compound",
      "name": "FEN",
      "attributes": {},
      "source_chunk_ids": [
        "dda0363fded7427259efde81f7397182"
      ],
      "confidence": 0.9,
      "evidence": "FEN (0.3 mg/kg)",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Compound",
      "name": "PHEN",
      "attributes": {},
      "source_chunk_ids": [
        "dda0363fded7427259efde81f7397182"
      ],
      "confidence": 0.9,
      "evidence": "PHEN (3 mg/kg)",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Effect",
      "name": "conditioned place preference",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "dda0363fded7427259efde81f7397182"
      ],
      "confidence": 0.85,
      "evidence": "Condition Place Preference",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Effect",
      "name": "reduced conditioned place preference",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "dda0363fded7427259efde81f7397182"
      ],
      "confidence": 0.8,
      "evidence": "Eliminates PHEN-Induced Condition Place Preference",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Rea et al. (1998)",
      "attributes": {
        "year": 1998,
        "design": "animal study"
      },
      "source_chunk_ids": [
        "fe44678f93a1da57f462f122e8074785"
      ],
      "confidence": 0.9,
      "evidence": "Data taken with permission from Rea et al. (1998)",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "in vivo animal study",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "fe44678f93a1da57f462f122e8074785"
      ],
      "confidence": 0.85,
      "evidence": "conditioned place preference in rats",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Compound",
      "name": "phentermine",
      "attributes": {},
      "source_chunk_ids": [
        "fe44678f93a1da57f462f122e8074785"
      ],
      "confidence": 0.95,
      "evidence": "phentermine (3 mg/kg)",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Compound",
      "name": "fenfluramine",
      "attributes": {},
      "source_chunk_ids": [
        "fe44678f93a1da57f462f122e8074785"
      ],
      "confidence": 0.95,
      "evidence": "fenfluramine (0.3 mg/kg)",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Effect",
      "name": "conditioned place preference",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "fe44678f93a1da57f462f122e8074785"
      ],
      "confidence": 0.9,
      "evidence": "conditioned place preference",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Dosage",
      "name": "3 mg/kg phentermine i.p.",
      "attributes": {
        "amount": 3,
        "unit": "mg/kg",
        "route": "intraperitoneal"
      },
      "source_chunk_ids": [
        "fe44678f93a1da57f462f122e8074785"
      ],
      "confidence": 0.8,
      "evidence": "phentermine (3 mg/kg) administered i.p.",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Dosage",
      "name": "0.3 mg/kg fenfluramine i.p.",
      "attributes": {
        "amount": 0.3,
        "unit": "mg/kg",
        "route": "intraperitoneal"
      },
      "source_chunk_ids": [
        "fe44678f93a1da57f462f122e8074785"
      ],
      "confidence": 0.8,
      "evidence": "fenfluramine (0.3 mg/kg) administered i.p.",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "serotonergic modulation of DA function",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "a0fa87456a5129678532e4a425705ea5"
      ],
      "confidence": 0.8,
      "evidence": "serotonergic modulation of DA function",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "5-HT receptor subtypes",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "a0fa87456a5129678532e4a425705ea5"
      ],
      "confidence": 0.9,
      "evidence": "14 different 5-HT receptor subtypes",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Study",
      "name": "Barnes and Sharp, 1999",
      "attributes": {
        "year": 1999
      },
      "source_chunk_ids": [
        "a0fa87456a5129678532e4a425705ea5"
      ],
      "confidence": 0.7,
      "evidence": "Barnes and Sharp, 1999",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Study",
      "name": "Hoyer et al., 2002",
      "attributes": {
        "year": 2002
      },
      "source_chunk_ids": [
        "a0fa87456a5129678532e4a425705ea5"
      ],
      "confidence": 0.7,
      "evidence": "Hoyer et al., 2002",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "5-HT receptor subtypes",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "a69bc2330b04aecbcdf9901bd8dfa90f"
      ],
      "confidence": 0.9,
      "evidence": "5-HT receptor subtypes",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Effect",
      "name": "enhance DA transmission",
      "attributes": {
        "level": "molecular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "a69bc2330b04aecbcdf9901bd8dfa90f"
      ],
      "confidence": 0.85,
      "evidence": "enhance DA transmission",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "5-HT2C receptors",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "a69bc2330b04aecbcdf9901bd8dfa90f"
      ],
      "confidence": 0.95,
      "evidence": "5-HT2C receptors",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Effect",
      "name": "inhibitory influence on mesolimbic DA neurons",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "a69bc2330b04aecbcdf9901bd8dfa90f"
      ],
      "confidence": 0.9,
      "evidence": "strong inhibitory influence on mesolimbic DA neurons",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Compound",
      "name": "Ro 60-0175",
      "attributes": {},
      "source_chunk_ids": [
        "a69bc2330b04aecbcdf9901bd8dfa90f"
      ],
      "confidence": 0.95,
      "evidence": "5-HT2C agonist Ro 60-0175",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "inhibits DA cell firing in the VTA",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "a69bc2330b04aecbcdf9901bd8dfa90f"
      ],
      "confidence": 0.85,
      "evidence": "inhibits DA cell firing in the VTA",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Effect",
      "name": "decreases extracellular levels of DA in forebrain projection areas",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "a69bc2330b04aecbcdf9901bd8dfa90f"
      ],
      "confidence": 0.85,
      "evidence": "decreases extracellular levels of DA",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Effect",
      "name": "reduces locomotor activity",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "a69bc2330b04aecbcdf9901bd8dfa90f"
      ],
      "confidence": 0.8,
      "evidence": "reduces locomotor activity",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Effect",
      "name": "reduces self-administration behaviour produced by cocaine",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "a69bc2330b04aecbcdf9901bd8dfa90f"
      ],
      "confidence": 0.8,
      "evidence": "reduces self-administration behaviour",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Compound",
      "name": "SB 242084",
      "attributes": {},
      "source_chunk_ids": [
        "a69bc2330b04aecbcdf9901bd8dfa90f"
      ],
      "confidence": 0.95,
      "evidence": "5-HT2C antagonist SB 242084",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Effect",
      "name": "increases burst firing of DA cells in the VTA",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "a69bc2330b04aecbcdf9901bd8dfa90f"
      ],
      "confidence": 0.85,
      "evidence": "increases burst firing of DA cells",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Effect",
      "name": "tonic inhibition of mesolimbic DA activity",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "a69bc2330b04aecbcdf9901bd8dfa90f"
      ],
      "confidence": 0.8,
      "evidence": "tonic inhibition of mesolimbic DA activity",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "5-HT2C receptor",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "e1e383aea24e95b5ee4324e98eec7bed"
      ],
      "confidence": 0.95,
      "evidence": "5-HT2C receptor activation",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Effect",
      "name": "anti-stimulant effects",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "e1e383aea24e95b5ee4324e98eec7bed"
      ],
      "confidence": 0.9,
      "evidence": "anti-stimulant effects of 5-HT2C receptor activation",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "VTA",
      "attributes": {
        "target_type": "brain region"
      },
      "source_chunk_ids": [
        "e1e383aea24e95b5ee4324e98eec7bed"
      ],
      "confidence": 0.85,
      "evidence": "mechanism in the VTA",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "prefrontal cortex",
      "attributes": {
        "target_type": "brain region"
      },
      "source_chunk_ids": [
        "e1e383aea24e95b5ee4324e98eec7bed"
      ],
      "confidence": 0.85,
      "evidence": "mechanism in the prefrontal cortex",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Compound",
      "name": "Ro 60-0175",
      "attributes": {},
      "source_chunk_ids": [
        "e1e383aea24e95b5ee4324e98eec7bed"
      ],
      "confidence": 0.9,
      "evidence": "Microinjection of Ro 60-0175",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Condition",
      "name": "cocaine effects",
      "attributes": {
        "condition_type": "substance use disorder"
      },
      "source_chunk_ids": [
        "e1e383aea24e95b5ee4324e98eec7bed"
      ],
      "confidence": 0.8,
      "evidence": "blocks behavioural effects of cocaine",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Effect",
      "name": "reduced cocaine-induced locomotor activity",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "e1e383aea24e95b5ee4324e98eec7bed"
      ],
      "confidence": 0.85,
      "evidence": "reduces cocaine-induced locomotor activity",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Target",
      "name": "GABA interneurons",
      "attributes": {
        "target_type": "neuron"
      },
      "source_chunk_ids": [
        "e1e383aea24e95b5ee4324e98eec7bed"
      ],
      "confidence": 0.8,
      "evidence": "stimulation of gamma-aminobutyric acid (GABA) interneurons",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Condition",
      "name": "substance use disorders",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "e1e383aea24e95b5ee4324e98eec7bed"
      ],
      "confidence": 0.9,
      "evidence": "medications for substance use disorders",
      "verified": true
    },
    {
      "id": "E10",
      "type": "CompoundClass",
      "name": "5-HT2C agonists",
      "attributes": {},
      "source_chunk_ids": [
        "e1e383aea24e95b5ee4324e98eec7bed"
      ],
      "confidence": 0.85,
      "evidence": "5-HT2C agonists as medications",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Compound",
      "name": "5-HT-releasing agents",
      "attributes": {},
      "source_chunk_ids": [
        "8b7d40ddc4cc4e2888c61d47da508346"
      ],
      "confidence": 0.9,
      "evidence": "5-HT-releasing agents as medications",
      "verified": true
    },
    {
      "id": "E2",
      "type": "AdverseEvent",
      "name": "valvular heart disease",
      "attributes": {
        "severity": "serious"
      },
      "source_chunk_ids": [
        "8b7d40ddc4cc4e2888c61d47da508346"
      ],
      "confidence": 0.85,
      "evidence": "valvular heart disease (VHD)",
      "verified": true
    },
    {
      "id": "E3",
      "type": "AdverseEvent",
      "name": "idiopathic pulmonary arterial hypertension",
      "attributes": {
        "severity": "serious"
      },
      "source_chunk_ids": [
        "8b7d40ddc4cc4e2888c61d47da508346"
      ],
      "confidence": 0.85,
      "evidence": "idiopathic pulmonary arterial hypertension (IPAH)",
      "verified": true
    },
    {
      "id": "E4",
      "type": "AdverseEvent",
      "name": "neurotoxicity",
      "attributes": {
        "severity": "serious"
      },
      "source_chunk_ids": [
        "8b7d40ddc4cc4e2888c61d47da508346"
      ],
      "confidence": 0.85,
      "evidence": "neurotoxicity",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Compound",
      "name": "D,L-fenfluramine",
      "attributes": {},
      "source_chunk_ids": [
        "8b7d40ddc4cc4e2888c61d47da508346"
      ],
      "confidence": 0.9,
      "evidence": "D,L-fenfluramine",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Compound",
      "name": "D-fenfluramine",
      "attributes": {},
      "source_chunk_ids": [
        "8b7d40ddc4cc4e2888c61d47da508346"
      ],
      "confidence": 0.9,
      "evidence": "D-fenfluramine",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Study",
      "name": "Rothman et al., 1999",
      "attributes": {
        "year": 1999
      },
      "source_chunk_ids": [
        "8b7d40ddc4cc4e2888c61d47da508346"
      ],
      "confidence": 0.8,
      "evidence": "Rothman et al., 1999",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Study",
      "name": "Rothman and Baumann, 2002",
      "attributes": {
        "year": 2002
      },
      "source_chunk_ids": [
        "8b7d40ddc4cc4e2888c61d47da508346"
      ],
      "confidence": 0.8,
      "evidence": "Rothman and Baumann, 2002",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Study",
      "name": "Zolkowska et al., 2006",
      "attributes": {
        "year": 2006
      },
      "source_chunk_ids": [
        "8b7d40ddc4cc4e2888c61d47da508346"
      ],
      "confidence": 0.8,
      "evidence": "Zolkowska et al., 2006",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Study",
      "name": "Connolly et al., 1997",
      "attributes": {
        "year": 1997
      },
      "source_chunk_ids": [
        "8b7d40ddc4cc4e2888c61d47da508346"
      ],
      "confidence": 0.8,
      "evidence": "Connolly et al., 1997",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Study",
      "name": "Connolly and McGoon, 1999",
      "attributes": {
        "year": 1999
      },
      "source_chunk_ids": [
        "8b7d40ddc4cc4e2888c61d47da508346"
      ],
      "confidence": 0.8,
      "evidence": "Connolly and McGoon, 1999",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Condition",
      "name": "valvular heart disease",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "63f73732993d7879bd9747980f26d498"
      ],
      "confidence": 0.9,
      "evidence": "Fenfluramine-associated VHD",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Condition",
      "name": "valvular regurgitation",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "63f73732993d7879bd9747980f26d498"
      ],
      "confidence": 0.85,
      "evidence": "valvular regurgitation",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Compound",
      "name": "fenfluramine",
      "attributes": {},
      "source_chunk_ids": [
        "63f73732993d7879bd9747980f26d498"
      ],
      "confidence": 0.95,
      "evidence": "fenfluramine",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Study",
      "name": "Sachdev et al., 2002",
      "attributes": {
        "year": 2002,
        "design": "meta-analysis"
      },
      "source_chunk_ids": [
        "63f73732993d7879bd9747980f26d498"
      ],
      "confidence": 0.9,
      "evidence": "meta-analysis (Sachdev et al., 2002)",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Evidence",
      "name": "meta-analysis",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "63f73732993d7879bd9747980f26d498"
      ],
      "confidence": 0.85,
      "evidence": "meta-analysis of available clinical data",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Compound",
      "name": "fenfluramines",
      "attributes": {},
      "source_chunk_ids": [
        "ef72e701ef5380abc08469099508962a"
      ],
      "confidence": 0.95,
      "evidence": "fenfluramines are potent 5-HT releasers",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "5-HT",
      "attributes": {
        "target_type": "neurotransmitter"
      },
      "source_chunk_ids": [
        "ef72e701ef5380abc08469099508962a"
      ],
      "confidence": 0.9,
      "evidence": "5-HT has established mitogenic effects",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Condition",
      "name": "VHD",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "ef72e701ef5380abc08469099508962a"
      ],
      "confidence": 0.9,
      "evidence": "serotonergic mechanisms might contribute to VHD",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Study",
      "name": "Rothman et al., 2000a",
      "attributes": {
        "year": 2000,
        "design": "investigation"
      },
      "source_chunk_ids": [
        "ef72e701ef5380abc08469099508962a"
      ],
      "confidence": 0.85,
      "evidence": "we carried out an investigation (Rothman et al., 2000a)",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Evidence",
      "name": "in vitro investigation",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "ef72e701ef5380abc08469099508962a"
      ],
      "confidence": 0.8,
      "evidence": "investigation to determine",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Compound",
      "name": "norfenfluramine",
      "attributes": {},
      "source_chunk_ids": [
        "ef72e701ef5380abc08469099508962a"
      ],
      "confidence": 0.9,
      "evidence": "N-dealkylated metabolite norfenfluramine",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Target",
      "name": "mitogenic 5-HT receptors",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "ef72e701ef5380abc08469099508962a"
      ],
      "confidence": 0.85,
      "evidence": "activate mitogenic 5-HT receptors",
      "verified": true
    },
    {
      "id": "E8",
      "type": "CompoundClass",
      "name": "ergot alkaloids",
      "attributes": {},
      "source_chunk_ids": [
        "ef72e701ef5380abc08469099508962a"
      ],
      "confidence": 0.9,
      "evidence": "ergot alkaloids known to increase the risk of VHD",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Compound",
      "name": "methysergide",
      "attributes": {},
      "source_chunk_ids": [
        "ef72e701ef5380abc08469099508962a"
      ],
      "confidence": 0.85,
      "evidence": "methysergide",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Compound",
      "name": "methylergonovine",
      "attributes": {},
      "source_chunk_ids": [
        "ef72e701ef5380abc08469099508962a"
      ],
      "confidence": 0.85,
      "evidence": "methylergonovine",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Compound",
      "name": "ergotamine",
      "attributes": {},
      "source_chunk_ids": [
        "ef72e701ef5380abc08469099508962a"
      ],
      "confidence": 0.85,
      "evidence": "ergotamine",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Compound",
      "name": "phentermine",
      "attributes": {},
      "source_chunk_ids": [
        "ef72e701ef5380abc08469099508962a"
      ],
      "confidence": 0.85,
      "evidence": "phentermine",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Compound",
      "name": "fluoxetine",
      "attributes": {},
      "source_chunk_ids": [
        "ef72e701ef5380abc08469099508962a"
      ],
      "confidence": 0.85,
      "evidence": "fluoxetine",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Compound",
      "name": "norfluoxetine",
      "attributes": {},
      "source_chunk_ids": [
        "ef72e701ef5380abc08469099508962a"
      ],
      "confidence": 0.85,
      "evidence": "norfluoxetine",
      "verified": true
    },
    {
      "id": "E15",
      "type": "Compound",
      "name": "trazodone",
      "attributes": {},
      "source_chunk_ids": [
        "ef72e701ef5380abc08469099508962a"
      ],
      "confidence": 0.85,
      "evidence": "trazodone",
      "verified": true
    },
    {
      "id": "E16",
      "type": "Compound",
      "name": "m-chlorophenylpiperazine",
      "attributes": {},
      "source_chunk_ids": [
        "ef72e701ef5380abc08469099508962a"
      ],
      "confidence": 0.85,
      "evidence": "m-chlorophenylpiperazine (mCPP)",
      "verified": true
    },
    {
      "id": "E17",
      "type": "Target",
      "name": "monoamine transporters",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "ef72e701ef5380abc08469099508962a"
      ],
      "confidence": 0.8,
      "evidence": "interacted with monoamine transporters",
      "verified": true
    },
    {
      "id": "E18",
      "type": "Effect",
      "name": "mitogenic effects",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "ef72e701ef5380abc08469099508962a"
      ],
      "confidence": 0.85,
      "evidence": "5-HT has established mitogenic effects",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Rothman et al., 2000a",
      "attributes": {
        "year": 2000,
        "design": "receptorome screen"
      },
      "source_chunk_ids": [
        "908c62c00afe99358ce80f4bdc6cea78"
      ],
      "confidence": 0.9,
      "evidence": "Rothman et al., 2000a",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "in vitro binding and functional assay",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "908c62c00afe99358ce80f4bdc6cea78"
      ],
      "confidence": 0.85,
      "evidence": "receptorome screen, binding data, functional effects",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "5-HT2A receptor",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "908c62c00afe99358ce80f4bdc6cea78"
      ],
      "confidence": 0.8,
      "evidence": "5-HT2A receptors",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "5-HT2B receptor",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "908c62c00afe99358ce80f4bdc6cea78"
      ],
      "confidence": 0.8,
      "evidence": "5-HT2B receptors",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "5-HT2C receptor",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "908c62c00afe99358ce80f4bdc6cea78"
      ],
      "confidence": 0.8,
      "evidence": "5-HT2C receptors",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Compound",
      "name": "fenfluramines",
      "attributes": {},
      "source_chunk_ids": [
        "00602f763f19f9b012d9d9621e8da917"
      ],
      "confidence": 0.95,
      "evidence": "fenfluramines have low affinity",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "5-HT2 receptor subtypes",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "00602f763f19f9b012d9d9621e8da917"
      ],
      "confidence": 0.9,
      "evidence": "5-HT2 receptor subtypes",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Compound",
      "name": "norfenfluramines",
      "attributes": {},
      "source_chunk_ids": [
        "00602f763f19f9b012d9d9621e8da917"
      ],
      "confidence": 0.95,
      "evidence": "norfenfluramines displayed high affinity",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "5-HT2B receptor subtype",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "00602f763f19f9b012d9d9621e8da917"
      ],
      "confidence": 0.9,
      "evidence": "5-HT2B receptor subtype",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Study",
      "name": "Porter et al., 1999; Fitzgerald et al., 2000",
      "attributes": {
        "year": "1999-2000"
      },
      "source_chunk_ids": [
        "00602f763f19f9b012d9d9621e8da917"
      ],
      "confidence": 0.8,
      "evidence": "Porter et al., 1999; Fitzgerald et al., 2000",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Evidence",
      "name": "in vitro",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "00602f763f19f9b012d9d9621e8da917"
      ],
      "confidence": 0.7,
      "evidence": "consistent with the findings",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Compound",
      "name": "Fenfluramine",
      "attributes": {},
      "source_chunk_ids": [
        "f14b7a7d39bde0fee233a8eb74658b93"
      ],
      "confidence": 0.9,
      "evidence": "(\u00b1)-Fenfluramine",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Compound",
      "name": "Norfenfluramine",
      "attributes": {},
      "source_chunk_ids": [
        "f14b7a7d39bde0fee233a8eb74658b93"
      ],
      "confidence": 0.9,
      "evidence": "(+)-Norfenfluramine",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Compound",
      "name": "Ergotamine",
      "attributes": {},
      "source_chunk_ids": [
        "f14b7a7d39bde0fee233a8eb74658b93"
      ],
      "confidence": 0.9,
      "evidence": "Ergotamine",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Compound",
      "name": "Methysergide",
      "attributes": {},
      "source_chunk_ids": [
        "f14b7a7d39bde0fee233a8eb74658b93"
      ],
      "confidence": 0.9,
      "evidence": "Methysergide",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Compound",
      "name": "Methylergonovine",
      "attributes": {},
      "source_chunk_ids": [
        "f14b7a7d39bde0fee233a8eb74658b93"
      ],
      "confidence": 0.9,
      "evidence": "Methylergonovine",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Compound",
      "name": "Fluoxetine",
      "attributes": {},
      "source_chunk_ids": [
        "f14b7a7d39bde0fee233a8eb74658b93"
      ],
      "confidence": 0.9,
      "evidence": "Fluoxetine",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Compound",
      "name": "Norfluoxetine",
      "attributes": {},
      "source_chunk_ids": [
        "f14b7a7d39bde0fee233a8eb74658b93"
      ],
      "confidence": 0.9,
      "evidence": "Norfluoxetine",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Compound",
      "name": "Trazodone",
      "attributes": {},
      "source_chunk_ids": [
        "f14b7a7d39bde0fee233a8eb74658b93"
      ],
      "confidence": 0.9,
      "evidence": "Trazodone",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Compound",
      "name": "mCPP",
      "attributes": {},
      "source_chunk_ids": [
        "f14b7a7d39bde0fee233a8eb74658b93"
      ],
      "confidence": 0.9,
      "evidence": "mCPP",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Compound",
      "name": "5-HT",
      "attributes": {},
      "source_chunk_ids": [
        "f14b7a7d39bde0fee233a8eb74658b93"
      ],
      "confidence": 0.9,
      "evidence": "5-HT",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Compound",
      "name": "Phentermine",
      "attributes": {},
      "source_chunk_ids": [
        "f14b7a7d39bde0fee233a8eb74658b93"
      ],
      "confidence": 0.9,
      "evidence": "Phentermine",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Target",
      "name": "5-HT2A",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "f14b7a7d39bde0fee233a8eb74658b93"
      ],
      "confidence": 0.95,
      "evidence": "Human 5-HT2A",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Target",
      "name": "5-HT2B",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "f14b7a7d39bde0fee233a8eb74658b93"
      ],
      "confidence": 0.95,
      "evidence": "Human 5-HT2B",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Target",
      "name": "5-HT2C",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "f14b7a7d39bde0fee233a8eb74658b93"
      ],
      "confidence": 0.95,
      "evidence": "Human 5-HT2C",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Compound",
      "name": "methysergide",
      "attributes": {},
      "source_chunk_ids": [
        "e7e5ebd39a62a7cfd1fea77fd20e9ced"
      ],
      "confidence": 0.95,
      "evidence": "Methysergide acts as a partial agonist",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "5-HT2B receptor",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "e7e5ebd39a62a7cfd1fea77fd20e9ced"
      ],
      "confidence": 0.95,
      "evidence": "5-HT2B receptor",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Compound",
      "name": "methylergonovine",
      "attributes": {},
      "source_chunk_ids": [
        "e7e5ebd39a62a7cfd1fea77fd20e9ced"
      ],
      "confidence": 0.9,
      "evidence": "metabolite methylergonovine",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Compound",
      "name": "ergotamine",
      "attributes": {},
      "source_chunk_ids": [
        "e7e5ebd39a62a7cfd1fea77fd20e9ced"
      ],
      "confidence": 0.95,
      "evidence": "Ergotamine is a potent partial agonist",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Compound",
      "name": "mCPP",
      "attributes": {},
      "source_chunk_ids": [
        "e7e5ebd39a62a7cfd1fea77fd20e9ced"
      ],
      "confidence": 0.9,
      "evidence": "mCPP exhibits agonist activity",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Compound",
      "name": "trazodone",
      "attributes": {},
      "source_chunk_ids": [
        "e7e5ebd39a62a7cfd1fea77fd20e9ced"
      ],
      "confidence": 0.95,
      "evidence": "trazodone binds to the 5-HT2B receptor",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Study",
      "name": "Ishida et al., 1995",
      "attributes": {
        "year": 1995
      },
      "source_chunk_ids": [
        "e7e5ebd39a62a7cfd1fea77fd20e9ced"
      ],
      "confidence": 0.8,
      "evidence": "Ishida et al., 1995",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Study",
      "name": "Otani et al., 1997",
      "attributes": {
        "year": 1997
      },
      "source_chunk_ids": [
        "e7e5ebd39a62a7cfd1fea77fd20e9ced"
      ],
      "confidence": 0.8,
      "evidence": "Otani et al., 1997",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "5-HT2B receptor",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "73a3c3857f5a509736a2bc86f69fbc90"
      ],
      "confidence": 0.95,
      "evidence": "5-HT2B receptor",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Condition",
      "name": "drug-induced VHD",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "73a3c3857f5a509736a2bc86f69fbc90"
      ],
      "confidence": 0.9,
      "evidence": "drug-induced VHD",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Study",
      "name": "Porter et al., 1999",
      "attributes": {
        "year": 1999
      },
      "source_chunk_ids": [
        "73a3c3857f5a509736a2bc86f69fbc90"
      ],
      "confidence": 0.8,
      "evidence": "Porter et al., 1999",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Study",
      "name": "Fitzgerald et al., 2000",
      "attributes": {
        "year": 2000
      },
      "source_chunk_ids": [
        "73a3c3857f5a509736a2bc86f69fbc90"
      ],
      "confidence": 0.8,
      "evidence": "Fitzgerald et al., 2000",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Study",
      "name": "Setola and Roth, 2005",
      "attributes": {
        "year": 2005
      },
      "source_chunk_ids": [
        "73a3c3857f5a509736a2bc86f69fbc90"
      ],
      "confidence": 0.8,
      "evidence": "Setola and Roth, 2005",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Study",
      "name": "Roth, 2007",
      "attributes": {
        "year": 2007
      },
      "source_chunk_ids": [
        "73a3c3857f5a509736a2bc86f69fbc90"
      ],
      "confidence": 0.8,
      "evidence": "Roth, 2007",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Study",
      "name": "Lopez-Illasaca, 1998",
      "attributes": {
        "year": 1998
      },
      "source_chunk_ids": [
        "73a3c3857f5a509736a2bc86f69fbc90"
      ],
      "confidence": 0.8,
      "evidence": "Lopez-Illasaca, 1998",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Study",
      "name": "Hafizi et al., 2000",
      "attributes": {
        "year": 2000
      },
      "source_chunk_ids": [
        "73a3c3857f5a509736a2bc86f69fbc90"
      ],
      "confidence": 0.8,
      "evidence": "Hafizi et al., 2000",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Compound",
      "name": "cabergoline",
      "attributes": {},
      "source_chunk_ids": [
        "73a3c3857f5a509736a2bc86f69fbc90"
      ],
      "confidence": 0.9,
      "evidence": "cabergoline",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Compound",
      "name": "pergolide",
      "attributes": {},
      "source_chunk_ids": [
        "73a3c3857f5a509736a2bc86f69fbc90"
      ],
      "confidence": 0.9,
      "evidence": "pergolide",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Study",
      "name": "Setola et al., 2003",
      "attributes": {
        "year": 2003
      },
      "source_chunk_ids": [
        "73a3c3857f5a509736a2bc86f69fbc90"
      ],
      "confidence": 0.8,
      "evidence": "Setola et al., 2003",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Compound",
      "name": "MDMA",
      "attributes": {},
      "source_chunk_ids": [
        "73a3c3857f5a509736a2bc86f69fbc90"
      ],
      "confidence": 0.9,
      "evidence": "MDMA",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Compound",
      "name": "MDA",
      "attributes": {},
      "source_chunk_ids": [
        "73a3c3857f5a509736a2bc86f69fbc90"
      ],
      "confidence": 0.9,
      "evidence": "MDA",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Effect",
      "name": "mitogenesis",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "73a3c3857f5a509736a2bc86f69fbc90"
      ],
      "confidence": 0.85,
      "evidence": "stimulate mitogenesis",
      "verified": true
    },
    {
      "id": "E15",
      "type": "Effect",
      "name": "prolonged mitogenic responses",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "73a3c3857f5a509736a2bc86f69fbc90"
      ],
      "confidence": 0.85,
      "evidence": "stimulate prolonged mitogenic responses",
      "verified": true
    },
    {
      "id": "E16",
      "type": "Study",
      "name": "Droogmans et al., 2007",
      "attributes": {
        "year": 2007
      },
      "source_chunk_ids": [
        "73a3c3857f5a509736a2bc86f69fbc90"
      ],
      "confidence": 0.8,
      "evidence": "Droogmans et al., 2007",
      "verified": true
    },
    {
      "id": "E17",
      "type": "Condition",
      "name": "valvular regurgitation",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "73a3c3857f5a509736a2bc86f69fbc90"
      ],
      "confidence": 0.9,
      "evidence": "valvular regurgitation",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Evidence",
      "name": "epidemiological evidence",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "d6abe988e1c0db745b99f54e543713ef"
      ],
      "confidence": 0.9,
      "evidence": "Epidemiological evidence indicates",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Compound",
      "name": "fenfluramines",
      "attributes": {},
      "source_chunk_ids": [
        "d6abe988e1c0db745b99f54e543713ef"
      ],
      "confidence": 0.95,
      "evidence": "fenfluramines",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Condition",
      "name": "IPAH",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "d6abe988e1c0db745b99f54e543713ef"
      ],
      "confidence": 0.95,
      "evidence": "IPAH, a debilitating and incurable disease",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Study",
      "name": "Abenhaim et al., 1996",
      "attributes": {
        "year": 1996
      },
      "source_chunk_ids": [
        "d6abe988e1c0db745b99f54e543713ef"
      ],
      "confidence": 0.8,
      "evidence": "Abenhaim et al., 1996",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Study",
      "name": "Fishman, 1999",
      "attributes": {
        "year": 1999
      },
      "source_chunk_ids": [
        "d6abe988e1c0db745b99f54e543713ef"
      ],
      "confidence": 0.8,
      "evidence": "Fishman, 1999",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Condition",
      "name": "IPAH",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "b261139371bea9fdf729ebdbad57e2f5"
      ],
      "confidence": 0.95,
      "evidence": "IPAH",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "5-HT",
      "attributes": {
        "target_type": "neurotransmitter"
      },
      "source_chunk_ids": [
        "b261139371bea9fdf729ebdbad57e2f5"
      ],
      "confidence": 0.9,
      "evidence": "5-HT",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "SERT",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "b261139371bea9fdf729ebdbad57e2f5"
      ],
      "confidence": 0.9,
      "evidence": "SERT proteins",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Study",
      "name": "Rothman et al., 1999",
      "attributes": {
        "year": 1999
      },
      "source_chunk_ids": [
        "b261139371bea9fdf729ebdbad57e2f5"
      ],
      "confidence": 0.85,
      "evidence": "Rothman et al., 1999",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Study",
      "name": "MacLean et al., 2000",
      "attributes": {
        "year": 2000
      },
      "source_chunk_ids": [
        "b261139371bea9fdf729ebdbad57e2f5"
      ],
      "confidence": 0.85,
      "evidence": "MacLean et al., 2000",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Study",
      "name": "Eddahibi et al., 2006",
      "attributes": {
        "year": 2006
      },
      "source_chunk_ids": [
        "b261139371bea9fdf729ebdbad57e2f5"
      ],
      "confidence": 0.85,
      "evidence": "Eddahibi et al., 2006",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Evidence",
      "name": "laboratory evidence",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "b261139371bea9fdf729ebdbad57e2f5"
      ],
      "confidence": 0.8,
      "evidence": "evidence from our laboratory",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Effect",
      "name": "pulmonary arterial vasoconstriction",
      "attributes": {
        "level": "systemic",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "b261139371bea9fdf729ebdbad57e2f5"
      ],
      "confidence": 0.85,
      "evidence": "pulmonary arterial vasoconstriction",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Effect",
      "name": "hyperplasia",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "b261139371bea9fdf729ebdbad57e2f5"
      ],
      "confidence": 0.85,
      "evidence": "hyperplasia",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Effect",
      "name": "severe hypertension",
      "attributes": {
        "level": "systemic",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "b261139371bea9fdf729ebdbad57e2f5"
      ],
      "confidence": 0.85,
      "evidence": "severe hypertension",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Effect",
      "name": "elevating plasma levels of 5-HT",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "b261139371bea9fdf729ebdbad57e2f5"
      ],
      "confidence": 0.8,
      "evidence": "elevating plasma levels of 5-HT",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Effect",
      "name": "pulmonary dysfunction",
      "attributes": {
        "level": "systemic",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "b261139371bea9fdf729ebdbad57e2f5"
      ],
      "confidence": 0.8,
      "evidence": "pulmonary dysfunction",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Target",
      "name": "5-HT2B receptors",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "b261139371bea9fdf729ebdbad57e2f5"
      ],
      "confidence": 0.85,
      "evidence": "5-HT2B receptors",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Condition",
      "name": "VHD",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "b261139371bea9fdf729ebdbad57e2f5"
      ],
      "confidence": 0.85,
      "evidence": "VHD",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "5-HT hypothesis",
      "attributes": {
        "target_type": "hypothesis"
      },
      "source_chunk_ids": [
        "47b27b75859f62166fd179ee3c1d231f"
      ],
      "confidence": 0.9,
      "evidence": "A key prediction of the 5-HT hypothesis",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Compound",
      "name": "fenfluramine",
      "attributes": {},
      "source_chunk_ids": [
        "47b27b75859f62166fd179ee3c1d231f"
      ],
      "confidence": 0.95,
      "evidence": "fenfluramine increases plasma 5-HT",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Effect",
      "name": "vasoconstriction",
      "attributes": {
        "level": "systemic",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "47b27b75859f62166fd179ee3c1d231f"
      ],
      "confidence": 0.85,
      "evidence": "produce vasoconstriction",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Effect",
      "name": "mitogenesis",
      "attributes": {
        "level": "cellular",
        "valence": "neutral"
      },
      "source_chunk_ids": [
        "47b27b75859f62166fd179ee3c1d231f"
      ],
      "confidence": 0.85,
      "evidence": "produce ... mitogenesis",
      "verified": true
    },
    {
      "id": "E5",
      "type": "AdverseEvent",
      "name": "serious side effects",
      "attributes": {
        "severity": "serious"
      },
      "source_chunk_ids": [
        "47b27b75859f62166fd179ee3c1d231f"
      ],
      "confidence": 0.8,
      "evidence": "leads to serious side effects",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Condition",
      "name": "IPAH",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "47b27b75859f62166fd179ee3c1d231f"
      ],
      "confidence": 0.75,
      "evidence": "fenfluramine-associated IPAH",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Study",
      "name": "Martin and Artigas, 1992",
      "attributes": {
        "year": 1992
      },
      "source_chunk_ids": [
        "47b27b75859f62166fd179ee3c1d231f"
      ],
      "confidence": 0.8,
      "evidence": "Martin and Artigas, 1992",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Study",
      "name": "Rothman et al., 2000b",
      "attributes": {
        "year": 2000
      },
      "source_chunk_ids": [
        "47b27b75859f62166fd179ee3c1d231f"
      ],
      "confidence": 0.8,
      "evidence": "Rothman et al., 2000b",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Evidence",
      "name": "in vitro/in vivo studies",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "47b27b75859f62166fd179ee3c1d231f"
      ],
      "confidence": 0.7,
      "evidence": "Studies conducted in the 1990s",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Compound",
      "name": "amphetamines",
      "attributes": {},
      "source_chunk_ids": [
        "47b27b75859f62166fd179ee3c1d231f"
      ],
      "confidence": 0.8,
      "evidence": "other amphetamines",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Zolkowska et al., 2006",
      "attributes": {
        "year": 2006
      },
      "source_chunk_ids": [
        "3a483a860877ea40e62005015647f8af"
      ],
      "confidence": 0.9,
      "evidence": "Zolkowska et al., 2006",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "in vivo microdialysis",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "3a483a860877ea40e62005015647f8af"
      ],
      "confidence": 0.8,
      "evidence": "microdialysis method in rats",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "SERT",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "3a483a860877ea40e62005015647f8af"
      ],
      "confidence": 0.85,
      "evidence": "SERT-mediated 5-HT release",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Effect",
      "name": "increase in plasma 5-HT",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "3a483a860877ea40e62005015647f8af"
      ],
      "confidence": 0.9,
      "evidence": "evokes transient dose-dependent increases in plasma 5-HT",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Compound",
      "name": "fenfluramine",
      "attributes": {},
      "source_chunk_ids": [
        "3a483a860877ea40e62005015647f8af"
      ],
      "confidence": 0.95,
      "evidence": "fenfluramine",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Compound",
      "name": "MDMA",
      "attributes": {},
      "source_chunk_ids": [
        "3a483a860877ea40e62005015647f8af"
      ],
      "confidence": 0.95,
      "evidence": "MDMA",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Compound",
      "name": "amphetamines",
      "attributes": {},
      "source_chunk_ids": [
        "3a483a860877ea40e62005015647f8af"
      ],
      "confidence": 0.8,
      "evidence": "other amphetamines",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Study",
      "name": "Herve et al., 1995",
      "attributes": {
        "year": 1995
      },
      "source_chunk_ids": [
        "3a483a860877ea40e62005015647f8af"
      ],
      "confidence": 0.9,
      "evidence": "Herve et al., 1995",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Study",
      "name": "Cortijo et al., 1997",
      "attributes": {
        "year": 1997
      },
      "source_chunk_ids": [
        "3a483a860877ea40e62005015647f8af"
      ],
      "confidence": 0.9,
      "evidence": "Cortijo et al., 1997",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Study",
      "name": "Eddahibi et al., 1999",
      "attributes": {
        "year": 1999
      },
      "source_chunk_ids": [
        "3a483a860877ea40e62005015647f8af"
      ],
      "confidence": 0.9,
      "evidence": "Eddahibi et al., 1999",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Zolkowska et al., 2008",
      "attributes": {
        "year": 2008
      },
      "source_chunk_ids": [
        "523066717b7900f68422629f96941825"
      ],
      "confidence": 0.9,
      "evidence": "Zolkowska et al., 2008",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "in vivo animal study",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "523066717b7900f68422629f96941825"
      ],
      "confidence": 0.85,
      "evidence": "chronic administration in rats",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Compound",
      "name": "fenfluramine",
      "attributes": {},
      "source_chunk_ids": [
        "523066717b7900f68422629f96941825"
      ],
      "confidence": 0.95,
      "evidence": "fenfluramine",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Compound",
      "name": "fluoxetine",
      "attributes": {},
      "source_chunk_ids": [
        "523066717b7900f68422629f96941825"
      ],
      "confidence": 0.95,
      "evidence": "fluoxetine",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "5-HT uptake",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "523066717b7900f68422629f96941825"
      ],
      "confidence": 0.8,
      "evidence": "5-HT uptake blocker",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "increased plasma 5-HT levels",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "523066717b7900f68422629f96941825"
      ],
      "confidence": 0.85,
      "evidence": "increases in baseline dialysate 5-HT levels",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Effect",
      "name": "reduced ability to increase plasma 5-HT",
      "attributes": {
        "level": "systemic",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "523066717b7900f68422629f96941825"
      ],
      "confidence": 0.8,
      "evidence": "reduces the ability of acute fenfluramine to evoke increases",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Dosage",
      "name": "10 mg/kg/day fenfluramine",
      "attributes": {
        "amount": 10,
        "unit": "mg/kg/day",
        "route": "oral"
      },
      "source_chunk_ids": [
        "523066717b7900f68422629f96941825"
      ],
      "confidence": 0.9,
      "evidence": "10 mg/kg/day",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Dosage",
      "name": "3 and 10 mg/kg/day fluoxetine",
      "attributes": {
        "amount": [
          3,
          10
        ],
        "unit": "mg/kg/day",
        "route": "oral"
      },
      "source_chunk_ids": [
        "523066717b7900f68422629f96941825"
      ],
      "confidence": 0.85,
      "evidence": "3 and 10 mg/kg/day",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Compound",
      "name": "5-HT",
      "attributes": {},
      "source_chunk_ids": [
        "59ee8d14482b70f5dcf3613901e017c8"
      ],
      "confidence": 0.95,
      "evidence": "5-HT provokes contraction",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Effect",
      "name": "contraction of human pulmonary arteries",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "59ee8d14482b70f5dcf3613901e017c8"
      ],
      "confidence": 0.9,
      "evidence": "provokes contraction of human pulmonary arteries",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Study",
      "name": "Cortijo et al., 1997",
      "attributes": {
        "year": 1997
      },
      "source_chunk_ids": [
        "59ee8d14482b70f5dcf3613901e017c8"
      ],
      "confidence": 0.85,
      "evidence": "Cortijo et al., 1997",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Evidence",
      "name": "in vitro",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "59ee8d14482b70f5dcf3613901e017c8"
      ],
      "confidence": 0.8,
      "evidence": "cultured human pulmonary artery smooth muscle",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Effect",
      "name": "mitogenic responses in cultured human pulmonary artery smooth muscle",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "59ee8d14482b70f5dcf3613901e017c8"
      ],
      "confidence": 0.85,
      "evidence": "stimulate mitogenic responses in cultured human pulmonary artery smooth muscle",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Figure 5 study",
      "attributes": {
        "design": "experimental study"
      },
      "source_chunk_ids": [
        "c928538e18a396a0ebc422b75851d71c"
      ],
      "confidence": 0.8,
      "evidence": "Figure 5: Effects of acute fenfluramine administration",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "in vivo experimental evidence",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "c928538e18a396a0ebc422b75851d71c"
      ],
      "confidence": 0.75,
      "evidence": "dialysate 5-HT levels",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Compound",
      "name": "fenfluramine",
      "attributes": {},
      "source_chunk_ids": [
        "c928538e18a396a0ebc422b75851d71c"
      ],
      "confidence": 0.9,
      "evidence": "fenfluramine",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Compound",
      "name": "fluoxetine",
      "attributes": {},
      "source_chunk_ids": [
        "c928538e18a396a0ebc422b75851d71c"
      ],
      "confidence": 0.9,
      "evidence": "fluoxetine",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "5-HT levels",
      "attributes": {
        "target_type": "neurotransmitter level"
      },
      "source_chunk_ids": [
        "c928538e18a396a0ebc422b75851d71c"
      ],
      "confidence": 0.85,
      "evidence": "dialysate 5-HT levels",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "increased 5-HT levels",
      "attributes": {
        "level": "molecular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "c928538e18a396a0ebc422b75851d71c"
      ],
      "confidence": 0.7,
      "evidence": "Effects of acute fenfluramine administration",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Dosage",
      "name": "3 mg/kg/day",
      "attributes": {
        "amount": 3,
        "unit": "mg/kg/day",
        "route": "administration"
      },
      "source_chunk_ids": [
        "c928538e18a396a0ebc422b75851d71c"
      ],
      "confidence": 0.8,
      "evidence": "3 mg/kg/day",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Dosage",
      "name": "10 mg/kg/day",
      "attributes": {
        "amount": 10,
        "unit": "mg/kg/day",
        "route": "administration"
      },
      "source_chunk_ids": [
        "c928538e18a396a0ebc422b75851d71c"
      ],
      "confidence": 0.8,
      "evidence": "10 mg/kg/day",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Zolkowska et al. (2008)",
      "attributes": {
        "year": 2008,
        "design": "animal study"
      },
      "source_chunk_ids": [
        "da57a52ca3729884f5cb4c5c4779fdcd"
      ],
      "confidence": 0.9,
      "evidence": "Data taken with permission from Zolkowska et al. (2008)",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "in vivo animal study",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "da57a52ca3729884f5cb4c5c4779fdcd"
      ],
      "confidence": 0.85,
      "evidence": "measured in blood from conscious rats",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Compound",
      "name": "fenfluramine",
      "attributes": {},
      "source_chunk_ids": [
        "da57a52ca3729884f5cb4c5c4779fdcd"
      ],
      "confidence": 0.95,
      "evidence": "fenfluramine administration",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Compound",
      "name": "fluoxetine",
      "attributes": {},
      "source_chunk_ids": [
        "da57a52ca3729884f5cb4c5c4779fdcd"
      ],
      "confidence": 0.95,
      "evidence": "fluoxetine (Panel B)",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "5-HT levels",
      "attributes": {
        "target_type": "biomarker"
      },
      "source_chunk_ids": [
        "da57a52ca3729884f5cb4c5c4779fdcd"
      ],
      "confidence": 0.8,
      "evidence": "dialysate 5-HT levels",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "increased 5-HT levels",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "da57a52ca3729884f5cb4c5c4779fdcd"
      ],
      "confidence": 0.7,
      "evidence": "Effects of acute fenfluramine administration",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Dosage",
      "name": "chronic administration via osmotic minipumps for 2 weeks",
      "attributes": {
        "duration": "2 weeks",
        "route": "subcutaneous"
      },
      "source_chunk_ids": [
        "da57a52ca3729884f5cb4c5c4779fdcd"
      ],
      "confidence": 0.75,
      "evidence": "administered s.c. via osmotic minipumps for 2 weeks",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Dosage",
      "name": "acute i.v. administration at 0 min",
      "attributes": {
        "route": "intravenous"
      },
      "source_chunk_ids": [
        "da57a52ca3729884f5cb4c5c4779fdcd"
      ],
      "confidence": 0.75,
      "evidence": "administered i.v. at 0 min",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Compound",
      "name": "5-HT",
      "attributes": {},
      "source_chunk_ids": [
        "175ac8e246ed2c19193e9fb3f3b1f4f7"
      ],
      "confidence": 0.95,
      "evidence": "plasma 5-HT",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "rat pulmonary artery smooth muscle cells",
      "attributes": {
        "target_type": "cellular"
      },
      "source_chunk_ids": [
        "175ac8e246ed2c19193e9fb3f3b1f4f7"
      ],
      "confidence": 0.85,
      "evidence": "rat pulmonary artery smooth muscle cells",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Effect",
      "name": "mitogenic responses",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "175ac8e246ed2c19193e9fb3f3b1f4f7"
      ],
      "confidence": 0.8,
      "evidence": "stimulate mitogenic responses",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Condition",
      "name": "pulmonary side effects",
      "attributes": {
        "condition_type": "adverse"
      },
      "source_chunk_ids": [
        "175ac8e246ed2c19193e9fb3f3b1f4f7"
      ],
      "confidence": 0.75,
      "evidence": "cause pulmonary side effects",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Condition",
      "name": "VHD",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "175ac8e246ed2c19193e9fb3f3b1f4f7"
      ],
      "confidence": 0.9,
      "evidence": "produce VHD",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Condition",
      "name": "IPAH",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "175ac8e246ed2c19193e9fb3f3b1f4f7"
      ],
      "confidence": 0.9,
      "evidence": "fenfluramine-associated IPAH",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Compound",
      "name": "fenfluramine",
      "attributes": {},
      "source_chunk_ids": [
        "175ac8e246ed2c19193e9fb3f3b1f4f7"
      ],
      "confidence": 0.95,
      "evidence": "fenfluramine",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Compound",
      "name": "lithium",
      "attributes": {},
      "source_chunk_ids": [
        "175ac8e246ed2c19193e9fb3f3b1f4f7"
      ],
      "confidence": 0.8,
      "evidence": "treatment with lithium",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Target",
      "name": "MAO inhibitors",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "175ac8e246ed2c19193e9fb3f3b1f4f7"
      ],
      "confidence": 0.8,
      "evidence": "MAO inhibitors",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Condition",
      "name": "fenfluramine-associated IPAH",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "8d0f8dcb51d6846a717565bc65c4e7cd"
      ],
      "confidence": 0.95,
      "evidence": "fenfluramine-associated IPAH",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Condition",
      "name": "non-drug-related IPAH",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "8d0f8dcb51d6846a717565bc65c4e7cd"
      ],
      "confidence": 0.9,
      "evidence": "non-drug-related IPAH",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Study",
      "name": "Launay et al., 2002",
      "attributes": {
        "year": 2002
      },
      "source_chunk_ids": [
        "8d0f8dcb51d6846a717565bc65c4e7cd"
      ],
      "confidence": 0.85,
      "evidence": "Launay et al., 2002",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Evidence",
      "name": "in vivo study",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "8d0f8dcb51d6846a717565bc65c4e7cd"
      ],
      "confidence": 0.8,
      "evidence": "hypoxic mouse model",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "5-HT2B receptors",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "8d0f8dcb51d6846a717565bc65c4e7cd"
      ],
      "confidence": 0.95,
      "evidence": "5-HT2B receptors",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Study",
      "name": "Rothman et al., 2000a",
      "attributes": {
        "year": 2000
      },
      "source_chunk_ids": [
        "8d0f8dcb51d6846a717565bc65c4e7cd"
      ],
      "confidence": 0.85,
      "evidence": "Rothman et al., 2000a",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Compound",
      "name": "norfenfluramine stereoisomers",
      "attributes": {},
      "source_chunk_ids": [
        "8d0f8dcb51d6846a717565bc65c4e7cd"
      ],
      "confidence": 0.9,
      "evidence": "stereoisomers of norfenfluramine",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Condition",
      "name": "VHD",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "8d0f8dcb51d6846a717565bc65c4e7cd"
      ],
      "confidence": 0.8,
      "evidence": "medications that produce VHD",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Compound",
      "name": "methysergide",
      "attributes": {},
      "source_chunk_ids": [
        "8d0f8dcb51d6846a717565bc65c4e7cd"
      ],
      "confidence": 0.85,
      "evidence": "methysergide",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Compound",
      "name": "ergotamine",
      "attributes": {},
      "source_chunk_ids": [
        "8d0f8dcb51d6846a717565bc65c4e7cd"
      ],
      "confidence": 0.85,
      "evidence": "ergotamine",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Compound",
      "name": "pergolide",
      "attributes": {},
      "source_chunk_ids": [
        "8d0f8dcb51d6846a717565bc65c4e7cd"
      ],
      "confidence": 0.85,
      "evidence": "pergolide",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Compound",
      "name": "cabergoline",
      "attributes": {},
      "source_chunk_ids": [
        "8d0f8dcb51d6846a717565bc65c4e7cd"
      ],
      "confidence": 0.85,
      "evidence": "cabergoline",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Rothman and Baumann, 2006",
      "attributes": {
        "year": 2006
      },
      "source_chunk_ids": [
        "772368d5086ff1bf833427f2648de55a"
      ],
      "confidence": 0.9,
      "evidence": "Rothman and Baumann, 2006",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "laboratory evidence",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "772368d5086ff1bf833427f2648de55a"
      ],
      "confidence": 0.8,
      "evidence": "evidence from our laboratory",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "5-HT2B receptor",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "772368d5086ff1bf833427f2648de55a"
      ],
      "confidence": 0.95,
      "evidence": "5-HT2B receptors",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Condition",
      "name": "IPAH",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "772368d5086ff1bf833427f2648de55a"
      ],
      "confidence": 0.9,
      "evidence": "IPAH",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Compound",
      "name": "aminorex",
      "attributes": {},
      "source_chunk_ids": [
        "772368d5086ff1bf833427f2648de55a"
      ],
      "confidence": 0.95,
      "evidence": "Aminorex",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Target",
      "name": "SERT",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "772368d5086ff1bf833427f2648de55a"
      ],
      "confidence": 0.9,
      "evidence": "SERT",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Study",
      "name": "Gurtner, 1985; Fishman, 1999",
      "attributes": {
        "year": "1985, 1999"
      },
      "source_chunk_ids": [
        "772368d5086ff1bf833427f2648de55a"
      ],
      "confidence": 0.85,
      "evidence": "Gurtner, 1985; Fishman, 1999",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Compound",
      "name": "4-methylaminorex",
      "attributes": {},
      "source_chunk_ids": [
        "772368d5086ff1bf833427f2648de55a"
      ],
      "confidence": 0.9,
      "evidence": "4-methylaminorex",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Study",
      "name": "Gaine et al., 2000",
      "attributes": {
        "year": 2000
      },
      "source_chunk_ids": [
        "772368d5086ff1bf833427f2648de55a"
      ],
      "confidence": 0.85,
      "evidence": "Gaine et al., 2000",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Target",
      "name": "NE release",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "772368d5086ff1bf833427f2648de55a"
      ],
      "confidence": 0.8,
      "evidence": "NE release",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Compound",
      "name": "D-norfenfluramine",
      "attributes": {},
      "source_chunk_ids": [
        "772368d5086ff1bf833427f2648de55a"
      ],
      "confidence": 0.9,
      "evidence": "D-norfenfluramine",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Eddahibi et al. (2006)",
      "attributes": {
        "year": 2006
      },
      "source_chunk_ids": [
        "6041a61fba27d3ca51f85f315f4d3b9a"
      ],
      "confidence": 0.95,
      "evidence": "Eddahibi et al. (2006)",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "immunohistochemical study",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "6041a61fba27d3ca51f85f315f4d3b9a"
      ],
      "confidence": 0.8,
      "evidence": "Immunohistochemical studies show",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "5-HT",
      "attributes": {
        "target_type": "neurotransmitter"
      },
      "source_chunk_ids": [
        "6041a61fba27d3ca51f85f315f4d3b9a"
      ],
      "confidence": 0.9,
      "evidence": "5-HT produced locally in the lung",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "SERT",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "6041a61fba27d3ca51f85f315f4d3b9a"
      ],
      "confidence": 0.9,
      "evidence": "over-expression of SERT",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Condition",
      "name": "IPAH",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "6041a61fba27d3ca51f85f315f4d3b9a"
      ],
      "confidence": 0.95,
      "evidence": "pathogenesis of IPAH",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "hyperplasia",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "6041a61fba27d3ca51f85f315f4d3b9a"
      ],
      "confidence": 0.85,
      "evidence": "hyperplasia observed in IPAH",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Compound",
      "name": "fenfluramine",
      "attributes": {},
      "source_chunk_ids": [
        "6041a61fba27d3ca51f85f315f4d3b9a"
      ],
      "confidence": 0.9,
      "evidence": "fenfluramine cannot release 5-HT",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Compound",
      "name": "L-5-hydroxytryptophan",
      "attributes": {},
      "source_chunk_ids": [
        "6041a61fba27d3ca51f85f315f4d3b9a"
      ],
      "confidence": 0.9,
      "evidence": "5-HT precursor L-5-hydroxytryptophan (5-HTP)",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Target",
      "name": "tryptophan hydroxylase",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "6041a61fba27d3ca51f85f315f4d3b9a"
      ],
      "confidence": 0.8,
      "evidence": "bypasses the rate-limiting enzyme tryptophan hydroxylase",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Study",
      "name": "Das et al. (2004)",
      "attributes": {
        "year": 2004
      },
      "source_chunk_ids": [
        "6041a61fba27d3ca51f85f315f4d3b9a"
      ],
      "confidence": 0.9,
      "evidence": "Das et al., 2004",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Evidence",
      "name": "safety study",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "6041a61fba27d3ca51f85f315f4d3b9a"
      ],
      "confidence": 0.75,
      "evidence": "well-established history of safety",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Product",
      "name": "5-HTP dietary supplement",
      "attributes": {},
      "source_chunk_ids": [
        "6041a61fba27d3ca51f85f315f4d3b9a"
      ],
      "confidence": 0.8,
      "evidence": "5-HTP is a commonly used dietary supplement",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Effect",
      "name": "increase in 5-HT synthesis",
      "attributes": {
        "level": "molecular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "6041a61fba27d3ca51f85f315f4d3b9a"
      ],
      "confidence": 0.8,
      "evidence": "increase 5-HT synthesis in pulmonary endothelial cells",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Compound",
      "name": "fenfluramine",
      "attributes": {},
      "source_chunk_ids": [
        "c1ffd50c57471cb24d810908cc9c7277"
      ],
      "confidence": 0.95,
      "evidence": "high-dose administration of fenfluramine",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Compound",
      "name": "\u03b1-fenfluramine",
      "attributes": {},
      "source_chunk_ids": [
        "c1ffd50c57471cb24d810908cc9c7277"
      ],
      "confidence": 0.95,
      "evidence": "\u03b1-fenfluramine can cause long-term depletion",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "5-HT",
      "attributes": {
        "target_type": "neurotransmitter"
      },
      "source_chunk_ids": [
        "c1ffd50c57471cb24d810908cc9c7277"
      ],
      "confidence": 0.9,
      "evidence": "long-term depletion of 5-HT",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "SERT",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "c1ffd50c57471cb24d810908cc9c7277"
      ],
      "confidence": 0.9,
      "evidence": "loss of SERT binding sites",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Effect",
      "name": "long-term depletion of 5-HT",
      "attributes": {
        "level": "molecular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "c1ffd50c57471cb24d810908cc9c7277"
      ],
      "confidence": 0.85,
      "evidence": "long-term depletion of 5-HT",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "loss of SERT binding sites",
      "attributes": {
        "level": "molecular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "c1ffd50c57471cb24d810908cc9c7277"
      ],
      "confidence": 0.85,
      "evidence": "loss of SERT binding sites",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Effect",
      "name": "neurotoxicity",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "c1ffd50c57471cb24d810908cc9c7277"
      ],
      "confidence": 0.8,
      "evidence": "evidence for neurotoxicity",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Compound",
      "name": "mCPP",
      "attributes": {},
      "source_chunk_ids": [
        "c1ffd50c57471cb24d810908cc9c7277"
      ],
      "confidence": 0.95,
      "evidence": "mCPP interacts with SERT",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Effect",
      "name": "release of 5-HT",
      "attributes": {
        "level": "molecular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "c1ffd50c57471cb24d810908cc9c7277"
      ],
      "confidence": 0.85,
      "evidence": "release 5-HT from neurons",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Study",
      "name": "Zaczek et al., 1990",
      "attributes": {
        "year": 1990
      },
      "source_chunk_ids": [
        "c1ffd50c57471cb24d810908cc9c7277"
      ],
      "confidence": 0.9,
      "evidence": "Zaczek et al., 1990",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Study",
      "name": "McCann et al., 1997",
      "attributes": {
        "year": 1997
      },
      "source_chunk_ids": [
        "c1ffd50c57471cb24d810908cc9c7277"
      ],
      "confidence": 0.9,
      "evidence": "McCann et al., 1997",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Study",
      "name": "Rose et al., 1996",
      "attributes": {
        "year": 1996
      },
      "source_chunk_ids": [
        "c1ffd50c57471cb24d810908cc9c7277"
      ],
      "confidence": 0.9,
      "evidence": "Rose et al., 1996",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Study",
      "name": "Rothman et al., 2003b",
      "attributes": {
        "year": 2003
      },
      "source_chunk_ids": [
        "c1ffd50c57471cb24d810908cc9c7277"
      ],
      "confidence": 0.9,
      "evidence": "Rothman et al., 2003b",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Study",
      "name": "Steranka and Sanders-Bush, 1979",
      "attributes": {
        "year": 1979
      },
      "source_chunk_ids": [
        "c1ffd50c57471cb24d810908cc9c7277"
      ],
      "confidence": 0.9,
      "evidence": "Steranka and Sanders-Bush, 1979",
      "verified": true
    },
    {
      "id": "E15",
      "type": "Study",
      "name": "Halladay et al., 2001",
      "attributes": {
        "year": 2001
      },
      "source_chunk_ids": [
        "c1ffd50c57471cb24d810908cc9c7277"
      ],
      "confidence": 0.9,
      "evidence": "Halladay et al., 2001",
      "verified": true
    },
    {
      "id": "E16",
      "type": "Study",
      "name": "Nichols et al., 1990",
      "attributes": {
        "year": 1990
      },
      "source_chunk_ids": [
        "c1ffd50c57471cb24d810908cc9c7277"
      ],
      "confidence": 0.9,
      "evidence": "Nichols et al., 1990",
      "verified": true
    },
    {
      "id": "E17",
      "type": "Study",
      "name": "Cozzi et al., 1998",
      "attributes": {
        "year": 1998
      },
      "source_chunk_ids": [
        "c1ffd50c57471cb24d810908cc9c7277"
      ],
      "confidence": 0.9,
      "evidence": "Cozzi et al., 1998",
      "verified": true
    },
    {
      "id": "E18",
      "type": "Study",
      "name": "Baumann et al., 2001",
      "attributes": {
        "year": 2001
      },
      "source_chunk_ids": [
        "c1ffd50c57471cb24d810908cc9c7277"
      ],
      "confidence": 0.9,
      "evidence": "Baumann et al., 2001",
      "verified": true
    },
    {
      "id": "E19",
      "type": "Study",
      "name": "Baumann et al., 1995b",
      "attributes": {
        "year": 1995
      },
      "source_chunk_ids": [
        "c1ffd50c57471cb24d810908cc9c7277"
      ],
      "confidence": 0.9,
      "evidence": "Baumann et al., 1995b",
      "verified": true
    },
    {
      "id": "E20",
      "type": "Study",
      "name": "Eriksson et al., 1999",
      "attributes": {
        "year": 1999
      },
      "source_chunk_ids": [
        "c1ffd50c57471cb24d810908cc9c7277"
      ],
      "confidence": 0.9,
      "evidence": "Eriksson et al., 1999",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "SERT",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "b3edff64c00ddb379d6620449284d29c"
      ],
      "confidence": 0.9,
      "evidence": "SERT substrates",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "5-HT2B receptor",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "b3edff64c00ddb379d6620449284d29c"
      ],
      "confidence": 0.85,
      "evidence": "5-HT2B agonist activity",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Condition",
      "name": "valvular heart disease",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "b3edff64c00ddb379d6620449284d29c"
      ],
      "confidence": 0.8,
      "evidence": "risk of VHD",
      "verified": true
    },
    {
      "id": "E4",
      "type": "AdverseEvent",
      "name": "neurotoxic effects",
      "attributes": {
        "severity": "severe"
      },
      "source_chunk_ids": [
        "b3edff64c00ddb379d6620449284d29c"
      ],
      "confidence": 0.75,
      "evidence": "causing neurotoxic effects",
      "verified": true
    },
    {
      "id": "E5",
      "type": "AdverseEvent",
      "name": "idiopathic pulmonary arterial hypertension",
      "attributes": {
        "severity": "severe"
      },
      "source_chunk_ids": [
        "b3edff64c00ddb379d6620449284d29c"
      ],
      "confidence": 0.7,
      "evidence": "possibly IPAH",
      "verified": true
    },
    {
      "id": "E6",
      "type": "CompoundClass",
      "name": "phenylethylamine",
      "attributes": {},
      "source_chunk_ids": [
        "b3edff64c00ddb379d6620449284d29c"
      ],
      "confidence": 0.8,
      "evidence": "phenylethylamine structure",
      "verified": true
    },
    {
      "id": "E7",
      "type": "CompoundClass",
      "name": "amphetamine-like agents",
      "attributes": {},
      "source_chunk_ids": [
        "b3edff64c00ddb379d6620449284d29c"
      ],
      "confidence": 0.75,
      "evidence": "amphetamine-like agents",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Compound",
      "name": "non-amphetamine transporter substrate",
      "attributes": {},
      "source_chunk_ids": [
        "79260f2edc2c1282bb4735835b854f8f"
      ],
      "confidence": 0.7,
      "evidence": "non-amphetamine transporter substrate",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "DA release",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "79260f2edc2c1282bb4735835b854f8f"
      ],
      "confidence": 0.8,
      "evidence": "release DA",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "5-HT release",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "79260f2edc2c1282bb4735835b854f8f"
      ],
      "confidence": 0.8,
      "evidence": "release 5-HT",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "NE release",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "79260f2edc2c1282bb4735835b854f8f"
      ],
      "confidence": 0.8,
      "evidence": "affecting release of NE",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Figure 6 study",
      "attributes": {
        "design": "animal study",
        "species": "rat",
        "tissue": "brain"
      },
      "source_chunk_ids": [
        "d1f0db506dd996e2d849697c53ef564b"
      ],
      "confidence": 0.9,
      "evidence": "Figure 6: Effects of high-dose administration",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "in vivo animal data",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "d1f0db506dd996e2d849697c53ef564b"
      ],
      "confidence": 0.85,
      "evidence": "postmortem tissue levels in rat brain",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Compound",
      "name": "d-FEN",
      "attributes": {},
      "source_chunk_ids": [
        "d1f0db506dd996e2d849697c53ef564b"
      ],
      "confidence": 0.95,
      "evidence": "d-FEN",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Compound",
      "name": "mCPP",
      "attributes": {},
      "source_chunk_ids": [
        "d1f0db506dd996e2d849697c53ef564b"
      ],
      "confidence": 0.95,
      "evidence": "mCPP",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Dosage",
      "name": "10 \u03bcmol/kg",
      "attributes": {
        "amount": 10,
        "unit": "\u03bcmol/kg",
        "route": "administration"
      },
      "source_chunk_ids": [
        "d1f0db506dd996e2d849697c53ef564b"
      ],
      "confidence": 0.9,
      "evidence": "10 \u03bcmol/kg",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Dosage",
      "name": "30 \u03bcmol/kg",
      "attributes": {
        "amount": 30,
        "unit": "\u03bcmol/kg",
        "route": "administration"
      },
      "source_chunk_ids": [
        "d1f0db506dd996e2d849697c53ef564b"
      ],
      "confidence": 0.9,
      "evidence": "30 \u03bcmol/kg",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Effect",
      "name": "increased 5-HT levels",
      "attributes": {
        "level": "molecular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "d1f0db506dd996e2d849697c53ef564b"
      ],
      "confidence": 0.85,
      "evidence": "5-HT levels are significantly higher",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Effect",
      "name": "stable 5-HIAA levels",
      "attributes": {
        "level": "molecular",
        "valence": "neutral"
      },
      "source_chunk_ids": [
        "d1f0db506dd996e2d849697c53ef564b"
      ],
      "confidence": 0.8,
      "evidence": "5-HIAA levels remain relatively stable",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Baumann et al. (2001)",
      "attributes": {
        "year": 2001,
        "design": "animal study"
      },
      "source_chunk_ids": [
        "f3a4c71678d371c8c4c4bf7d78a37e33"
      ],
      "confidence": 0.9,
      "evidence": "Data taken with permission from Baumann et al. (2001)",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "in vivo animal study",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "f3a4c71678d371c8c4c4bf7d78a37e33"
      ],
      "confidence": 0.85,
      "evidence": "postmortem tissue levels in rat brain",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Compound",
      "name": "d-FEN",
      "attributes": {},
      "source_chunk_ids": [
        "f3a4c71678d371c8c4c4bf7d78a37e33"
      ],
      "confidence": 0.95,
      "evidence": "d-FEN or mCPP",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Compound",
      "name": "mCPP",
      "attributes": {},
      "source_chunk_ids": [
        "f3a4c71678d371c8c4c4bf7d78a37e33"
      ],
      "confidence": 0.95,
      "evidence": "d-FEN or mCPP",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "5-HT",
      "attributes": {
        "target_type": "neurotransmitter"
      },
      "source_chunk_ids": [
        "f3a4c71678d371c8c4c4bf7d78a37e33"
      ],
      "confidence": 0.9,
      "evidence": "tissue levels of 5-HT",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Target",
      "name": "5-HIAA",
      "attributes": {
        "target_type": "metabolite"
      },
      "source_chunk_ids": [
        "f3a4c71678d371c8c4c4bf7d78a37e33"
      ],
      "confidence": 0.9,
      "evidence": "metabolite 5-hydroxyindoleacetic acid (5-HIAA)",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Effect",
      "name": "increased extracellular 5-HT",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "f3a4c71678d371c8c4c4bf7d78a37e33"
      ],
      "confidence": 0.85,
      "evidence": "produce equivalent increases in extracellular 5-HT",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Dosage",
      "name": "10 or 30 \u03bcmol/kg every 2 h for four doses",
      "attributes": {
        "amount": "10 or 30",
        "unit": "\u03bcmol/kg",
        "frequency": "every 2 h",
        "duration": "four doses",
        "route": "i.p."
      },
      "source_chunk_ids": [
        "f3a4c71678d371c8c4c4bf7d78a37e33"
      ],
      "confidence": 0.8,
      "evidence": "doses of 10 or 30 \u03bcmol/kg, every 2 h, for four doses",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "PAL-287 effects study",
      "attributes": {
        "design": "experimental"
      },
      "source_chunk_ids": [
        "be3c1fa204d1fe03e278412a1d79c839"
      ],
      "confidence": 0.8,
      "evidence": "Effects of PAL-287 on neurochemical and locomotor parameters",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "in vivo experimental",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "be3c1fa204d1fe03e278412a1d79c839"
      ],
      "confidence": 0.75,
      "evidence": "dialysate amine concentrations",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Compound",
      "name": "PAL-287",
      "attributes": {},
      "source_chunk_ids": [
        "be3c1fa204d1fe03e278412a1d79c839"
      ],
      "confidence": 0.9,
      "evidence": "PAL-287",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "DA",
      "attributes": {
        "target_type": "neurotransmitter"
      },
      "source_chunk_ids": [
        "be3c1fa204d1fe03e278412a1d79c839"
      ],
      "confidence": 0.85,
      "evidence": "DA (% baseline)",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "5-HT",
      "attributes": {
        "target_type": "neurotransmitter"
      },
      "source_chunk_ids": [
        "be3c1fa204d1fe03e278412a1d79c839"
      ],
      "confidence": 0.85,
      "evidence": "5-HT (% baseline)",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "ambulation increase",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "be3c1fa204d1fe03e278412a1d79c839"
      ],
      "confidence": 0.7,
      "evidence": "Ambulation (cm) over time",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Effect",
      "name": "stereotypy increase",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "be3c1fa204d1fe03e278412a1d79c839"
      ],
      "confidence": 0.7,
      "evidence": "Stereotypy (events) over time",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Rothman et al. (2005) microdialysis study",
      "attributes": {
        "design": "in vivo microdialysis",
        "sample_size": 7,
        "year": 2005
      },
      "source_chunk_ids": [
        "f43712c6ca99d243814087984163e882"
      ],
      "confidence": 0.9,
      "evidence": "Data taken with permission from Rothman et al. (2005)",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "in vivo animal study",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "f43712c6ca99d243814087984163e882"
      ],
      "confidence": 0.85,
      "evidence": "in vivo microdialysis in rats",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Compound",
      "name": "PAL-287",
      "attributes": {},
      "source_chunk_ids": [
        "f43712c6ca99d243814087984163e882"
      ],
      "confidence": 0.95,
      "evidence": "PAL-287",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Dosage",
      "name": "1 mg/kg i.v. injection",
      "attributes": {
        "amount": 1,
        "unit": "mg/kg",
        "route": "intravenous"
      },
      "source_chunk_ids": [
        "f43712c6ca99d243814087984163e882"
      ],
      "confidence": 0.8,
      "evidence": "1 mg/kg PAL-287 at time zero",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Dosage",
      "name": "3 mg/kg i.v. injection",
      "attributes": {
        "amount": 3,
        "unit": "mg/kg",
        "route": "intravenous"
      },
      "source_chunk_ids": [
        "f43712c6ca99d243814087984163e882"
      ],
      "confidence": 0.8,
      "evidence": "3 mg/kg 60 min later",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Target",
      "name": "dopamine",
      "attributes": {
        "target_type": "neurotransmitter"
      },
      "source_chunk_ids": [
        "f43712c6ca99d243814087984163e882"
      ],
      "confidence": 0.85,
      "evidence": "DA (dopamine) concentrations",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Target",
      "name": "serotonin",
      "attributes": {
        "target_type": "neurotransmitter"
      },
      "source_chunk_ids": [
        "f43712c6ca99d243814087984163e882"
      ],
      "confidence": 0.85,
      "evidence": "5-HT (serotonin) concentrations",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Effect",
      "name": "increased dopamine levels",
      "attributes": {
        "level": "molecular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "f43712c6ca99d243814087984163e882"
      ],
      "confidence": 0.75,
      "evidence": "Concentrations of DA expressed as percentage of baseline",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Effect",
      "name": "increased serotonin levels",
      "attributes": {
        "level": "molecular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "f43712c6ca99d243814087984163e882"
      ],
      "confidence": 0.75,
      "evidence": "Concentrations of 5-HT expressed as percentage of baseline",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Effect",
      "name": "increased locomotor activity",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "f43712c6ca99d243814087984163e882"
      ],
      "confidence": 0.7,
      "evidence": "Locomotor parameters: distance traveled (ambulation)",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Effect",
      "name": "increased stereotypy",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "f43712c6ca99d243814087984163e882"
      ],
      "confidence": 0.7,
      "evidence": "Locomotor parameters: number of repetitive movements (stereotypy)",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Compound",
      "name": "PAL-287",
      "attributes": {
        "synonyms": [
          "1-naphthyl-2-aminopropane"
        ]
      },
      "source_chunk_ids": [
        "6c48e219fa7c33fe1c88a5bc26d0ac6d"
      ],
      "confidence": 0.95,
      "evidence": "PAL-287 (1-naphthyl-2-aminopropane)",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "DAT",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "6c48e219fa7c33fe1c88a5bc26d0ac6d"
      ],
      "confidence": 0.9,
      "evidence": "DAT",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "NET",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "6c48e219fa7c33fe1c88a5bc26d0ac6d"
      ],
      "confidence": 0.9,
      "evidence": "NET",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "SERT",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "6c48e219fa7c33fe1c88a5bc26d0ac6d"
      ],
      "confidence": 0.9,
      "evidence": "SERT",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "5-HT2B receptor",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "6c48e219fa7c33fe1c88a5bc26d0ac6d"
      ],
      "confidence": 0.85,
      "evidence": "5-HT2B receptors",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Target",
      "name": "5-HT2A receptor",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "6c48e219fa7c33fe1c88a5bc26d0ac6d"
      ],
      "confidence": 0.85,
      "evidence": "5-HT2A receptors",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Target",
      "name": "5-HT2C receptor",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "6c48e219fa7c33fe1c88a5bc26d0ac6d"
      ],
      "confidence": 0.85,
      "evidence": "5-HT2C receptor sites",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Effect",
      "name": "increases extracellular 5-HT",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "6c48e219fa7c33fe1c88a5bc26d0ac6d"
      ],
      "confidence": 0.8,
      "evidence": "increases extracellular 5-HT",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Effect",
      "name": "increases extracellular DA",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "6c48e219fa7c33fe1c88a5bc26d0ac6d"
      ],
      "confidence": 0.8,
      "evidence": "increases extracellular DA",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Effect",
      "name": "anorectic actions",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "6c48e219fa7c33fe1c88a5bc26d0ac6d"
      ],
      "confidence": 0.7,
      "evidence": "possible anorectic actions",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Effect",
      "name": "minimal reinforcing properties",
      "attributes": {
        "level": "behavioral",
        "valence": "neutral",
        "verification_needed": true
      },
      "source_chunk_ids": [
        "6c48e219fa7c33fe1c88a5bc26d0ac6d"
      ],
      "confidence": 0.65,
      "evidence": "minimal reinforcing properties",
      "verified": false
    },
    {
      "id": "E12",
      "type": "Evidence",
      "name": "in vitro",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "6c48e219fa7c33fe1c88a5bc26d0ac6d"
      ],
      "confidence": 0.9,
      "evidence": "in vitro potency",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Study",
      "name": "Rothman et al., 2005",
      "attributes": {
        "year": 2005
      },
      "source_chunk_ids": [
        "6c48e219fa7c33fe1c88a5bc26d0ac6d"
      ],
      "confidence": 0.8,
      "evidence": "Rothman et al., 2005",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Study",
      "name": "Vickers et al., 1999; Nilsson, 2006",
      "attributes": {},
      "source_chunk_ids": [
        "6c48e219fa7c33fe1c88a5bc26d0ac6d"
      ],
      "confidence": 0.7,
      "evidence": "Vickers et al., 1999; Nilsson, 2006",
      "verified": true
    },
    {
      "id": "E15",
      "type": "Study",
      "name": "Czoty et al., 2002; Higgins and Fletcher, 2003",
      "attributes": {},
      "source_chunk_ids": [
        "6c48e219fa7c33fe1c88a5bc26d0ac6d"
      ],
      "confidence": 0.7,
      "evidence": "Czoty et al., 2002; Higgins and Fletcher, 2003",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Compound",
      "name": "PAL-287",
      "attributes": {},
      "source_chunk_ids": [
        "0b3ecff2cc2fb09334edabbd47ea1873"
      ],
      "confidence": 0.95,
      "evidence": "PAL-287 produces minimal locomotor activation",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Effect",
      "name": "locomotor activation",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "0b3ecff2cc2fb09334edabbd47ea1873"
      ],
      "confidence": 0.85,
      "evidence": "minimal locomotor activation",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Effect",
      "name": "elevations in extracellular DA",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "0b3ecff2cc2fb09334edabbd47ea1873"
      ],
      "confidence": 0.9,
      "evidence": "substantial elevations in extracellular DA",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Effect",
      "name": "ambulation",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "0b3ecff2cc2fb09334edabbd47ea1873"
      ],
      "confidence": 0.8,
      "evidence": "amount of ambulation produced",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Compound",
      "name": "D-amphetamine",
      "attributes": {},
      "source_chunk_ids": [
        "0b3ecff2cc2fb09334edabbd47ea1873"
      ],
      "confidence": 0.95,
      "evidence": "1 mg/kg D-amphetamine",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "DA release",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "0b3ecff2cc2fb09334edabbd47ea1873"
      ],
      "confidence": 0.85,
      "evidence": "cause equivalent DA release",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Target",
      "name": "5-HT",
      "attributes": {
        "target_type": "neurotransmitter"
      },
      "source_chunk_ids": [
        "0b3ecff2cc2fb09334edabbd47ea1873"
      ],
      "confidence": 0.9,
      "evidence": "5-HT-releasing properties",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Effect",
      "name": "stimulant effects",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "0b3ecff2cc2fb09334edabbd47ea1873"
      ],
      "confidence": 0.8,
      "evidence": "limit the stimulant effects",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Dosage",
      "name": "18 mg/kg i.p., every 2 h, for three doses",
      "attributes": {
        "amount": 18,
        "unit": "mg/kg",
        "frequency": "every 2 h",
        "duration": "three doses",
        "route": "i.p."
      },
      "source_chunk_ids": [
        "0b3ecff2cc2fb09334edabbd47ea1873"
      ],
      "confidence": 0.85,
      "evidence": "18 mg/kg i.p., every 2 h, for three doses",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Effect",
      "name": "brain tissue 5-HT levels",
      "attributes": {
        "level": "cellular",
        "valence": "neutral"
      },
      "source_chunk_ids": [
        "0b3ecff2cc2fb09334edabbd47ea1873"
      ],
      "confidence": 0.8,
      "evidence": "fails to affect brain tissue 5-HT levels",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Compound",
      "name": "D-methamphetamine",
      "attributes": {},
      "source_chunk_ids": [
        "0b3ecff2cc2fb09334edabbd47ea1873"
      ],
      "confidence": 0.95,
      "evidence": "D-methamphetamine (6.0 mg/kg i.p., every 2 h, for three doses)",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Compound",
      "name": "MDMA",
      "attributes": {},
      "source_chunk_ids": [
        "0b3ecff2cc2fb09334edabbd47ea1873"
      ],
      "confidence": 0.95,
      "evidence": "MDMA (7.5 mg/kg i.p., every 2 h, for three doses)",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Effect",
      "name": "5-HT depletions",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "0b3ecff2cc2fb09334edabbd47ea1873"
      ],
      "confidence": 0.85,
      "evidence": "cause significant 5-HT depletions",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Effect",
      "name": "self-administration behaviour",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "0b3ecff2cc2fb09334edabbd47ea1873"
      ],
      "confidence": 0.8,
      "evidence": "does not support self-administration behaviour",
      "verified": true
    },
    {
      "id": "E15",
      "type": "Effect",
      "name": "cocaine self-administration",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "0b3ecff2cc2fb09334edabbd47ea1873"
      ],
      "confidence": 0.85,
      "evidence": "decreases cocaine self-administration",
      "verified": true
    },
    {
      "id": "E16",
      "type": "Dosage",
      "name": "1.0 mg/kg/h PAL-287",
      "attributes": {
        "amount": 1.0,
        "unit": "mg/kg/h",
        "route": "i.v."
      },
      "source_chunk_ids": [
        "0b3ecff2cc2fb09334edabbd47ea1873"
      ],
      "confidence": 0.8,
      "evidence": "1.0 mg/kg/h PAL-287",
      "verified": true
    },
    {
      "id": "E17",
      "type": "Effect",
      "name": "cocaine-maintained responding",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "0b3ecff2cc2fb09334edabbd47ea1873"
      ],
      "confidence": 0.85,
      "evidence": "significantly reduces both cocaine- and food-maintained responding",
      "verified": true
    },
    {
      "id": "E18",
      "type": "Effect",
      "name": "food-maintained responding",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "0b3ecff2cc2fb09334edabbd47ea1873"
      ],
      "confidence": 0.85,
      "evidence": "reduction in food-maintained responding",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "monkey self-administration assay",
      "attributes": {
        "design": "animal study",
        "species": "monkey"
      },
      "source_chunk_ids": [
        "d141ff97b8e39f3e7bf86dc91db523a4"
      ],
      "confidence": 0.9,
      "evidence": "monkey self-administration assay",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "in vivo animal study",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "d141ff97b8e39f3e7bf86dc91db523a4"
      ],
      "confidence": 0.85,
      "evidence": "monkey self-administration assay",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Compound",
      "name": "PAL-287",
      "attributes": {},
      "source_chunk_ids": [
        "d141ff97b8e39f3e7bf86dc91db523a4"
      ],
      "confidence": 0.95,
      "evidence": "PAL-287",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Compound",
      "name": "cocaine",
      "attributes": {},
      "source_chunk_ids": [
        "d141ff97b8e39f3e7bf86dc91db523a4"
      ],
      "confidence": 0.95,
      "evidence": "Cocaine",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Effect",
      "name": "self-administration reduction",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "d141ff97b8e39f3e7bf86dc91db523a4"
      ],
      "confidence": 0.8,
      "evidence": "Effects of PAL-287 in the monkey self-administration assay",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "food intake reduction",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "d141ff97b8e39f3e7bf86dc91db523a4"
      ],
      "confidence": 0.75,
      "evidence": "Food (1 gm pellets) (%) ~40*",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Dosage",
      "name": "0.1-1.0 mg/kg/hr PAL-287",
      "attributes": {
        "amount_min": 0.1,
        "amount_max": 1.0,
        "unit": "mg/kg/hr",
        "route": "intravenous"
      },
      "source_chunk_ids": [
        "d141ff97b8e39f3e7bf86dc91db523a4"
      ],
      "confidence": 0.8,
      "evidence": "Dose PAL-287 (mg/kg/hr) 0.1, 0.32, 1.0",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Rothman et al. (2005) monkey self-administration assay",
      "attributes": {
        "design": "monkey self-administration assay",
        "sample_size": 4,
        "year": 2005
      },
      "source_chunk_ids": [
        "7b2be919fcbd22a9d66fff4c903a6159"
      ],
      "confidence": 0.9,
      "evidence": "Data taken with permission from Rothman et al. (2005)",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "in vivo animal study",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "7b2be919fcbd22a9d66fff4c903a6159"
      ],
      "confidence": 0.85,
      "evidence": "monkey self-administration assay",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Compound",
      "name": "PAL-287",
      "attributes": {},
      "source_chunk_ids": [
        "7b2be919fcbd22a9d66fff4c903a6159"
      ],
      "confidence": 0.95,
      "evidence": "PAL-287",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Compound",
      "name": "cocaine",
      "attributes": {},
      "source_chunk_ids": [
        "7b2be919fcbd22a9d66fff4c903a6159"
      ],
      "confidence": 0.95,
      "evidence": "cocaine",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Effect",
      "name": "self-administration behavior",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "7b2be919fcbd22a9d66fff4c903a6159"
      ],
      "confidence": 0.8,
      "evidence": "Self-administration of cocaine and PAL-287",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "reduced cocaine-maintained responding",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "7b2be919fcbd22a9d66fff4c903a6159"
      ],
      "confidence": 0.75,
      "evidence": "Effects of chronic 7-day treatment with PAL-287 on cocaine-maintained responding",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Effect",
      "name": "reduced food-maintained responding",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "7b2be919fcbd22a9d66fff4c903a6159"
      ],
      "confidence": 0.75,
      "evidence": "Effects of chronic 7-day treatment with PAL-287 on food-maintained responding",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Compound",
      "name": "PAL-287",
      "attributes": {},
      "source_chunk_ids": [
        "9714e3ec9dab0906ab6b538a3d3eb149"
      ],
      "confidence": 0.95,
      "evidence": "PAL-287 displays a number",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "SERT",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "9714e3ec9dab0906ab6b538a3d3eb149"
      ],
      "confidence": 0.9,
      "evidence": "SERT will release DA and 5-HT",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "5-HT2B",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "9714e3ec9dab0906ab6b538a3d3eb149"
      ],
      "confidence": 0.85,
      "evidence": "5-HT2B agonist effects",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Effect",
      "name": "release DA and 5-HT from neurons",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "9714e3ec9dab0906ab6b538a3d3eb149"
      ],
      "confidence": 0.8,
      "evidence": "SERT will release DA and 5-HT",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Effect",
      "name": "minimally reinforcing",
      "attributes": {
        "level": "behavioral",
        "valence": "neutral"
      },
      "source_chunk_ids": [
        "9714e3ec9dab0906ab6b538a3d3eb149"
      ],
      "confidence": 0.75,
      "evidence": "be minimally reinforcing",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "suppress cocaine self-administration",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "9714e3ec9dab0906ab6b538a3d3eb149"
      ],
      "confidence": 0.85,
      "evidence": "suppress ongoing cocaine self-administration",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Effect",
      "name": "minimal locomotor activation",
      "attributes": {
        "level": "behavioral",
        "valence": "neutral"
      },
      "source_chunk_ids": [
        "9714e3ec9dab0906ab6b538a3d3eb149"
      ],
      "confidence": 0.8,
      "evidence": "minimal locomotor activation",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Effect",
      "name": "lack of long-term 5-HT neurotoxicity",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "9714e3ec9dab0906ab6b538a3d3eb149"
      ],
      "confidence": 0.8,
      "evidence": "lack of long-term 5-HT neurotoxicity",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Effect",
      "name": "low abuse potential",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "9714e3ec9dab0906ab6b538a3d3eb149"
      ],
      "confidence": 0.8,
      "evidence": "low abuse potential",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Condition",
      "name": "VHD",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "9714e3ec9dab0906ab6b538a3d3eb149"
      ],
      "confidence": 0.7,
      "evidence": "risk of VHD",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Condition",
      "name": "IPAH",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "9714e3ec9dab0906ab6b538a3d3eb149"
      ],
      "confidence": 0.7,
      "evidence": "risk of ... IPAH",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Condition",
      "name": "stimulant addictions",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "9714e3ec9dab0906ab6b538a3d3eb149"
      ],
      "confidence": 0.85,
      "evidence": "treatment of stimulant addictions",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Condition",
      "name": "cocaine addiction",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "9714e3ec9dab0906ab6b538a3d3eb149"
      ],
      "confidence": 0.8,
      "evidence": "cocaine self-administration",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Dosage",
      "name": "1.0 mg/kg/h PAL-287 for 7 days",
      "attributes": {
        "amount": 1.0,
        "unit": "mg/kg/h",
        "duration": "7-day",
        "route": "intravenous"
      },
      "source_chunk_ids": [
        "9714e3ec9dab0906ab6b538a3d3eb149"
      ],
      "confidence": 0.75,
      "evidence": "1.0 mg/kg/h PAL-287 ... 7-day treatment",
      "verified": true
    },
    {
      "id": "E15",
      "type": "Study",
      "name": "Rothman et al., 2001",
      "attributes": {
        "year": 2001
      },
      "source_chunk_ids": [
        "9714e3ec9dab0906ab6b538a3d3eb149"
      ],
      "confidence": 0.9,
      "evidence": "Rothman et al., 2001",
      "verified": true
    },
    {
      "id": "E16",
      "type": "Evidence",
      "name": "in vivo study",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "9714e3ec9dab0906ab6b538a3d3eb149"
      ],
      "confidence": 0.8,
      "evidence": "in vivo",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Compound",
      "name": "PAL-287",
      "attributes": {},
      "source_chunk_ids": [
        "84b0c5deb9ccfd550d8548bcc03a3b52"
      ],
      "confidence": 0.95,
      "evidence": "PAL-287",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Compound",
      "name": "d-amphetamine",
      "attributes": {},
      "source_chunk_ids": [
        "84b0c5deb9ccfd550d8548bcc03a3b52"
      ],
      "confidence": 0.95,
      "evidence": "d-amphetamine",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "DA/5-HT-releasing activity",
      "attributes": {
        "target_type": "activity"
      },
      "source_chunk_ids": [
        "84b0c5deb9ccfd550d8548bcc03a3b52"
      ],
      "confidence": 0.8,
      "evidence": "mixed DA/5-HT-releasing activity",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Effect",
      "name": "suppression of cocaine self-administration",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "84b0c5deb9ccfd550d8548bcc03a3b52"
      ],
      "confidence": 0.85,
      "evidence": "suppression of cocaine self-administration",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Effect",
      "name": "reducing illicit cocaine use",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "84b0c5deb9ccfd550d8548bcc03a3b52"
      ],
      "confidence": 0.85,
      "evidence": "reducing illicit cocaine use",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "suppress alcohol ingestion",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "84b0c5deb9ccfd550d8548bcc03a3b52"
      ],
      "confidence": 0.85,
      "evidence": "suppress alcohol ingestion",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Condition",
      "name": "cocaine addiction",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "84b0c5deb9ccfd550d8548bcc03a3b52"
      ],
      "confidence": 0.8,
      "evidence": "cocaine addicts",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Condition",
      "name": "alcohol ingestion",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "84b0c5deb9ccfd550d8548bcc03a3b52"
      ],
      "confidence": 0.8,
      "evidence": "alcohol ingestion",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Study",
      "name": "Negus and Mello, 2003a",
      "attributes": {
        "year": "2003a"
      },
      "source_chunk_ids": [
        "84b0c5deb9ccfd550d8548bcc03a3b52"
      ],
      "confidence": 0.9,
      "evidence": "Negus and Mello, 2003a",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Study",
      "name": "Grabowski et al., 2001, 2004b",
      "attributes": {
        "year": "2001, 2004b"
      },
      "source_chunk_ids": [
        "84b0c5deb9ccfd550d8548bcc03a3b52"
      ],
      "confidence": 0.9,
      "evidence": "Grabowski et al. (2001, 2004b)",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Study",
      "name": "Yu et al., 1997",
      "attributes": {
        "year": "1997"
      },
      "source_chunk_ids": [
        "84b0c5deb9ccfd550d8548bcc03a3b52"
      ],
      "confidence": 0.9,
      "evidence": "Yu et al., 1997",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Study",
      "name": "Halladay et al., 1999, 2006",
      "attributes": {
        "year": "1999, 2006"
      },
      "source_chunk_ids": [
        "84b0c5deb9ccfd550d8548bcc03a3b52"
      ],
      "confidence": 0.9,
      "evidence": "Halladay et al., 1999, 2006",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Evidence",
      "name": "in vivo study",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "84b0c5deb9ccfd550d8548bcc03a3b52"
      ],
      "confidence": 0.7,
      "evidence": "findings with PAL-287 in monkeys",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Condition",
      "name": "alcohol addiction",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "f7a131a0b3f48442c08655d370849fb0"
      ],
      "confidence": 0.95,
      "evidence": "alcohol addiction",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Study",
      "name": "Yu et al., 1997",
      "attributes": {
        "year": 1997
      },
      "source_chunk_ids": [
        "f7a131a0b3f48442c08655d370849fb0"
      ],
      "confidence": 0.9,
      "evidence": "Yu et al., 1997",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Evidence",
      "name": "in vivo study",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "f7a131a0b3f48442c08655d370849fb0"
      ],
      "confidence": 0.8,
      "evidence": "blocks alcohol withdrawal seizures",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Compound",
      "name": "DA",
      "attributes": {},
      "source_chunk_ids": [
        "f7a131a0b3f48442c08655d370849fb0"
      ],
      "confidence": 0.85,
      "evidence": "DA",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Compound",
      "name": "5-HT",
      "attributes": {},
      "source_chunk_ids": [
        "f7a131a0b3f48442c08655d370849fb0"
      ],
      "confidence": 0.85,
      "evidence": "5-HT",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Condition",
      "name": "alcohol withdrawal seizures",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "f7a131a0b3f48442c08655d370849fb0"
      ],
      "confidence": 0.9,
      "evidence": "alcohol withdrawal seizures",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Compound",
      "name": "PAL-287",
      "attributes": {},
      "source_chunk_ids": [
        "f7a131a0b3f48442c08655d370849fb0"
      ],
      "confidence": 0.95,
      "evidence": "PAL-287",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Target",
      "name": "5-HT2B receptors",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "f7a131a0b3f48442c08655d370849fb0"
      ],
      "confidence": 0.9,
      "evidence": "5-HT2B receptors",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Target",
      "name": "monoamine transporters",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "f7a131a0b3f48442c08655d370849fb0"
      ],
      "confidence": 0.85,
      "evidence": "multiple transporters",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Effect",
      "name": "blocks seizures",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "f7a131a0b3f48442c08655d370849fb0"
      ],
      "confidence": 0.8,
      "evidence": "blocks alcohol withdrawal seizures",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Effect",
      "name": "enhances monoamine release",
      "attributes": {
        "level": "molecular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "f7a131a0b3f48442c08655d370849fb0"
      ],
      "confidence": 0.85,
      "evidence": "enhance monoamine release",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Compound",
      "name": "PAL-287",
      "attributes": {},
      "source_chunk_ids": [
        "24593cf040b711b34d26c5a00eec814d"
      ],
      "confidence": 0.95,
      "evidence": "compounds such as PAL-287",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Compound",
      "name": "d-amphetamine",
      "attributes": {},
      "source_chunk_ids": [
        "24593cf040b711b34d26c5a00eec814d"
      ],
      "confidence": 0.9,
      "evidence": "DA releaser d-amphetamine",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Compound",
      "name": "5-HTP",
      "attributes": {},
      "source_chunk_ids": [
        "24593cf040b711b34d26c5a00eec814d"
      ],
      "confidence": 0.9,
      "evidence": "5-HT precursor 5-HTP",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Compound",
      "name": "carbidopa",
      "attributes": {},
      "source_chunk_ids": [
        "24593cf040b711b34d26c5a00eec814d"
      ],
      "confidence": 0.85,
      "evidence": "peripheral decarboxylase inhibitor carbidopa",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Compound",
      "name": "phentermine",
      "attributes": {},
      "source_chunk_ids": [
        "24593cf040b711b34d26c5a00eec814d"
      ],
      "confidence": 0.85,
      "evidence": "phentermine and 5-HTP/carbidopa",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Condition",
      "name": "addictive disorders",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "24593cf040b711b34d26c5a00eec814d"
      ],
      "confidence": 0.8,
      "evidence": "treatments for addictive disorders",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Condition",
      "name": "stimulant addictions",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "24593cf040b711b34d26c5a00eec814d"
      ],
      "confidence": 0.8,
      "evidence": "stimulant addictions",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Condition",
      "name": "depression",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "24593cf040b711b34d26c5a00eec814d"
      ],
      "confidence": 0.9,
      "evidence": "treating depression",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Condition",
      "name": "obsessive compulsive disorder",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "24593cf040b711b34d26c5a00eec814d"
      ],
      "confidence": 0.9,
      "evidence": "obsessive compulsive disorder",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Condition",
      "name": "attention deficit hyperactivity disorder",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "24593cf040b711b34d26c5a00eec814d"
      ],
      "confidence": 0.9,
      "evidence": "attention deficit hyperactivity disorder",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Condition",
      "name": "obesity",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "24593cf040b711b34d26c5a00eec814d"
      ],
      "confidence": 0.9,
      "evidence": "obesity",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Study",
      "name": "Halladay et al., 2006",
      "attributes": {
        "year": 2006
      },
      "source_chunk_ids": [
        "24593cf040b711b34d26c5a00eec814d"
      ],
      "confidence": 0.7,
      "evidence": "Halladay et al., 2006",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Study",
      "name": "Rothman and Baumann, 2008",
      "attributes": {
        "year": 2008
      },
      "source_chunk_ids": [
        "24593cf040b711b34d26c5a00eec814d"
      ],
      "confidence": 0.7,
      "evidence": "Rothman and Baumann, 2008",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Evidence",
      "name": "preclinical",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "24593cf040b711b34d26c5a00eec814d"
      ],
      "confidence": 0.75,
      "evidence": "preclinical arena",
      "verified": true
    },
    {
      "id": "E15",
      "type": "Evidence",
      "name": "clinical",
      "attributes": {
        "evidence_level": 4
      },
      "source_chunk_ids": [
        "24593cf040b711b34d26c5a00eec814d"
      ],
      "confidence": 0.8,
      "evidence": "clinical development",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "central nervous system",
      "attributes": {
        "target_type": "system"
      },
      "source_chunk_ids": [
        "40781cc877ba4c2ccdc002f4689815f7"
      ],
      "confidence": 0.9,
      "evidence": "CNScentral nervous system",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Condition",
      "name": "idiopathic pulmonary arterial hypertension",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "40781cc877ba4c2ccdc002f4689815f7"
      ],
      "confidence": 0.9,
      "evidence": "IPAHidiopathic pulmonary arterial hypertension",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Effect",
      "name": "conditioned place preference",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "40781cc877ba4c2ccdc002f4689815f7"
      ],
      "confidence": 0.85,
      "evidence": "CPPconditioned place preference",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Compound",
      "name": "m-chlorophenylpiperazine",
      "attributes": {},
      "source_chunk_ids": [
        "40781cc877ba4c2ccdc002f4689815f7"
      ],
      "confidence": 0.9,
      "evidence": "mCPPm-chlorophenylpiperazine",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Compound",
      "name": "dopamine",
      "attributes": {},
      "source_chunk_ids": [
        "40781cc877ba4c2ccdc002f4689815f7"
      ],
      "confidence": 0.95,
      "evidence": "DAdopamine",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Compound",
      "name": "3,4-methylenedioxyamphetamine",
      "attributes": {},
      "source_chunk_ids": [
        "40781cc877ba4c2ccdc002f4689815f7"
      ],
      "confidence": 0.9,
      "evidence": "MDA3,4-methylenedioxyamphetamine",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Target",
      "name": "dopamine transporter",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "40781cc877ba4c2ccdc002f4689815f7"
      ],
      "confidence": 0.9,
      "evidence": "DATdopamine transporter",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Compound",
      "name": "3,4-methylenedioxymethamphetamine",
      "attributes": {},
      "source_chunk_ids": [
        "40781cc877ba4c2ccdc002f4689815f7"
      ],
      "confidence": 0.9,
      "evidence": "MDMA3,4-methylenedioxymethamphetamine",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Target",
      "name": "half-maximal effective concentration",
      "attributes": {
        "target_type": "measurement"
      },
      "source_chunk_ids": [
        "40781cc877ba4c2ccdc002f4689815f7"
      ],
      "confidence": 0.8,
      "evidence": "EC50half-maximal effective concentration",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Compound",
      "name": "norepinephrine",
      "attributes": {},
      "source_chunk_ids": [
        "40781cc877ba4c2ccdc002f4689815f7"
      ],
      "confidence": 0.95,
      "evidence": "NEnorepinephrine",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Target",
      "name": "maximal efficacy",
      "attributes": {
        "target_type": "measurement"
      },
      "source_chunk_ids": [
        "40781cc877ba4c2ccdc002f4689815f7"
      ],
      "confidence": 0.8,
      "evidence": "EMAXmaximal efficacy",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Target",
      "name": "norepinephrine transporter",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "40781cc877ba4c2ccdc002f4689815f7"
      ],
      "confidence": 0.9,
      "evidence": "NETnorepinephrine transporter",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Compound",
      "name": "gamma-aminobutyric acid",
      "attributes": {},
      "source_chunk_ids": [
        "40781cc877ba4c2ccdc002f4689815f7"
      ],
      "confidence": 0.95,
      "evidence": "GABAgamma-aminobutyric acid",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Compound",
      "name": "1-naphthyl-2-aminopropane",
      "attributes": {},
      "source_chunk_ids": [
        "40781cc877ba4c2ccdc002f4689815f7"
      ],
      "confidence": 0.85,
      "evidence": "PAL-2871-naphthyl-2-aminopropane",
      "verified": true
    },
    {
      "id": "E15",
      "type": "Compound",
      "name": "5-hydroxytryptamine",
      "attributes": {},
      "source_chunk_ids": [
        "40781cc877ba4c2ccdc002f4689815f7"
      ],
      "confidence": 0.9,
      "evidence": "5-HT5-hydroxytryptamine or serotonin",
      "verified": true
    },
    {
      "id": "E16",
      "type": "Compound",
      "name": "5-hydroxytryptophan",
      "attributes": {},
      "source_chunk_ids": [
        "40781cc877ba4c2ccdc002f4689815f7"
      ],
      "confidence": 0.9,
      "evidence": "5-HTPL-5-hydroxytryptophan",
      "verified": true
    },
    {
      "id": "E17",
      "type": "Compound",
      "name": "p-methylamphetamine",
      "attributes": {},
      "source_chunk_ids": [
        "40781cc877ba4c2ccdc002f4689815f7"
      ],
      "confidence": 0.85,
      "evidence": "PAL-313p-methylamphetamine",
      "verified": true
    },
    {
      "id": "E18",
      "type": "Compound",
      "name": "m-fluoroamphetamine",
      "attributes": {},
      "source_chunk_ids": [
        "40781cc877ba4c2ccdc002f4689815f7"
      ],
      "confidence": 0.85,
      "evidence": "PAL-353m-fluoroamphetamine",
      "verified": true
    },
    {
      "id": "E19",
      "type": "Compound",
      "name": "(S)-2-(6-chloro-5-fluoroindol-1-yl)-1-methylethylamine",
      "attributes": {},
      "source_chunk_ids": [
        "40781cc877ba4c2ccdc002f4689815f7"
      ],
      "confidence": 0.8,
      "evidence": "Ro 60-0175(S)-2-(6-chloro-5-fluoroindol-1-yl)-1-methylethylamine",
      "verified": true
    },
    {
      "id": "E20",
      "type": "Compound",
      "name": "6-chloro-5-methyl-1-[[2-[(2-methyl-3-pyridyl)oxy]-5-pyridyl]carbamoyl]-indoline",
      "attributes": {},
      "source_chunk_ids": [
        "40781cc877ba4c2ccdc002f4689815f7"
      ],
      "confidence": 0.8,
      "evidence": "SB 2420846-chloro-5-methyl-1-[[2-[(2-methyl-3-pyridyl)oxy]-5-pyridyl]carbamoyl]-indoline",
      "verified": true
    },
    {
      "id": "E21",
      "type": "Target",
      "name": "serotonin transporter",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "40781cc877ba4c2ccdc002f4689815f7"
      ],
      "confidence": 0.9,
      "evidence": "SERTserotonin transporter",
      "verified": true
    },
    {
      "id": "E22",
      "type": "Condition",
      "name": "valvular heart disease",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "40781cc877ba4c2ccdc002f4689815f7"
      ],
      "confidence": 0.9,
      "evidence": "VHDvalvular heart disease",
      "verified": true
    },
    {
      "id": "E23",
      "type": "Target",
      "name": "vesicular monoamine transporter type 2",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "40781cc877ba4c2ccdc002f4689815f7"
      ],
      "confidence": 0.9,
      "evidence": "VMAT2vesicular monoamine transporter type 2",
      "verified": true
    },
    {
      "id": "E24",
      "type": "Target",
      "name": "ventral tegmental area",
      "attributes": {
        "target_type": "brain region"
      },
      "source_chunk_ids": [
        "40781cc877ba4c2ccdc002f4689815f7"
      ],
      "confidence": 0.85,
      "evidence": "VTAventral tegmental area",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Abenhaim et al. (1996)",
      "attributes": {
        "year": 1996,
        "design": "study"
      },
      "source_chunk_ids": [
        "ba24f9acfd0b569d2da6a8bf7cc6be46"
      ],
      "confidence": 0.9,
      "evidence": "Abenhaim, L., Moride, Y., Brenot, F., Rich, S., Benichou, J., Kurz, X., Higenbottam, T., Oakley, C., Wouters, E., Aubier, M., Simonneau, G. and Begaud, B. (1996)",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "clinical study",
      "attributes": {
        "evidence_level": 4
      },
      "source_chunk_ids": [
        "ba24f9acfd0b569d2da6a8bf7cc6be46"
      ],
      "confidence": 0.8,
      "evidence": "Appetite-suppressant drugs and the risk of primary pulmonary hypertension",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Condition",
      "name": "primary pulmonary hypertension",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "ba24f9acfd0b569d2da6a8bf7cc6be46"
      ],
      "confidence": 0.9,
      "evidence": "primary pulmonary hypertension",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Study",
      "name": "Alex and Pehek (2007)",
      "attributes": {
        "year": 2007,
        "design": "review"
      },
      "source_chunk_ids": [
        "ba24f9acfd0b569d2da6a8bf7cc6be46"
      ],
      "confidence": 0.9,
      "evidence": "Alex, K.D. and Pehek, E.A. (2007)",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Evidence",
      "name": "pharmacological review",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "ba24f9acfd0b569d2da6a8bf7cc6be46"
      ],
      "confidence": 0.8,
      "evidence": "Pharmacologic mechanisms of serotonergic regulation",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Study",
      "name": "Alexander et al. (2005)",
      "attributes": {
        "year": 2005,
        "design": "animal study"
      },
      "source_chunk_ids": [
        "ba24f9acfd0b569d2da6a8bf7cc6be46"
      ],
      "confidence": 0.9,
      "evidence": "Alexander, M., Rothman, R.B., Baumann, M.H., Endres, C.J., Brasic, J.R. and Wong, D.F. (2005)",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Evidence",
      "name": "animal study",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "ba24f9acfd0b569d2da6a8bf7cc6be46"
      ],
      "confidence": 0.8,
      "evidence": "Noradrenergic and dopaminergic effects in baboon",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Study",
      "name": "Alim et al. (1995)",
      "attributes": {
        "year": 1995,
        "design": "clinical trial"
      },
      "source_chunk_ids": [
        "ba24f9acfd0b569d2da6a8bf7cc6be46"
      ],
      "confidence": 0.9,
      "evidence": "Alim, T.N., Rosse, R.B., Voci, F.J., Jr., Lindquist, T. and Deutsch, S.I. (1995)",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Evidence",
      "name": "clinical trial",
      "attributes": {
        "evidence_level": 4
      },
      "source_chunk_ids": [
        "ba24f9acfd0b569d2da6a8bf7cc6be46"
      ],
      "confidence": 0.8,
      "evidence": "Diethylpropion adjunct therapy for cocaine dependence",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Condition",
      "name": "cocaine dependence",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "ba24f9acfd0b569d2da6a8bf7cc6be46"
      ],
      "confidence": 0.9,
      "evidence": "cocaine dependence",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Study",
      "name": "Amara and Kuhar (1993)",
      "attributes": {
        "year": 1993,
        "design": "review"
      },
      "source_chunk_ids": [
        "ba24f9acfd0b569d2da6a8bf7cc6be46"
      ],
      "confidence": 0.9,
      "evidence": "Amara, S.G. and Kuhar, M.J. (1993)",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Evidence",
      "name": "neuroscience review",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "ba24f9acfd0b569d2da6a8bf7cc6be46"
      ],
      "confidence": 0.8,
      "evidence": "Neurotransmitter transporters: recent progress",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "serotonin transporter",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "d4fb025eccb3dcf3df18dc15056aad91"
      ],
      "confidence": 0.9,
      "evidence": "serotonin transporter (SERT)",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "5-HT1A receptor",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "d4fb025eccb3dcf3df18dc15056aad91"
      ],
      "confidence": 0.85,
      "evidence": "5-HT1A agonist",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "serotonin2C receptor",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "d4fb025eccb3dcf3df18dc15056aad91"
      ],
      "confidence": 0.8,
      "evidence": "Serotonin2C receptor",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "mitogen-activated protein kinase",
      "attributes": {
        "target_type": "pathway"
      },
      "source_chunk_ids": [
        "d4fb025eccb3dcf3df18dc15056aad91"
      ],
      "confidence": 0.75,
      "evidence": "mitogen-activated protein (MAP)-kinase cascades",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "dopamine systems",
      "attributes": {
        "target_type": "pathway"
      },
      "source_chunk_ids": [
        "d4fb025eccb3dcf3df18dc15056aad91"
      ],
      "confidence": 0.7,
      "evidence": "dopamine systems",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Target",
      "name": "5-HT receptors",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "d4fb025eccb3dcf3df18dc15056aad91"
      ],
      "confidence": 0.8,
      "evidence": "5-HT receptors",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Target",
      "name": "5-HT2C receptor",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "d4fb025eccb3dcf3df18dc15056aad91"
      ],
      "confidence": 0.75,
      "evidence": "5-Hydroxytryptamine 2C (5-HT2C) receptor",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Condition",
      "name": "pulmonary arterial hypertension",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "d4fb025eccb3dcf3df18dc15056aad91"
      ],
      "confidence": 0.85,
      "evidence": "pulmonary arterial hypertension",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Condition",
      "name": "hypoxic pulmonary hypertension",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "d4fb025eccb3dcf3df18dc15056aad91"
      ],
      "confidence": 0.8,
      "evidence": "hypoxic pulmonary hypertension",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Condition",
      "name": "cocaine withdrawal",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "d4fb025eccb3dcf3df18dc15056aad91"
      ],
      "confidence": 0.75,
      "evidence": "cocaine withdrawal",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Condition",
      "name": "cocaine dependence",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "d4fb025eccb3dcf3df18dc15056aad91"
      ],
      "confidence": 0.8,
      "evidence": "cocaine dependence",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Condition",
      "name": "suicidal behaviour",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "d4fb025eccb3dcf3df18dc15056aad91"
      ],
      "confidence": 0.7,
      "evidence": "suicidal behaviour",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Condition",
      "name": "obesity",
      "attributes": {
        "condition_type": "disease",
        "verification_needed": true
      },
      "source_chunk_ids": [
        "d4fb025eccb3dcf3df18dc15056aad91"
      ],
      "confidence": 0.65,
      "evidence": "antiobesity",
      "verified": false
    },
    {
      "id": "E14",
      "type": "AdverseEvent",
      "name": "primary pulmonary hypertension",
      "attributes": {
        "severity": "severe"
      },
      "source_chunk_ids": [
        "d4fb025eccb3dcf3df18dc15056aad91"
      ],
      "confidence": 0.75,
      "evidence": "primary pulmonary hypertension",
      "verified": true
    },
    {
      "id": "E15",
      "type": "Compound",
      "name": "\u03b4-fenfluramine",
      "attributes": {},
      "source_chunk_ids": [
        "d4fb025eccb3dcf3df18dc15056aad91"
      ],
      "confidence": 0.9,
      "evidence": "\u03b4-fenfluramine",
      "verified": true
    },
    {
      "id": "E16",
      "type": "Compound",
      "name": "8-OH-DPAT",
      "attributes": {},
      "source_chunk_ids": [
        "d4fb025eccb3dcf3df18dc15056aad91"
      ],
      "confidence": 0.85,
      "evidence": "8-OH-DPAT",
      "verified": true
    },
    {
      "id": "E17",
      "type": "Compound",
      "name": "fluoxetine",
      "attributes": {},
      "source_chunk_ids": [
        "d4fb025eccb3dcf3df18dc15056aad91"
      ],
      "confidence": 0.8,
      "evidence": "fluoxetine",
      "verified": true
    },
    {
      "id": "E18",
      "type": "Compound",
      "name": "p-chloroamphetamine",
      "attributes": {},
      "source_chunk_ids": [
        "d4fb025eccb3dcf3df18dc15056aad91"
      ],
      "confidence": 0.75,
      "evidence": "p-chloroamphetamine",
      "verified": true
    },
    {
      "id": "E19",
      "type": "Compound",
      "name": "reserpine",
      "attributes": {},
      "source_chunk_ids": [
        "d4fb025eccb3dcf3df18dc15056aad91"
      ],
      "confidence": 0.7,
      "evidence": "reserpine",
      "verified": true
    },
    {
      "id": "E20",
      "type": "Compound",
      "name": "amphetamine",
      "attributes": {},
      "source_chunk_ids": [
        "d4fb025eccb3dcf3df18dc15056aad91"
      ],
      "confidence": 0.8,
      "evidence": "amphetamine",
      "verified": true
    },
    {
      "id": "E21",
      "type": "Compound",
      "name": "cocaine",
      "attributes": {},
      "source_chunk_ids": [
        "d4fb025eccb3dcf3df18dc15056aad91"
      ],
      "confidence": 0.9,
      "evidence": "cocaine",
      "verified": true
    },
    {
      "id": "E22",
      "type": "Compound",
      "name": "serotonin",
      "attributes": {},
      "source_chunk_ids": [
        "d4fb025eccb3dcf3df18dc15056aad91"
      ],
      "confidence": 0.85,
      "evidence": "serotonin",
      "verified": true
    },
    {
      "id": "E23",
      "type": "Compound",
      "name": "L-tryptophan",
      "attributes": {},
      "source_chunk_ids": [
        "d4fb025eccb3dcf3df18dc15056aad91"
      ],
      "confidence": 0.7,
      "evidence": "L-tryptophan",
      "verified": true
    },
    {
      "id": "E24",
      "type": "Compound",
      "name": "trazodone",
      "attributes": {
        "verification_needed": true
      },
      "source_chunk_ids": [
        "d4fb025eccb3dcf3df18dc15056aad91"
      ],
      "confidence": 0.65,
      "evidence": "trazodone",
      "verified": false
    },
    {
      "id": "E25",
      "type": "Compound",
      "name": "m-chlorophenylpiperazine",
      "attributes": {
        "verification_needed": true
      },
      "source_chunk_ids": [
        "d4fb025eccb3dcf3df18dc15056aad91"
      ],
      "confidence": 0.6,
      "evidence": "m-chlorophenylpiperazine",
      "verified": false
    },
    {
      "id": "E26",
      "type": "Study",
      "name": "Marcos et al. (2003)",
      "attributes": {
        "year": 2003
      },
      "source_chunk_ids": [
        "d4fb025eccb3dcf3df18dc15056aad91"
      ],
      "confidence": 0.8,
      "evidence": "Marcos, E., Adnot, S., Pham, M.H., Nosjean, A., Raffestin, B., Hamon, M. and Eddahibi, S. (2003)",
      "verified": true
    },
    {
      "id": "E27",
      "type": "Study",
      "name": "McCann et al. (1997)",
      "attributes": {
        "year": 1997
      },
      "source_chunk_ids": [
        "d4fb025eccb3dcf3df18dc15056aad91"
      ],
      "confidence": 0.75,
      "evidence": "McCann, U.D., Seiden, L.S., Rubin, L.J. and Ricaurte, G.A. (1997)",
      "verified": true
    },
    {
      "id": "E28",
      "type": "Evidence",
      "name": "systematic review",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "d4fb025eccb3dcf3df18dc15056aad91"
      ],
      "confidence": 0.7,
      "evidence": "systematic review",
      "verified": true
    },
    {
      "id": "E29",
      "type": "Evidence",
      "name": "in vitro",
      "attributes": {
        "evidence_level": 2,
        "verification_needed": true
      },
      "source_chunk_ids": [
        "d4fb025eccb3dcf3df18dc15056aad91"
      ],
      "confidence": 0.6,
      "evidence": "in vitro",
      "verified": false
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Rothman et al. 1999",
      "attributes": {
        "year": 1999,
        "design": "in vitro study"
      },
      "source_chunk_ids": [
        "f463c7b416f26ce3da280b67c2e85439"
      ],
      "confidence": 0.8,
      "evidence": "Rothman, R.B., Ayestas, M.A., Dersch, C.M. and Baumann, M.H. (1999)",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "in vitro",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "f463c7b416f26ce3da280b67c2e85439"
      ],
      "confidence": 0.7,
      "evidence": "in vitro study",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Compound",
      "name": "aminorex",
      "attributes": {},
      "source_chunk_ids": [
        "f463c7b416f26ce3da280b67c2e85439"
      ],
      "confidence": 0.9,
      "evidence": "Aminorex",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Compound",
      "name": "fenfluramine",
      "attributes": {},
      "source_chunk_ids": [
        "f463c7b416f26ce3da280b67c2e85439"
      ],
      "confidence": 0.9,
      "evidence": "fenfluramine",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Compound",
      "name": "chlorphenamine",
      "attributes": {},
      "source_chunk_ids": [
        "f463c7b416f26ce3da280b67c2e85439"
      ],
      "confidence": 0.9,
      "evidence": "chlorphenamine",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Target",
      "name": "serotonin transporter",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "f463c7b416f26ce3da280b67c2e85439"
      ],
      "confidence": 0.85,
      "evidence": "serotonin transporter",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Condition",
      "name": "primary pulmonary hypertension",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "f463c7b416f26ce3da280b67c2e85439"
      ],
      "confidence": 0.8,
      "evidence": "primary pulmonary hypertension",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Study",
      "name": "Rothman et al. 2000a",
      "attributes": {
        "year": 2000,
        "design": "in vitro study"
      },
      "source_chunk_ids": [
        "f463c7b416f26ce3da280b67c2e85439"
      ],
      "confidence": 0.8,
      "evidence": "Rothman, R.B., Baumann, M.H., Savage, J.E., Rauser, L., McBride, A., Hufstein, S. and Roth, B.L. (2000a)",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Target",
      "name": "5-HT2B receptor",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "f463c7b416f26ce3da280b67c2e85439"
      ],
      "confidence": 0.85,
      "evidence": "5-HT2B receptors",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Condition",
      "name": "cardiac valvulopathy",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "f463c7b416f26ce3da280b67c2e85439"
      ],
      "confidence": 0.8,
      "evidence": "cardiac valvulopathy",
      "verified": true
    },
    {
      "id": "E11",
      "type": "AdverseEvent",
      "name": "valvular heart disease",
      "attributes": {
        "severity": "severe"
      },
      "source_chunk_ids": [
        "f463c7b416f26ce3da280b67c2e85439"
      ],
      "confidence": 0.75,
      "evidence": "valvular heart disease",
      "verified": true
    }
  ],
  "relationships": [
    {
      "id": "R1",
      "type": "SUGGESTS",
      "source_entity_id": "E15",
      "target_entity_id": "E1",
      "attributes": {
        "mapping_type": "interpretive",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "agonist therapy for cocaine addiction",
      "source_chunk_ids": [
        "5e4e759866a368650b92c7c1c6812eae"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R2",
      "type": "SUGGESTS",
      "source_entity_id": "E15",
      "target_entity_id": "E2",
      "attributes": {
        "mapping_type": "interpretive",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "agonist therapy for methamphetamine addiction",
      "source_chunk_ids": [
        "5e4e759866a368650b92c7c1c6812eae"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E8",
      "target_entity_id": "E10",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "5-HT neurons provide an inhibitory influence",
      "source_chunk_ids": [
        "5e4e759866a368650b92c7c1c6812eae"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E8",
      "target_entity_id": "E11",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "5-HT release can dampen DA-mediated stimulant effects",
      "source_chunk_ids": [
        "5e4e759866a368650b92c7c1c6812eae"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "TREATS",
      "source_entity_id": "E12",
      "target_entity_id": "E1",
      "attributes": {
        "context": "theoretical"
      },
      "confidence": 0.75,
      "evidence": "suppresses cocaine self-administration",
      "source_chunk_ids": [
        "5e4e759866a368650b92c7c1c6812eae"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "TREATS",
      "source_entity_id": "E12",
      "target_entity_id": "E3",
      "attributes": {
        "context": "theoretical"
      },
      "confidence": 0.7,
      "evidence": "treatment of alcohol addictions",
      "source_chunk_ids": [
        "5e4e759866a368650b92c7c1c6812eae"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "TREATS",
      "source_entity_id": "E12",
      "target_entity_id": "E4",
      "attributes": {
        "context": "theoretical"
      },
      "confidence": 0.7,
      "evidence": "treatment for obesity",
      "source_chunk_ids": [
        "5e4e759866a368650b92c7c1c6812eae"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "TREATS",
      "source_entity_id": "E12",
      "target_entity_id": "E5",
      "attributes": {
        "context": "theoretical"
      },
      "confidence": 0.7,
      "evidence": "treatment for attention deficit disorder",
      "source_chunk_ids": [
        "5e4e759866a368650b92c7c1c6812eae"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "TREATS",
      "source_entity_id": "E12",
      "target_entity_id": "E6",
      "attributes": {
        "context": "theoretical"
      },
      "confidence": 0.7,
      "evidence": "treatment for depression",
      "source_chunk_ids": [
        "5e4e759866a368650b92c7c1c6812eae"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "REPORTS",
      "source_entity_id": "E12",
      "target_entity_id": "E13",
      "attributes": {
        "outcome": "observed"
      },
      "confidence": 0.8,
      "evidence": "suppresses cocaine self-administration",
      "source_chunk_ids": [
        "5e4e759866a368650b92c7c1c6812eae"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "REPORTS",
      "source_entity_id": "E12",
      "target_entity_id": "E14",
      "attributes": {
        "outcome": "observed"
      },
      "confidence": 0.8,
      "evidence": "lacks positive reinforcing properties",
      "source_chunk_ids": [
        "5e4e759866a368650b92c7c1c6812eae"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E5",
      "target_entity_id": "E10",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "Rea et al., 1998",
      "source_chunk_ids": [
        "5268763697f5f696c251e9886636a663"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E6",
      "target_entity_id": "E10",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "Wojnicki et al., 1999",
      "source_chunk_ids": [
        "5268763697f5f696c251e9886636a663"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E7",
      "target_entity_id": "E10",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "Baumann et al., 2000",
      "source_chunk_ids": [
        "5268763697f5f696c251e9886636a663"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E8",
      "target_entity_id": "E10",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "Baumann et al., 2001",
      "source_chunk_ids": [
        "5268763697f5f696c251e9886636a663"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E9",
      "target_entity_id": "E10",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "Rothman and",
      "source_chunk_ids": [
        "5268763697f5f696c251e9886636a663"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R6",
      "type": "REPORTS",
      "source_entity_id": "E5",
      "target_entity_id": "E3",
      "attributes": {
        "outcome": "treats"
      },
      "confidence": 0.75,
      "evidence": "stimulant addiction",
      "source_chunk_ids": [
        "5268763697f5f696c251e9886636a663"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "REPORTS",
      "source_entity_id": "E5",
      "target_entity_id": "E4",
      "attributes": {
        "outcome": "treats"
      },
      "confidence": 0.75,
      "evidence": "alcohol addiction",
      "source_chunk_ids": [
        "5268763697f5f696c251e9886636a663"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "REPORTS",
      "source_entity_id": "E6",
      "target_entity_id": "E3",
      "attributes": {
        "outcome": "treats"
      },
      "confidence": 0.75,
      "evidence": "stimulant addiction",
      "source_chunk_ids": [
        "5268763697f5f696c251e9886636a663"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "REPORTS",
      "source_entity_id": "E6",
      "target_entity_id": "E4",
      "attributes": {
        "outcome": "treats"
      },
      "confidence": 0.75,
      "evidence": "alcohol addiction",
      "source_chunk_ids": [
        "5268763697f5f696c251e9886636a663"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "REPORTS",
      "source_entity_id": "E7",
      "target_entity_id": "E3",
      "attributes": {
        "outcome": "treats"
      },
      "confidence": 0.75,
      "evidence": "stimulant addiction",
      "source_chunk_ids": [
        "5268763697f5f696c251e9886636a663"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "REPORTS",
      "source_entity_id": "E7",
      "target_entity_id": "E4",
      "attributes": {
        "outcome": "treats"
      },
      "confidence": 0.75,
      "evidence": "alcohol addiction",
      "source_chunk_ids": [
        "5268763697f5f696c251e9886636a663"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "REPORTS",
      "source_entity_id": "E8",
      "target_entity_id": "E3",
      "attributes": {
        "outcome": "treats"
      },
      "confidence": 0.75,
      "evidence": "stimulant addiction",
      "source_chunk_ids": [
        "5268763697f5f696c251e9886636a663"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "REPORTS",
      "source_entity_id": "E8",
      "target_entity_id": "E4",
      "attributes": {
        "outcome": "treats"
      },
      "confidence": 0.75,
      "evidence": "alcohol addiction",
      "source_chunk_ids": [
        "5268763697f5f696c251e9886636a663"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R13",
      "type": "REPORTS",
      "source_entity_id": "E9",
      "target_entity_id": "E3",
      "attributes": {
        "outcome": "treats"
      },
      "confidence": 0.7,
      "evidence": "stimulant addiction",
      "source_chunk_ids": [
        "5268763697f5f696c251e9886636a663"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R14",
      "type": "REPORTS",
      "source_entity_id": "E9",
      "target_entity_id": "E4",
      "attributes": {
        "outcome": "treats"
      },
      "confidence": 0.7,
      "evidence": "alcohol addiction",
      "source_chunk_ids": [
        "5268763697f5f696c251e9886636a663"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "integrate our findings with the existing literature",
      "source_chunk_ids": [
        "1d21f261392efbd361304acd60d7267d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E2",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "integrate our findings with the existing literature",
      "source_chunk_ids": [
        "1d21f261392efbd361304acd60d7267d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E3",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "integrate our findings with the existing literature",
      "source_chunk_ids": [
        "1d21f261392efbd361304acd60d7267d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E6",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "cocaine and amphetamines that produce cardiovascular stimulation",
      "source_chunk_ids": [
        "1d21f261392efbd361304acd60d7267d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E6",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "cocaine and amphetamines that produce mood elevation",
      "source_chunk_ids": [
        "1d21f261392efbd361304acd60d7267d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "PRODUCES",
      "source_entity_id": "E6",
      "target_entity_id": "E10",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "cocaine and amphetamines that produce decreased need for sleep",
      "source_chunk_ids": [
        "1d21f261392efbd361304acd60d7267d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "PRODUCES",
      "source_entity_id": "E7",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "cocaine and amphetamines that produce cardiovascular stimulation",
      "source_chunk_ids": [
        "1d21f261392efbd361304acd60d7267d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "PRODUCES",
      "source_entity_id": "E7",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "cocaine and amphetamines that produce mood elevation",
      "source_chunk_ids": [
        "1d21f261392efbd361304acd60d7267d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "PRODUCES",
      "source_entity_id": "E7",
      "target_entity_id": "E10",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "cocaine and amphetamines that produce decreased need for sleep",
      "source_chunk_ids": [
        "1d21f261392efbd361304acd60d7267d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "CAUSES",
      "source_entity_id": "E6",
      "target_entity_id": "E11",
      "attributes": {
        "context": "high doses or longer use"
      },
      "confidence": 0.75,
      "evidence": "stimulants can cause disordered thoughts",
      "source_chunk_ids": [
        "1d21f261392efbd361304acd60d7267d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "CAUSES",
      "source_entity_id": "E7",
      "target_entity_id": "E11",
      "attributes": {
        "context": "high doses or longer use"
      },
      "confidence": 0.75,
      "evidence": "stimulants can cause disordered thoughts",
      "source_chunk_ids": [
        "1d21f261392efbd361304acd60d7267d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "REPORTS",
      "source_entity_id": "E5",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "Uhl and Johnson, 1994",
      "source_chunk_ids": [
        "ac1a75296f8c89bda21b6071a5d3238a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "REPORTS",
      "source_entity_id": "E6",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "Torres and Amara, 2007",
      "source_chunk_ids": [
        "ac1a75296f8c89bda21b6071a5d3238a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E7",
      "target_entity_id": "E10",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "Amara and Sonders, 1998",
      "source_chunk_ids": [
        "ac1a75296f8c89bda21b6071a5d3238a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E8",
      "target_entity_id": "E10",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "Iversen, 2006",
      "source_chunk_ids": [
        "ac1a75296f8c89bda21b6071a5d3238a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E9",
      "target_entity_id": "E10",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "inactivation of monoamine signalling ... profound effects on CNS function",
      "source_chunk_ids": [
        "ac1a75296f8c89bda21b6071a5d3238a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_CLASS",
      "source_entity_id": "E1",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "stimulant drugs",
      "source_chunk_ids": [
        "54188172c7a6b92f330b827dccbfbdad"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "HAS_CLASS",
      "source_entity_id": "E2",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "stimulant drugs",
      "source_chunk_ids": [
        "54188172c7a6b92f330b827dccbfbdad"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "HAS_CLASS",
      "source_entity_id": "E3",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "stimulant drugs",
      "source_chunk_ids": [
        "54188172c7a6b92f330b827dccbfbdad"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "HAS_CLASS",
      "source_entity_id": "E4",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "stimulant drugs",
      "source_chunk_ids": [
        "54188172c7a6b92f330b827dccbfbdad"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "HAS_CLASS",
      "source_entity_id": "E5",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "stimulant drugs",
      "source_chunk_ids": [
        "54188172c7a6b92f330b827dccbfbdad"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "HAS_CLASS",
      "source_entity_id": "E6",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "stimulant drugs",
      "source_chunk_ids": [
        "54188172c7a6b92f330b827dccbfbdad"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "HAS_CLASS",
      "source_entity_id": "E7",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "stimulant drugs",
      "source_chunk_ids": [
        "54188172c7a6b92f330b827dccbfbdad"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "HAS_CLASS",
      "source_entity_id": "E8",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "stimulant drugs",
      "source_chunk_ids": [
        "54188172c7a6b92f330b827dccbfbdad"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {
        "action": "interacts with"
      },
      "confidence": 0.75,
      "evidence": "interactions with the vesicular monoamine transporter 2",
      "source_chunk_ids": [
        "373e0a0b0e91145a4c78062620948992"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E4",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "promote efflux of transmitter by a process",
      "source_chunk_ids": [
        "373e0a0b0e91145a4c78062620948992"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E5",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "increase cytoplasmic levels of transmitter",
      "source_chunk_ids": [
        "373e0a0b0e91145a4c78062620948992"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E6",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "disrupting storage of transmitters in vesicles",
      "source_chunk_ids": [
        "373e0a0b0e91145a4c78062620948992"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E7",
      "target_entity_id": "E3",
      "attributes": {
        "assertion": "refutes",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "reuptake inhibitors can block the effects of releasers",
      "source_chunk_ids": [
        "373e0a0b0e91145a4c78062620948992"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "stimulants such as cocaine ... produces a 'high'",
      "source_chunk_ids": [
        "99340e432914aeae370104e5f4090e3a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "stimulants such as ... methamphetamine produces a 'high'",
      "source_chunk_ids": [
        "99340e432914aeae370104e5f4090e3a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "mediated by elevations in extracellular DA levels",
      "source_chunk_ids": [
        "99340e432914aeae370104e5f4090e3a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "mediated by elevations in extracellular DA levels",
      "source_chunk_ids": [
        "99340e432914aeae370104e5f4090e3a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "elevations in extracellular NE may also contribute",
      "source_chunk_ids": [
        "99340e432914aeae370104e5f4090e3a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E6",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "elevations in extracellular NE may also contribute",
      "source_chunk_ids": [
        "99340e432914aeae370104e5f4090e3a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "alcohol-induced increases ... positive reinforcing effects",
      "source_chunk_ids": [
        "99340e432914aeae370104e5f4090e3a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "alcohol-induced increases in extracellular DA",
      "source_chunk_ids": [
        "99340e432914aeae370104e5f4090e3a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "CAUSES",
      "source_entity_id": "E1",
      "target_entity_id": "E8",
      "attributes": {
        "context": "chronic misuse"
      },
      "confidence": 0.8,
      "evidence": "Repeated misuse of stimulants ... can lead to serious addiction",
      "source_chunk_ids": [
        "99340e432914aeae370104e5f4090e3a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "CAUSES",
      "source_entity_id": "E2",
      "target_entity_id": "E8",
      "attributes": {
        "context": "chronic misuse"
      },
      "confidence": 0.8,
      "evidence": "Repeated misuse of stimulants ... can lead to serious addiction",
      "source_chunk_ids": [
        "99340e432914aeae370104e5f4090e3a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "CAUSES",
      "source_entity_id": "E3",
      "target_entity_id": "E8",
      "attributes": {
        "context": "chronic abuse"
      },
      "confidence": 0.75,
      "evidence": "chronic abuse of stimulants and alcohol ... addiction",
      "source_chunk_ids": [
        "99340e432914aeae370104e5f4090e3a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "CAUSES",
      "source_entity_id": "E1",
      "target_entity_id": "E9",
      "attributes": {
        "context": "chronic abuse"
      },
      "confidence": 0.8,
      "evidence": "chronic abuse ... causes long-term changes",
      "source_chunk_ids": [
        "99340e432914aeae370104e5f4090e3a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R13",
      "type": "CAUSES",
      "source_entity_id": "E2",
      "target_entity_id": "E9",
      "attributes": {
        "context": "chronic abuse"
      },
      "confidence": 0.8,
      "evidence": "chronic abuse ... causes long-term changes",
      "source_chunk_ids": [
        "99340e432914aeae370104e5f4090e3a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R14",
      "type": "CAUSES",
      "source_entity_id": "E3",
      "target_entity_id": "E9",
      "attributes": {
        "context": "chronic abuse"
      },
      "confidence": 0.8,
      "evidence": "chronic abuse ... causes long-term changes",
      "source_chunk_ids": [
        "99340e432914aeae370104e5f4090e3a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R15",
      "type": "PRODUCES",
      "source_entity_id": "E5",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "mediated by elevations in extracellular DA levels",
      "source_chunk_ids": [
        "99340e432914aeae370104e5f4090e3a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R16",
      "type": "PRODUCES",
      "source_entity_id": "E8",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "addiction ... causes long-term changes",
      "source_chunk_ids": [
        "99340e432914aeae370104e5f4090e3a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "REPORTS",
      "source_entity_id": "E11",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "decreases"
      },
      "confidence": 0.75,
      "evidence": "decreased levels of extracellular DA",
      "source_chunk_ids": [
        "e75e60fb30c47f351ae165c2a93a3147"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "REPORTS",
      "source_entity_id": "E11",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "decreases"
      },
      "confidence": 0.75,
      "evidence": "decreased levels of extracellular 5-HT",
      "source_chunk_ids": [
        "e75e60fb30c47f351ae165c2a93a3147"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E12",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "decreases"
      },
      "confidence": 0.75,
      "evidence": "decreased levels of extracellular DA",
      "source_chunk_ids": [
        "e75e60fb30c47f351ae165c2a93a3147"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E12",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "decreases"
      },
      "confidence": 0.75,
      "evidence": "decreased levels of extracellular 5-HT",
      "source_chunk_ids": [
        "e75e60fb30c47f351ae165c2a93a3147"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E13",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "decreases"
      },
      "confidence": 0.75,
      "evidence": "decreased levels of extracellular DA",
      "source_chunk_ids": [
        "e75e60fb30c47f351ae165c2a93a3147"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "REPORTS",
      "source_entity_id": "E13",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "decreases"
      },
      "confidence": 0.75,
      "evidence": "decreased levels of extracellular 5-HT",
      "source_chunk_ids": [
        "e75e60fb30c47f351ae165c2a93a3147"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "REPORTS",
      "source_entity_id": "E14",
      "target_entity_id": "E7",
      "attributes": {
        "outcome": "decreases"
      },
      "confidence": 0.75,
      "evidence": "loss of DA D2 receptors",
      "source_chunk_ids": [
        "e75e60fb30c47f351ae165c2a93a3147"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "REPORTS",
      "source_entity_id": "E15",
      "target_entity_id": "E7",
      "attributes": {
        "outcome": "decreases"
      },
      "confidence": 0.75,
      "evidence": "loss of DA D2 receptors",
      "source_chunk_ids": [
        "e75e60fb30c47f351ae165c2a93a3147"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "REPORTS",
      "source_entity_id": "E16",
      "target_entity_id": "E8",
      "attributes": {
        "outcome": "decreases"
      },
      "confidence": 0.75,
      "evidence": "Neuroendocrine responsiveness to 5-HT releasers is diminished",
      "source_chunk_ids": [
        "e75e60fb30c47f351ae165c2a93a3147"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "REPORTS",
      "source_entity_id": "E17",
      "target_entity_id": "E8",
      "attributes": {
        "outcome": "decreases"
      },
      "confidence": 0.75,
      "evidence": "Neuroendocrine responsiveness to 5-HT releasers is diminished",
      "source_chunk_ids": [
        "e75e60fb30c47f351ae165c2a93a3147"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "REPORTS",
      "source_entity_id": "E18",
      "target_entity_id": "E8",
      "attributes": {
        "outcome": "decreases"
      },
      "confidence": 0.75,
      "evidence": "similar findings have been reported in abstinent human cocaine addicts",
      "source_chunk_ids": [
        "e75e60fb30c47f351ae165c2a93a3147"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "REPORTS",
      "source_entity_id": "E19",
      "target_entity_id": "E8",
      "attributes": {
        "outcome": "decreases"
      },
      "confidence": 0.75,
      "evidence": "similar findings have been reported in abstinent human cocaine addicts",
      "source_chunk_ids": [
        "e75e60fb30c47f351ae165c2a93a3147"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R13",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "withdrawal from chronic cocaine is decreased synaptic levels of DA",
      "source_chunk_ids": [
        "e75e60fb30c47f351ae165c2a93a3147"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R14",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E10",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "withdrawal from chronic cocaine is decreased synaptic levels of 5-HT",
      "source_chunk_ids": [
        "e75e60fb30c47f351ae165c2a93a3147"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R15",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "withdrawal from chronic cocaine, and possibly alcohol, is decreased synaptic levels of DA",
      "source_chunk_ids": [
        "e75e60fb30c47f351ae165c2a93a3147"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R16",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E10",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "withdrawal from chronic cocaine, and possibly alcohol, is decreased synaptic levels of 5-HT",
      "source_chunk_ids": [
        "e75e60fb30c47f351ae165c2a93a3147"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "SUGGESTS",
      "source_entity_id": "E4",
      "target_entity_id": "E5",
      "attributes": {
        "mapping_type": "direct"
      },
      "confidence": 0.8,
      "evidence": "5-HT dysfunction in mediating depression",
      "source_chunk_ids": [
        "739019506863bb79bcc7d89e6a0fec8c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "SUGGESTS",
      "source_entity_id": "E4",
      "target_entity_id": "E6",
      "attributes": {
        "mapping_type": "direct"
      },
      "confidence": 0.75,
      "evidence": "5-HT dysfunction in mediating suicide",
      "source_chunk_ids": [
        "739019506863bb79bcc7d89e6a0fec8c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "SUGGESTS",
      "source_entity_id": "E7",
      "target_entity_id": "E8",
      "attributes": {
        "mapping_type": "direct"
      },
      "confidence": 0.7,
      "evidence": "decreased synaptic 5-HT in cocaine withdrawal",
      "source_chunk_ids": [
        "739019506863bb79bcc7d89e6a0fec8c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "SUGGESTS",
      "source_entity_id": "E7",
      "target_entity_id": "E9",
      "attributes": {
        "mapping_type": "direct"
      },
      "confidence": 0.7,
      "evidence": "decreased synaptic 5-HT in alcohol withdrawal",
      "source_chunk_ids": [
        "739019506863bb79bcc7d89e6a0fec8c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "SUGGESTS",
      "source_entity_id": "E16",
      "target_entity_id": "E10",
      "attributes": {
        "mapping_type": "interpretive",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "deficits in monoamine systems underlie symptoms",
      "source_chunk_ids": [
        "739019506863bb79bcc7d89e6a0fec8c"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R6",
      "type": "SUGGESTS",
      "source_entity_id": "E16",
      "target_entity_id": "E11",
      "attributes": {
        "mapping_type": "interpretive",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "deficits in monoamine systems underlie symptoms",
      "source_chunk_ids": [
        "739019506863bb79bcc7d89e6a0fec8c"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R7",
      "type": "SUGGESTS",
      "source_entity_id": "E16",
      "target_entity_id": "E12",
      "attributes": {
        "mapping_type": "interpretive",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "deficits in monoamine systems underlie symptoms",
      "source_chunk_ids": [
        "739019506863bb79bcc7d89e6a0fec8c"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R8",
      "type": "SUGGESTS",
      "source_entity_id": "E16",
      "target_entity_id": "E13",
      "attributes": {
        "mapping_type": "interpretive",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "deficits in monoamine systems underlie symptoms",
      "source_chunk_ids": [
        "739019506863bb79bcc7d89e6a0fec8c"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R9",
      "type": "SUGGESTS",
      "source_entity_id": "E16",
      "target_entity_id": "E14",
      "attributes": {
        "mapping_type": "interpretive",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "deficits in monoamine systems underlie symptoms",
      "source_chunk_ids": [
        "739019506863bb79bcc7d89e6a0fec8c"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R10",
      "type": "SUGGESTS",
      "source_entity_id": "E16",
      "target_entity_id": "E15",
      "attributes": {
        "mapping_type": "interpretive",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "deficits in monoamine systems underlie symptoms",
      "source_chunk_ids": [
        "739019506863bb79bcc7d89e6a0fec8c"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "DA dysfunction contributes to withdrawal symptoms",
      "source_chunk_ids": [
        "27d60c76638cac35174e70812a614f27"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "DA dysfunction contributes to drug craving",
      "source_chunk_ids": [
        "27d60c76638cac35174e70812a614f27"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "DA dysfunction contributes to relapse",
      "source_chunk_ids": [
        "27d60c76638cac35174e70812a614f27"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E3",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "5-HT dysfunction contributes to withdrawal symptoms",
      "source_chunk_ids": [
        "27d60c76638cac35174e70812a614f27"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E4",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "5-HT dysfunction contributes to drug craving",
      "source_chunk_ids": [
        "27d60c76638cac35174e70812a614f27"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R6",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E5",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "5-HT dysfunction contributes to relapse",
      "source_chunk_ids": [
        "27d60c76638cac35174e70812a614f27"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R7",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E6",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "Baumann and Rothman, 1998a, b",
      "source_chunk_ids": [
        "27d60c76638cac35174e70812a614f27"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "REPORTS",
      "source_entity_id": "E6",
      "target_entity_id": "E1",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "drug-induced DA dysfunction",
      "source_chunk_ids": [
        "27d60c76638cac35174e70812a614f27"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R9",
      "type": "REPORTS",
      "source_entity_id": "E6",
      "target_entity_id": "E2",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "drug-induced 5-HT dysfunction",
      "source_chunk_ids": [
        "27d60c76638cac35174e70812a614f27"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R10",
      "type": "REPORTS",
      "source_entity_id": "E6",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "withdrawal symptoms",
      "source_chunk_ids": [
        "27d60c76638cac35174e70812a614f27"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "REPORTS",
      "source_entity_id": "E6",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "drug craving",
      "source_chunk_ids": [
        "27d60c76638cac35174e70812a614f27"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "REPORTS",
      "source_entity_id": "E6",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "relapse",
      "source_chunk_ids": [
        "27d60c76638cac35174e70812a614f27"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "action": "decrease"
      },
      "confidence": 0.75,
      "evidence": "decreased synaptic DA underlies anhedonia",
      "source_chunk_ids": [
        "a8c8d0c88ed162af1354041ab7d1fdb9"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "action": "decrease"
      },
      "confidence": 0.75,
      "evidence": "decreased synaptic DA underlies psychomotor retardation",
      "source_chunk_ids": [
        "a8c8d0c88ed162af1354041ab7d1fdb9"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E5",
      "attributes": {
        "action": "decrease"
      },
      "confidence": 0.75,
      "evidence": "decreased synaptic 5-HT gives rise to depressed mood",
      "source_chunk_ids": [
        "a8c8d0c88ed162af1354041ab7d1fdb9"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E6",
      "attributes": {
        "action": "decrease"
      },
      "confidence": 0.7,
      "evidence": "decreased synaptic 5-HT gives rise to obsessive thoughts",
      "source_chunk_ids": [
        "a8c8d0c88ed162af1354041ab7d1fdb9"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E7",
      "attributes": {
        "action": "decrease"
      },
      "confidence": 0.7,
      "evidence": "decreased synaptic 5-HT gives rise to lack of impulse control",
      "source_chunk_ids": [
        "a8c8d0c88ed162af1354041ab7d1fdb9"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "preclinical results",
      "source_chunk_ids": [
        "0cc6a8fb8c98dc1494145ccbd1d3dd98"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E2",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "preclinical results",
      "source_chunk_ids": [
        "0cc6a8fb8c98dc1494145ccbd1d3dd98"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E3",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "preclinical results",
      "source_chunk_ids": [
        "0cc6a8fb8c98dc1494145ccbd1d3dd98"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E8",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.75,
      "evidence": "d-amphetamine",
      "source_chunk_ids": [
        "0cc6a8fb8c98dc1494145ccbd1d3dd98"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "STUDIES",
      "source_entity_id": "E3",
      "target_entity_id": "E9",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.75,
      "evidence": "phentermine",
      "source_chunk_ids": [
        "0cc6a8fb8c98dc1494145ccbd1d3dd98"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E12",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.7,
      "evidence": "decreases cocaine self-administration",
      "source_chunk_ids": [
        "0cc6a8fb8c98dc1494145ccbd1d3dd98"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "REPORTS",
      "source_entity_id": "E3",
      "target_entity_id": "E13",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.7,
      "evidence": "suppresses responding for cocaine injections",
      "source_chunk_ids": [
        "0cc6a8fb8c98dc1494145ccbd1d3dd98"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "REPORTS",
      "source_entity_id": "E4",
      "target_entity_id": "E11",
      "attributes": {
        "outcome": "suggests_treatment",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "treating cocaine addiction",
      "source_chunk_ids": [
        "0cc6a8fb8c98dc1494145ccbd1d3dd98"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R9",
      "type": "REPORTS",
      "source_entity_id": "E5",
      "target_entity_id": "E11",
      "attributes": {
        "outcome": "suggests_treatment",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "treating cocaine addiction",
      "source_chunk_ids": [
        "0cc6a8fb8c98dc1494145ccbd1d3dd98"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R10",
      "type": "REPORTS",
      "source_entity_id": "E6",
      "target_entity_id": "E11",
      "attributes": {
        "outcome": "suggests_treatment",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "treating cocaine addiction",
      "source_chunk_ids": [
        "0cc6a8fb8c98dc1494145ccbd1d3dd98"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R11",
      "type": "HAS_CLASS",
      "source_entity_id": "E8",
      "target_entity_id": "E10",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "DA releasers, such as d-amphetamine",
      "source_chunk_ids": [
        "0cc6a8fb8c98dc1494145ccbd1d3dd98"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "HAS_CLASS",
      "source_entity_id": "E9",
      "target_entity_id": "E10",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "DA-releasing agent phentermine",
      "source_chunk_ids": [
        "0cc6a8fb8c98dc1494145ccbd1d3dd98"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R13",
      "type": "TREATS",
      "source_entity_id": "E10",
      "target_entity_id": "E11",
      "attributes": {
        "context": "preclinical"
      },
      "confidence": 0.75,
      "evidence": "using DA releasers as medications for treating cocaine addiction",
      "source_chunk_ids": [
        "0cc6a8fb8c98dc1494145ccbd1d3dd98"
      ],
      "supporting_study_ids": [
        "E1",
        "E2",
        "E3",
        "E4",
        "E5",
        "E6"
      ],
      "verified": true
    },
    {
      "id": "R14",
      "type": "PRODUCES",
      "source_entity_id": "E8",
      "target_entity_id": "E12",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "d-amphetamine, decreases cocaine self-administration",
      "source_chunk_ids": [
        "0cc6a8fb8c98dc1494145ccbd1d3dd98"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R15",
      "type": "PRODUCES",
      "source_entity_id": "E9",
      "target_entity_id": "E13",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "phentermine suppresses responding for cocaine injections",
      "source_chunk_ids": [
        "0cc6a8fb8c98dc1494145ccbd1d3dd98"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "fenfluramine decreases responding for cocaine",
      "source_chunk_ids": [
        "3363929e19d1bdb8822dee231bd8508d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "phentermine plus fenfluramine produces decrease",
      "source_chunk_ids": [
        "3363929e19d1bdb8822dee231bd8508d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E5",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "Negus et al., 2007 reports decrease",
      "source_chunk_ids": [
        "3363929e19d1bdb8822dee231bd8508d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E6",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "Glowa et al., 1997 reports decrease",
      "source_chunk_ids": [
        "3363929e19d1bdb8822dee231bd8508d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E5",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "study in rhesus monkeys",
      "source_chunk_ids": [
        "3363929e19d1bdb8822dee231bd8508d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E6",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "study in monkeys",
      "source_chunk_ids": [
        "3363929e19d1bdb8822dee231bd8508d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E15",
      "target_entity_id": "E17",
      "attributes": {
        "context": "deficit model"
      },
      "confidence": 0.8,
      "evidence": "DOPAMINE DEFICIT, decreased synaptic DA",
      "source_chunk_ids": [
        "3afe1d9ef100e1705e32be19daa3ab2e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E15",
      "target_entity_id": "E18",
      "attributes": {
        "context": "deficit model"
      },
      "confidence": 0.8,
      "evidence": "DOPAMINE DEFICIT, altered DA transporter function",
      "source_chunk_ids": [
        "3afe1d9ef100e1705e32be19daa3ab2e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E15",
      "target_entity_id": "E19",
      "attributes": {
        "context": "deficit model"
      },
      "confidence": 0.75,
      "evidence": "DOPAMINE DEFICIT, postsynaptic receptor changes",
      "source_chunk_ids": [
        "3afe1d9ef100e1705e32be19daa3ab2e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E16",
      "target_entity_id": "E20",
      "attributes": {
        "context": "deficit model"
      },
      "confidence": 0.8,
      "evidence": "SEROTONIN DEFICIT, decreased synaptic 5-HT",
      "source_chunk_ids": [
        "3afe1d9ef100e1705e32be19daa3ab2e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E16",
      "target_entity_id": "E21",
      "attributes": {
        "context": "deficit model"
      },
      "confidence": 0.8,
      "evidence": "SEROTONIN DEFICIT, decreased 5-HT cell activity",
      "source_chunk_ids": [
        "3afe1d9ef100e1705e32be19daa3ab2e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "PRODUCES",
      "source_entity_id": "E16",
      "target_entity_id": "E19",
      "attributes": {
        "context": "deficit model"
      },
      "confidence": 0.75,
      "evidence": "SEROTONIN DEFICIT, postsynaptic receptor changes",
      "source_chunk_ids": [
        "3afe1d9ef100e1705e32be19daa3ab2e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {
        "level": "systemic",
        "valence": "negative"
      },
      "confidence": 0.75,
      "evidence": "DA dysfunction underlies anhedonia",
      "source_chunk_ids": [
        "c993c9c96de91fea924b3244322dd7ae"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E7",
      "attributes": {
        "level": "systemic",
        "valence": "negative"
      },
      "confidence": 0.75,
      "evidence": "DA dysfunction underlies psychomotor disturbances",
      "source_chunk_ids": [
        "c993c9c96de91fea924b3244322dd7ae"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E8",
      "attributes": {
        "level": "systemic",
        "valence": "negative"
      },
      "confidence": 0.75,
      "evidence": "5-HT dysfunction causes depressed mood",
      "source_chunk_ids": [
        "c993c9c96de91fea924b3244322dd7ae"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E9",
      "attributes": {
        "level": "systemic",
        "valence": "negative"
      },
      "confidence": 0.75,
      "evidence": "5-HT dysfunction causes obsessive thoughts",
      "source_chunk_ids": [
        "c993c9c96de91fea924b3244322dd7ae"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E10",
      "attributes": {
        "level": "systemic",
        "valence": "negative"
      },
      "confidence": 0.75,
      "evidence": "5-HT dysfunction causes lack of impulse control",
      "source_chunk_ids": [
        "c993c9c96de91fea924b3244322dd7ae"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E11",
      "target_entity_id": "E12",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "Adapted with permission from Rothman and Baumann (2003)",
      "source_chunk_ids": [
        "c993c9c96de91fea924b3244322dd7ae"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "REPORTS",
      "source_entity_id": "E11",
      "target_entity_id": "E1",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "decreased synaptic availability of DA",
      "source_chunk_ids": [
        "c993c9c96de91fea924b3244322dd7ae"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "REPORTS",
      "source_entity_id": "E11",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "decreased synaptic availability of 5-HT",
      "source_chunk_ids": [
        "c993c9c96de91fea924b3244322dd7ae"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "REPORTS",
      "source_entity_id": "E11",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "contributes to withdrawal symptoms",
      "source_chunk_ids": [
        "c993c9c96de91fea924b3244322dd7ae"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "REPORTS",
      "source_entity_id": "E11",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "contributes to drug craving",
      "source_chunk_ids": [
        "c993c9c96de91fea924b3244322dd7ae"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "REPORTS",
      "source_entity_id": "E11",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "contributes to relapse",
      "source_chunk_ids": [
        "c993c9c96de91fea924b3244322dd7ae"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "REPORTS",
      "source_entity_id": "E3",
      "target_entity_id": "E2",
      "attributes": {
        "outcome": "reduces"
      },
      "confidence": 0.85,
      "evidence": "reduces cocaine self-administration",
      "source_chunk_ids": [
        "9f3218ad44d746766a5bfa5f02e43312"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E3",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "in rats",
      "source_chunk_ids": [
        "9f3218ad44d746766a5bfa5f02e43312"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "STUDIES",
      "source_entity_id": "E3",
      "target_entity_id": "E1",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.85,
      "evidence": "D-fenfluramine",
      "source_chunk_ids": [
        "9f3218ad44d746766a5bfa5f02e43312"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E7",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "suppresses"
      },
      "confidence": 0.85,
      "evidence": "suppress cue-elicited cocaine-seeking behaviour",
      "source_chunk_ids": [
        "9f3218ad44d746766a5bfa5f02e43312"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E7",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "in rats",
      "source_chunk_ids": [
        "9f3218ad44d746766a5bfa5f02e43312"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "STUDIES",
      "source_entity_id": "E7",
      "target_entity_id": "E5",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.85,
      "evidence": "5-HT-releasing agents",
      "source_chunk_ids": [
        "9f3218ad44d746766a5bfa5f02e43312"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "REPORTS",
      "source_entity_id": "E9",
      "target_entity_id": "E8",
      "attributes": {
        "outcome": "decrease"
      },
      "confidence": 0.85,
      "evidence": "decrease cocaine craving",
      "source_chunk_ids": [
        "9f3218ad44d746766a5bfa5f02e43312"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E9",
      "target_entity_id": "E10",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "cocaine-dependent human patients",
      "source_chunk_ids": [
        "9f3218ad44d746766a5bfa5f02e43312"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "STUDIES",
      "source_entity_id": "E9",
      "target_entity_id": "E5",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.85,
      "evidence": "5-HT-releasing agents",
      "source_chunk_ids": [
        "9f3218ad44d746766a5bfa5f02e43312"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "TREATS",
      "source_entity_id": "E11",
      "target_entity_id": "E12",
      "attributes": {
        "context": "therapeutic"
      },
      "confidence": 0.75,
      "evidence": "decreasing stimulant self-administration",
      "source_chunk_ids": [
        "9f3218ad44d746766a5bfa5f02e43312"
      ],
      "supporting_study_ids": [
        "E3",
        "E7",
        "E9"
      ],
      "verified": true
    },
    {
      "id": "R11",
      "type": "TREATS",
      "source_entity_id": "E11",
      "target_entity_id": "E13",
      "attributes": {
        "context": "therapeutic"
      },
      "confidence": 0.75,
      "evidence": "reducing cue-induced relapse",
      "source_chunk_ids": [
        "9f3218ad44d746766a5bfa5f02e43312"
      ],
      "supporting_study_ids": [
        "E3",
        "E7",
        "E9"
      ],
      "verified": true
    },
    {
      "id": "R12",
      "type": "TREATS",
      "source_entity_id": "E11",
      "target_entity_id": "E14",
      "attributes": {
        "context": "therapeutic"
      },
      "confidence": 0.7,
      "evidence": "therapeutic benefits for alcohol dependence",
      "source_chunk_ids": [
        "9f3218ad44d746766a5bfa5f02e43312"
      ],
      "supporting_study_ids": [
        "E15",
        "E16"
      ],
      "verified": true
    },
    {
      "id": "R13",
      "type": "STUDIES",
      "source_entity_id": "E15",
      "target_entity_id": "E11",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.8,
      "evidence": "DA/5-HT-releasing agents",
      "source_chunk_ids": [
        "9f3218ad44d746766a5bfa5f02e43312"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R14",
      "type": "STUDIES",
      "source_entity_id": "E16",
      "target_entity_id": "E11",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.8,
      "evidence": "DA/5-HT-releasing agents",
      "source_chunk_ids": [
        "9f3218ad44d746766a5bfa5f02e43312"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "SUGGESTS",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {
        "mapping_type": "interpretive"
      },
      "confidence": 0.7,
      "evidence": "decrease stimulant abuse",
      "source_chunk_ids": [
        "62675204c6afc820766a5babedc84411"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "SUGGESTS",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "mapping_type": "interpretive"
      },
      "confidence": 0.7,
      "evidence": "nicotine dependence",
      "source_chunk_ids": [
        "62675204c6afc820766a5babedc84411"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "SUGGESTS",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "mapping_type": "interpretive"
      },
      "confidence": 0.7,
      "evidence": "opioid dependence",
      "source_chunk_ids": [
        "62675204c6afc820766a5babedc84411"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "SUGGESTS",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "mapping_type": "interpretive"
      },
      "confidence": 0.7,
      "evidence": "cocaine dependence",
      "source_chunk_ids": [
        "62675204c6afc820766a5babedc84411"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "ACTS_ON",
      "source_entity_id": "E7",
      "target_entity_id": "E6",
      "attributes": {
        "action": "activates"
      },
      "confidence": 0.75,
      "evidence": "activation of mesolimbic DA neurons",
      "source_chunk_ids": [
        "62675204c6afc820766a5babedc84411"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "synaptic 5-HT counteract the stimulant and reinforcing effects",
      "source_chunk_ids": [
        "d2ed63a86880844af8294b6dd89d65d6"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "effects mediated by elevations in synaptic DA",
      "source_chunk_ids": [
        "d2ed63a86880844af8294b6dd89d65d6"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E4",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "L-tryptophan, which increases 5-HT synthesis and release",
      "source_chunk_ids": [
        "d2ed63a86880844af8294b6dd89d65d6"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "TREATS",
      "source_entity_id": "E4",
      "target_entity_id": "E6",
      "attributes": {
        "context": "preclinical"
      },
      "confidence": 0.7,
      "evidence": "decreases self-administration of cocaine",
      "source_chunk_ids": [
        "d2ed63a86880844af8294b6dd89d65d6"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "TREATS",
      "source_entity_id": "E4",
      "target_entity_id": "E7",
      "attributes": {
        "context": "preclinical"
      },
      "confidence": 0.7,
      "evidence": "amphetamine in rats",
      "source_chunk_ids": [
        "d2ed63a86880844af8294b6dd89d65d6"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "TREATS",
      "source_entity_id": "E8",
      "target_entity_id": "E9",
      "attributes": {
        "context": "preclinical"
      },
      "confidence": 0.7,
      "evidence": "reduce intravenous cocaine self-administration",
      "source_chunk_ids": [
        "d2ed63a86880844af8294b6dd89d65d6"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "ACTS_ON",
      "source_entity_id": "E8",
      "target_entity_id": "E10",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.75,
      "evidence": "5-HT reuptake inhibitors",
      "source_chunk_ids": [
        "d2ed63a86880844af8294b6dd89d65d6"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "PRODUCES",
      "source_entity_id": "E10",
      "target_entity_id": "E11",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "potent affinity at SERT support less self-administration behaviour",
      "source_chunk_ids": [
        "d2ed63a86880844af8294b6dd89d65d6"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E12",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "anti-stimulant effects of increasing extracellular 5-HT",
      "source_chunk_ids": [
        "d2ed63a86880844af8294b6dd89d65d6"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "indirect DA agonists are strong locomotor stimulants",
      "source_chunk_ids": [
        "de55bb27b736b486b5727fd154119b0b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "support self-administration behaviour",
      "source_chunk_ids": [
        "de55bb27b736b486b5727fd154119b0b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "ACTS_ON",
      "source_entity_id": "E5",
      "target_entity_id": "E1",
      "attributes": {
        "action": "releases"
      },
      "confidence": 0.75,
      "evidence": "Drugs that release [^{3}\\text{H}]5-HT more potently",
      "source_chunk_ids": [
        "de55bb27b736b486b5727fd154119b0b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "ACTS_ON",
      "source_entity_id": "E6",
      "target_entity_id": "E1",
      "attributes": {
        "action": "releases"
      },
      "confidence": 0.75,
      "evidence": "Drugs that release [^{3}\\text{H}]5-HT more potently",
      "source_chunk_ids": [
        "de55bb27b736b486b5727fd154119b0b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "increase endogenous extracellular 5-HT",
      "source_chunk_ids": [
        "de55bb27b736b486b5727fd154119b0b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "more than extracellular DA",
      "source_chunk_ids": [
        "de55bb27b736b486b5727fd154119b0b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "produce minimal motor activity",
      "source_chunk_ids": [
        "de55bb27b736b486b5727fd154119b0b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E10",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "do not support self-administration behaviour",
      "source_chunk_ids": [
        "de55bb27b736b486b5727fd154119b0b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E11",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "anti-stimulant effect of 5-HT releasers",
      "source_chunk_ids": [
        "de55bb27b736b486b5727fd154119b0b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "REPORTS",
      "source_entity_id": "E12",
      "target_entity_id": "E14",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "positive CPP induced by phentermine",
      "source_chunk_ids": [
        "de55bb27b736b486b5727fd154119b0b"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R11",
      "type": "REPORTS",
      "source_entity_id": "E12",
      "target_entity_id": "E15",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "greatly reduces the positive CPP",
      "source_chunk_ids": [
        "de55bb27b736b486b5727fd154119b0b"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R12",
      "type": "PRODUCES",
      "source_entity_id": "E13",
      "target_entity_id": "E14",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "positive CPP induced by phentermine",
      "source_chunk_ids": [
        "de55bb27b736b486b5727fd154119b0b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R13",
      "type": "PRODUCES",
      "source_entity_id": "E5",
      "target_entity_id": "E15",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "low dose of fenfluramine greatly reduces the positive CPP",
      "source_chunk_ids": [
        "de55bb27b736b486b5727fd154119b0b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E7",
      "target_entity_id": "E6",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "increases in extracellular 5-HT would be expected",
      "source_chunk_ids": [
        "30f8a86b00b9d3a882a7db7899d606d6"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "ACTS_ON",
      "source_entity_id": "E7",
      "target_entity_id": "E1",
      "attributes": {
        "action": "activates"
      },
      "confidence": 0.8,
      "evidence": "activate multiple 5-HT receptor subtypes",
      "source_chunk_ids": [
        "30f8a86b00b9d3a882a7db7899d606d6"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {
        "action": "modulates"
      },
      "confidence": 0.8,
      "evidence": "modulate DA function",
      "source_chunk_ids": [
        "30f8a86b00b9d3a882a7db7899d606d6"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "mediated via the activation of mesolimbic DA neurons",
      "source_chunk_ids": [
        "30f8a86b00b9d3a882a7db7899d606d6"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E9",
      "target_entity_id": "E1",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "Muller and Huston, 2006",
      "source_chunk_ids": [
        "30f8a86b00b9d3a882a7db7899d606d6"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "REPORTS",
      "source_entity_id": "E10",
      "target_entity_id": "E1",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "Alex and Pehek, 2007",
      "source_chunk_ids": [
        "30f8a86b00b9d3a882a7db7899d606d6"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "REPORTS",
      "source_entity_id": "E11",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "Ungerstedt, 1971",
      "source_chunk_ids": [
        "30f8a86b00b9d3a882a7db7899d606d6"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "REPORTS",
      "source_entity_id": "E12",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "Moore and Bloom, 1978",
      "source_chunk_ids": [
        "30f8a86b00b9d3a882a7db7899d606d6"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "PHEN-Induced Condition Place Preference",
      "source_chunk_ids": [
        "dda0363fded7427259efde81f7397182"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "FEN Eliminates PHEN-Induced Condition Place Preference",
      "source_chunk_ids": [
        "dda0363fded7427259efde81f7397182"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "INTERACTS_WITH",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {
        "interaction_type": "antagonistic",
        "bidirectional": true
      },
      "confidence": 0.75,
      "evidence": "FEN Eliminates PHEN-Induced Condition Place Preference",
      "source_chunk_ids": [
        "dda0363fded7427259efde81f7397182"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "Data taken with permission from Rea et al. (1998)",
      "source_chunk_ids": [
        "fe44678f93a1da57f462f122e8074785"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.85,
      "evidence": "Effects of phentermine",
      "source_chunk_ids": [
        "fe44678f93a1da57f462f122e8074785"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.85,
      "evidence": "Effects of fenfluramine",
      "source_chunk_ids": [
        "fe44678f93a1da57f462f122e8074785"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "TESTED_AT",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "phentermine (3 mg/kg) administered i.p.",
      "source_chunk_ids": [
        "fe44678f93a1da57f462f122e8074785"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "TESTED_AT",
      "source_entity_id": "E1",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "fenfluramine (0.3 mg/kg) administered i.p.",
      "source_chunk_ids": [
        "fe44678f93a1da57f462f122e8074785"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "produces"
      },
      "confidence": 0.85,
      "evidence": "Effects on conditioned place preference",
      "source_chunk_ids": [
        "fe44678f93a1da57f462f122e8074785"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "phentermine effects on place preference",
      "source_chunk_ids": [
        "fe44678f93a1da57f462f122e8074785"
      ],
      "supporting_study_ids": [
        "E1"
      ],
      "verified": true
    },
    {
      "id": "R8",
      "type": "PRODUCES",
      "source_entity_id": "E4",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "fenfluramine effects on place preference",
      "source_chunk_ids": [
        "fe44678f93a1da57f462f122e8074785"
      ],
      "supporting_study_ids": [
        "E1"
      ],
      "verified": true
    },
    {
      "id": "R1",
      "type": "REPORTS",
      "source_entity_id": "E3",
      "target_entity_id": "E2",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "Barnes and Sharp, 1999",
      "source_chunk_ids": [
        "a0fa87456a5129678532e4a425705ea5"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R2",
      "type": "REPORTS",
      "source_entity_id": "E4",
      "target_entity_id": "E2",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "Hoyer et al., 2002",
      "source_chunk_ids": [
        "a0fa87456a5129678532e4a425705ea5"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {
        "action": "enhances"
      },
      "confidence": 0.85,
      "evidence": "5-HT receptor subtypes enhance DA transmission",
      "source_chunk_ids": [
        "a69bc2330b04aecbcdf9901bd8dfa90f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "ACTS_ON",
      "source_entity_id": "E3",
      "target_entity_id": "E4",
      "attributes": {
        "action": "provides"
      },
      "confidence": 0.9,
      "evidence": "5-HT2C receptors provide a strong inhibitory influence",
      "source_chunk_ids": [
        "a69bc2330b04aecbcdf9901bd8dfa90f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "ACTS_ON",
      "source_entity_id": "E5",
      "target_entity_id": "E3",
      "attributes": {
        "action": "agonist"
      },
      "confidence": 0.9,
      "evidence": "5-HT2C agonist Ro 60-0175",
      "source_chunk_ids": [
        "a69bc2330b04aecbcdf9901bd8dfa90f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E5",
      "target_entity_id": "E6",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "Ro 60-0175 markedly inhibits DA cell firing",
      "source_chunk_ids": [
        "a69bc2330b04aecbcdf9901bd8dfa90f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E5",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "decreases extracellular levels of DA",
      "source_chunk_ids": [
        "a69bc2330b04aecbcdf9901bd8dfa90f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "PRODUCES",
      "source_entity_id": "E5",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "reduces locomotor activity",
      "source_chunk_ids": [
        "a69bc2330b04aecbcdf9901bd8dfa90f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "PRODUCES",
      "source_entity_id": "E5",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "reduces self-administration behaviour",
      "source_chunk_ids": [
        "a69bc2330b04aecbcdf9901bd8dfa90f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "ACTS_ON",
      "source_entity_id": "E10",
      "target_entity_id": "E3",
      "attributes": {
        "action": "antagonist"
      },
      "confidence": 0.9,
      "evidence": "5-HT2C antagonist SB 242084",
      "source_chunk_ids": [
        "a69bc2330b04aecbcdf9901bd8dfa90f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "PRODUCES",
      "source_entity_id": "E10",
      "target_entity_id": "E11",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "SB 242084 increases burst firing of DA cells",
      "source_chunk_ids": [
        "a69bc2330b04aecbcdf9901bd8dfa90f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E12",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "5-HT2C receptors provide tonic inhibition",
      "source_chunk_ids": [
        "a69bc2330b04aecbcdf9901bd8dfa90f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "anti-stimulant effects of 5-HT2C receptor activation",
      "source_chunk_ids": [
        "e1e383aea24e95b5ee4324e98eec7bed"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "ACTS_ON",
      "source_entity_id": "E5",
      "target_entity_id": "E1",
      "attributes": {
        "action": "activates"
      },
      "confidence": 0.8,
      "evidence": "Microinjection of Ro 60-0175",
      "source_chunk_ids": [
        "e1e383aea24e95b5ee4324e98eec7bed"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "TREATS",
      "source_entity_id": "E5",
      "target_entity_id": "E6",
      "attributes": {
        "context": "preclinical"
      },
      "confidence": 0.75,
      "evidence": "blocks behavioural effects of cocaine",
      "source_chunk_ids": [
        "e1e383aea24e95b5ee4324e98eec7bed"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "TREATS",
      "source_entity_id": "E5",
      "target_entity_id": "E7",
      "attributes": {
        "context": "preclinical"
      },
      "confidence": 0.75,
      "evidence": "reduces cocaine-induced locomotor activity",
      "source_chunk_ids": [
        "e1e383aea24e95b5ee4324e98eec7bed"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "mediated by the stimulation of GABA interneurons",
      "source_chunk_ids": [
        "e1e383aea24e95b5ee4324e98eec7bed"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "SUGGESTS",
      "source_entity_id": "E10",
      "target_entity_id": "E9",
      "attributes": {
        "mapping_type": "direct"
      },
      "confidence": 0.8,
      "evidence": "5-HT2C agonists as medications for substance use disorders",
      "source_chunk_ids": [
        "e1e383aea24e95b5ee4324e98eec7bed"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "HAS_CLASS",
      "source_entity_id": "E5",
      "target_entity_id": "E10",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "Ro 60-0175 is a 5-HT2C agonist",
      "source_chunk_ids": [
        "e1e383aea24e95b5ee4324e98eec7bed"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "CAUSES",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.7,
      "evidence": "associated with adverse effects",
      "source_chunk_ids": [
        "8b7d40ddc4cc4e2888c61d47da508346"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "CAUSES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.7,
      "evidence": "associated with adverse effects",
      "source_chunk_ids": [
        "8b7d40ddc4cc4e2888c61d47da508346"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "CAUSES",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.7,
      "evidence": "associated with adverse effects",
      "source_chunk_ids": [
        "8b7d40ddc4cc4e2888c61d47da508346"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "CAUSES",
      "source_entity_id": "E5",
      "target_entity_id": "E2",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.75,
      "evidence": "experience with D,L-fenfluramine",
      "source_chunk_ids": [
        "8b7d40ddc4cc4e2888c61d47da508346"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "CAUSES",
      "source_entity_id": "E6",
      "target_entity_id": "E2",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.75,
      "evidence": "experience with D-fenfluramine",
      "source_chunk_ids": [
        "8b7d40ddc4cc4e2888c61d47da508346"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "REPORTS",
      "source_entity_id": "E7",
      "target_entity_id": "E2",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "Rothman et al., 1999",
      "source_chunk_ids": [
        "8b7d40ddc4cc4e2888c61d47da508346"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R7",
      "type": "REPORTS",
      "source_entity_id": "E8",
      "target_entity_id": "E2",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "Rothman and Baumann, 2002",
      "source_chunk_ids": [
        "8b7d40ddc4cc4e2888c61d47da508346"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R8",
      "type": "REPORTS",
      "source_entity_id": "E9",
      "target_entity_id": "E2",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "Zolkowska et al., 2006",
      "source_chunk_ids": [
        "8b7d40ddc4cc4e2888c61d47da508346"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R9",
      "type": "REPORTS",
      "source_entity_id": "E10",
      "target_entity_id": "E2",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "Connolly et al., 1997",
      "source_chunk_ids": [
        "8b7d40ddc4cc4e2888c61d47da508346"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R10",
      "type": "REPORTS",
      "source_entity_id": "E11",
      "target_entity_id": "E2",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "Connolly and McGoon, 1999",
      "source_chunk_ids": [
        "8b7d40ddc4cc4e2888c61d47da508346"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R1",
      "type": "CAUSES",
      "source_entity_id": "E3",
      "target_entity_id": "E1",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.8,
      "evidence": "Fenfluramine-associated VHD",
      "source_chunk_ids": [
        "63f73732993d7879bd9747980f26d498"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E4",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "meta-analysis (Sachdev et al., 2002)",
      "source_chunk_ids": [
        "63f73732993d7879bd9747980f26d498"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "STUDIES",
      "source_entity_id": "E4",
      "target_entity_id": "E3",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.85,
      "evidence": "fenfluramine-treated patients",
      "source_chunk_ids": [
        "63f73732993d7879bd9747980f26d498"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E4",
      "target_entity_id": "E2",
      "attributes": {
        "outcome": "incidence"
      },
      "confidence": 0.8,
      "evidence": "incidence of clinically significant valvular regurgitation",
      "source_chunk_ids": [
        "63f73732993d7879bd9747980f26d498"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {
        "action": "releases"
      },
      "confidence": 0.9,
      "evidence": "fenfluramines are potent 5-HT releasers",
      "source_chunk_ids": [
        "ef72e701ef5380abc08469099508962a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E18",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "5-HT has established mitogenic effects",
      "source_chunk_ids": [
        "ef72e701ef5380abc08469099508962a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "SUGGESTS",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "mapping_type": "indirect"
      },
      "confidence": 0.7,
      "evidence": "serotonergic mechanisms might contribute to VHD",
      "source_chunk_ids": [
        "ef72e701ef5380abc08469099508962a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E4",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "investigation (Rothman et al., 2000a)",
      "source_chunk_ids": [
        "ef72e701ef5380abc08469099508962a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "STUDIES",
      "source_entity_id": "E4",
      "target_entity_id": "E1",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.8,
      "evidence": "test drugs included fenfluramines",
      "source_chunk_ids": [
        "ef72e701ef5380abc08469099508962a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "STUDIES",
      "source_entity_id": "E4",
      "target_entity_id": "E6",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.8,
      "evidence": "norfenfluramine tested",
      "source_chunk_ids": [
        "ef72e701ef5380abc08469099508962a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "REPORTS",
      "source_entity_id": "E4",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "activate mitogenic 5-HT receptors",
      "source_chunk_ids": [
        "ef72e701ef5380abc08469099508962a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "HAS_CLASS",
      "source_entity_id": "E9",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "ergot alkaloids such as methysergide",
      "source_chunk_ids": [
        "ef72e701ef5380abc08469099508962a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "HAS_CLASS",
      "source_entity_id": "E10",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "ergot alkaloids such as methylergonovine",
      "source_chunk_ids": [
        "ef72e701ef5380abc08469099508962a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "HAS_CLASS",
      "source_entity_id": "E11",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "ergot alkaloids such as ergotamine",
      "source_chunk_ids": [
        "ef72e701ef5380abc08469099508962a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "CAUSES",
      "source_entity_id": "E8",
      "target_entity_id": "E3",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.75,
      "evidence": "ergot alkaloids known to increase the risk of VHD",
      "source_chunk_ids": [
        "ef72e701ef5380abc08469099508962a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "ACTS_ON",
      "source_entity_id": "E12",
      "target_entity_id": "E17",
      "attributes": {
        "action": "interacts"
      },
      "confidence": 0.7,
      "evidence": "phentermine interacted with monoamine transporters",
      "source_chunk_ids": [
        "ef72e701ef5380abc08469099508962a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R13",
      "type": "ACTS_ON",
      "source_entity_id": "E13",
      "target_entity_id": "E17",
      "attributes": {
        "action": "interacts"
      },
      "confidence": 0.7,
      "evidence": "fluoxetine interacted with monoamine transporters",
      "source_chunk_ids": [
        "ef72e701ef5380abc08469099508962a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R14",
      "type": "ACTS_ON",
      "source_entity_id": "E14",
      "target_entity_id": "E17",
      "attributes": {
        "action": "interacts"
      },
      "confidence": 0.7,
      "evidence": "norfluoxetine interacted with monoamine transporters",
      "source_chunk_ids": [
        "ef72e701ef5380abc08469099508962a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R15",
      "type": "ACTS_ON",
      "source_entity_id": "E16",
      "target_entity_id": "E2",
      "attributes": {
        "action": "releases"
      },
      "confidence": 0.7,
      "evidence": "mCPP is capable of releasing neuronal 5-HT",
      "source_chunk_ids": [
        "ef72e701ef5380abc08469099508962a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "receptorome screen led to evaluation",
      "source_chunk_ids": [
        "908c62c00afe99358ce80f4bdc6cea78"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "outcome": "binding and functional effects"
      },
      "confidence": 0.8,
      "evidence": "binding and functional effects at 5-HT2A receptors",
      "source_chunk_ids": [
        "908c62c00afe99358ce80f4bdc6cea78"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "outcome": "binding and functional effects"
      },
      "confidence": 0.8,
      "evidence": "binding and functional effects at 5-HT2B receptors",
      "source_chunk_ids": [
        "908c62c00afe99358ce80f4bdc6cea78"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "binding and functional effects"
      },
      "confidence": 0.8,
      "evidence": "binding and functional effects at 5-HT2C receptors",
      "source_chunk_ids": [
        "908c62c00afe99358ce80f4bdc6cea78"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {
        "action": "binds",
        "outcome": "low_affinity"
      },
      "confidence": 0.85,
      "evidence": "low affinity for all 5-HT2 receptor subtypes",
      "source_chunk_ids": [
        "00602f763f19f9b012d9d9621e8da917"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "ACTS_ON",
      "source_entity_id": "E3",
      "target_entity_id": "E4",
      "attributes": {
        "action": "binds",
        "measurement": {
          "value": 10,
          "unit": "nM",
          "measurement_type": "Ki",
          "notes": "range 10-50 nM"
        }
      },
      "confidence": 0.9,
      "evidence": "K_i = 10-50 nM",
      "source_chunk_ids": [
        "00602f763f19f9b012d9d9621e8da917"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E5",
      "target_entity_id": "E6",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "consistent with the findings of others",
      "source_chunk_ids": [
        "00602f763f19f9b012d9d9621e8da917"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "STUDIES",
      "source_entity_id": "E5",
      "target_entity_id": "E3",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.7,
      "evidence": "consistent with the findings",
      "source_chunk_ids": [
        "00602f763f19f9b012d9d9621e8da917"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E5",
      "target_entity_id": "E4",
      "attributes": {
        "outcome": "high_affinity"
      },
      "confidence": 0.7,
      "evidence": "consistent with the findings",
      "source_chunk_ids": [
        "00602f763f19f9b012d9d9621e8da917"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E12",
      "attributes": {
        "action": "agonist",
        "measurement": {
          "value": 4131,
          "unit": "nM",
          "measurement_type": "K_act",
          "notes": "\u00b1SD 244"
        }
      },
      "confidence": 0.85,
      "evidence": "K_{act} 4131\u00b1244",
      "source_chunk_ids": [
        "f14b7a7d39bde0fee233a8eb74658b93"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E13",
      "attributes": {
        "action": "agonist",
        "measurement": {
          "value": 815,
          "unit": "percent",
          "measurement_type": "V_max",
          "notes": "\u00b14"
        }
      },
      "confidence": 0.85,
      "evidence": "V_{max} 815\u00b14%",
      "source_chunk_ids": [
        "f14b7a7d39bde0fee233a8eb74658b93"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "ACTS_ON",
      "source_entity_id": "E2",
      "target_entity_id": "E12",
      "attributes": {
        "action": "agonist",
        "measurement": {
          "value": 630,
          "unit": "nM",
          "measurement_type": "K_act",
          "notes": "\u00b1240"
        }
      },
      "confidence": 0.85,
      "evidence": "K_{act} 630\u00b1240",
      "source_chunk_ids": [
        "f14b7a7d39bde0fee233a8eb74658b93"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "ACTS_ON",
      "source_entity_id": "E2",
      "target_entity_id": "E13",
      "attributes": {
        "action": "agonist",
        "measurement": {
          "value": 88,
          "unit": "percent",
          "measurement_type": "V_max",
          "notes": "\u00b19"
        }
      },
      "confidence": 0.85,
      "evidence": "V_{max} 88\u00b19%",
      "source_chunk_ids": [
        "f14b7a7d39bde0fee233a8eb74658b93"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "ACTS_ON",
      "source_entity_id": "E3",
      "target_entity_id": "E12",
      "attributes": {
        "action": "agonist",
        "measurement": {
          "value": 16,
          "unit": "nM",
          "measurement_type": "K_act",
          "notes": "\u00b14"
        }
      },
      "confidence": 0.85,
      "evidence": "K_{act} 16\u00b14",
      "source_chunk_ids": [
        "f14b7a7d39bde0fee233a8eb74658b93"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "ACTS_ON",
      "source_entity_id": "E3",
      "target_entity_id": "E13",
      "attributes": {
        "action": "agonist",
        "measurement": {
          "value": 75,
          "unit": "percent",
          "measurement_type": "V_max",
          "notes": "\u00b13"
        }
      },
      "confidence": 0.85,
      "evidence": "V_{max} 75\u00b13%",
      "source_chunk_ids": [
        "f14b7a7d39bde0fee233a8eb74658b93"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "ACTS_ON",
      "source_entity_id": "E4",
      "target_entity_id": "E12",
      "attributes": {
        "action": "agonist",
        "measurement": {
          "value": 3.5,
          "unit": "nM",
          "measurement_type": "K_act",
          "notes": "\u00b11.7"
        }
      },
      "confidence": 0.85,
      "evidence": "K_{act} 3.5\u00b11.7",
      "source_chunk_ids": [
        "f14b7a7d39bde0fee233a8eb74658b93"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "ACTS_ON",
      "source_entity_id": "E4",
      "target_entity_id": "E13",
      "attributes": {
        "action": "agonist",
        "measurement": {
          "value": 24,
          "unit": "percent",
          "measurement_type": "V_max",
          "notes": "\u00b13"
        }
      },
      "confidence": 0.85,
      "evidence": "V_{max} 24\u00b13%",
      "source_chunk_ids": [
        "f14b7a7d39bde0fee233a8eb74658b93"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "ACTS_ON",
      "source_entity_id": "E5",
      "target_entity_id": "E12",
      "attributes": {
        "action": "agonist",
        "measurement": {
          "value": 1.3,
          "unit": "nM",
          "measurement_type": "K_act",
          "notes": "\u00b10.4"
        }
      },
      "confidence": 0.85,
      "evidence": "K_{act} 1.3\u00b10.4",
      "source_chunk_ids": [
        "f14b7a7d39bde0fee233a8eb74658b93"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "ACTS_ON",
      "source_entity_id": "E5",
      "target_entity_id": "E13",
      "attributes": {
        "action": "agonist",
        "measurement": {
          "value": 70,
          "unit": "percent",
          "measurement_type": "V_max",
          "notes": "\u00b17"
        }
      },
      "confidence": 0.85,
      "evidence": "V_{max} 70\u00b17%",
      "source_chunk_ids": [
        "f14b7a7d39bde0fee233a8eb74658b93"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "ACTS_ON",
      "source_entity_id": "E6",
      "target_entity_id": "E14",
      "attributes": {
        "action": "antagonist",
        "measurement": {
          "value": 616,
          "unit": "nM",
          "measurement_type": "K_i",
          "notes": "\u00b1172"
        }
      },
      "confidence": 0.85,
      "evidence": "Antagonist K_i = 616\u00b1172",
      "source_chunk_ids": [
        "f14b7a7d39bde0fee233a8eb74658b93"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "ACTS_ON",
      "source_entity_id": "E7",
      "target_entity_id": "E14",
      "attributes": {
        "action": "antagonist",
        "measurement": {
          "value": 43,
          "unit": "nM",
          "measurement_type": "K_i",
          "notes": "\u00b117"
        }
      },
      "confidence": 0.85,
      "evidence": "Antagonist K_i = 43\u00b117",
      "source_chunk_ids": [
        "f14b7a7d39bde0fee233a8eb74658b93"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R13",
      "type": "ACTS_ON",
      "source_entity_id": "E8",
      "target_entity_id": "E12",
      "attributes": {
        "action": "antagonist"
      },
      "confidence": 0.8,
      "evidence": "Trazodone Antagonist",
      "source_chunk_ids": [
        "f14b7a7d39bde0fee233a8eb74658b93"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R14",
      "type": "ACTS_ON",
      "source_entity_id": "E8",
      "target_entity_id": "E13",
      "attributes": {
        "action": "antagonist"
      },
      "confidence": 0.8,
      "evidence": "Trazodone Antagonist",
      "source_chunk_ids": [
        "f14b7a7d39bde0fee233a8eb74658b93"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R15",
      "type": "ACTS_ON",
      "source_entity_id": "E8",
      "target_entity_id": "E14",
      "attributes": {
        "action": "antagonist"
      },
      "confidence": 0.8,
      "evidence": "Trazodone Antagonist",
      "source_chunk_ids": [
        "f14b7a7d39bde0fee233a8eb74658b93"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R16",
      "type": "ACTS_ON",
      "source_entity_id": "E9",
      "target_entity_id": "E12",
      "attributes": {
        "action": "agonist",
        "measurement": {
          "value": 65,
          "unit": "nM",
          "measurement_type": "K_act",
          "notes": "\u00b117"
        }
      },
      "confidence": 0.85,
      "evidence": "K_{act} 65\u00b117",
      "source_chunk_ids": [
        "f14b7a7d39bde0fee233a8eb74658b93"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R17",
      "type": "ACTS_ON",
      "source_entity_id": "E9",
      "target_entity_id": "E13",
      "attributes": {
        "action": "agonist",
        "measurement": {
          "value": 55,
          "unit": "percent",
          "measurement_type": "V_max",
          "notes": "\u00b111"
        }
      },
      "confidence": 0.85,
      "evidence": "V_{max} 55\u00b111%",
      "source_chunk_ids": [
        "f14b7a7d39bde0fee233a8eb74658b93"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R18",
      "type": "ACTS_ON",
      "source_entity_id": "E10",
      "target_entity_id": "E12",
      "attributes": {
        "action": "agonist",
        "measurement": {
          "value": 66,
          "unit": "nM",
          "measurement_type": "K_act",
          "notes": "\u00b126"
        }
      },
      "confidence": 0.85,
      "evidence": "K_{act} 66\u00b126",
      "source_chunk_ids": [
        "f14b7a7d39bde0fee233a8eb74658b93"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R19",
      "type": "ACTS_ON",
      "source_entity_id": "E10",
      "target_entity_id": "E13",
      "attributes": {
        "action": "agonist",
        "measurement": {
          "value": 100,
          "unit": "percent",
          "measurement_type": "V_max",
          "notes": "\u00b10"
        }
      },
      "confidence": 0.85,
      "evidence": "V_{max} 100%",
      "source_chunk_ids": [
        "f14b7a7d39bde0fee233a8eb74658b93"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R20",
      "type": "ACTS_ON",
      "source_entity_id": "E11",
      "target_entity_id": "E13",
      "attributes": {
        "action": "agonist",
        "measurement": {
          "value": 1394,
          "unit": "nM",
          "measurement_type": "K_act",
          "notes": "\u00b1450"
        }
      },
      "confidence": 0.85,
      "evidence": "K_{act} 1394\u00b1450",
      "source_chunk_ids": [
        "f14b7a7d39bde0fee233a8eb74658b93"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {
        "action": "partial agonist"
      },
      "confidence": 0.9,
      "evidence": "Methysergide acts as a partial agonist",
      "source_chunk_ids": [
        "e7e5ebd39a62a7cfd1fea77fd20e9ced"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "ACTS_ON",
      "source_entity_id": "E3",
      "target_entity_id": "E2",
      "attributes": {
        "action": "agonist",
        "notes": "greater affinity and efficacy"
      },
      "confidence": 0.85,
      "evidence": "methylergonovine has even greater affinity and efficacy",
      "source_chunk_ids": [
        "e7e5ebd39a62a7cfd1fea77fd20e9ced"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "ACTS_ON",
      "source_entity_id": "E4",
      "target_entity_id": "E2",
      "attributes": {
        "action": "partial agonist"
      },
      "confidence": 0.9,
      "evidence": "Ergotamine is a potent partial agonist",
      "source_chunk_ids": [
        "e7e5ebd39a62a7cfd1fea77fd20e9ced"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "ACTS_ON",
      "source_entity_id": "E5",
      "target_entity_id": "E2",
      "attributes": {
        "action": "agonist"
      },
      "confidence": 0.85,
      "evidence": "mCPP exhibits agonist activity",
      "source_chunk_ids": [
        "e7e5ebd39a62a7cfd1fea77fd20e9ced"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "ACTS_ON",
      "source_entity_id": "E6",
      "target_entity_id": "E2",
      "attributes": {
        "action": "antagonist",
        "notes": "binds with moderate affinity"
      },
      "confidence": 0.9,
      "evidence": "trazodone binds to the 5-HT2B receptor as an antagonist",
      "source_chunk_ids": [
        "e7e5ebd39a62a7cfd1fea77fd20e9ced"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "INTERACTS_WITH",
      "source_entity_id": "E5",
      "target_entity_id": "E6",
      "attributes": {
        "interaction_type": "metabolic conversion",
        "notes": "trazodone metabolized to mCPP in vivo",
        "bidirectional": true
      },
      "confidence": 0.8,
      "evidence": "trazodone is metabolized to mCPP in vivo",
      "source_chunk_ids": [
        "e7e5ebd39a62a7cfd1fea77fd20e9ced"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "REPORTS",
      "source_entity_id": "E7",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "metabolism"
      },
      "confidence": 0.7,
      "evidence": "Ishida et al., 1995",
      "source_chunk_ids": [
        "e7e5ebd39a62a7cfd1fea77fd20e9ced"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "REPORTS",
      "source_entity_id": "E8",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "metabolism"
      },
      "confidence": 0.7,
      "evidence": "Otani et al., 1997",
      "source_chunk_ids": [
        "e7e5ebd39a62a7cfd1fea77fd20e9ced"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "REPORTS",
      "source_entity_id": "E3",
      "target_entity_id": "E2",
      "attributes": {
        "outcome": "implicates"
      },
      "confidence": 0.7,
      "evidence": "implicate the 5-HT2B receptor in drug-induced VHD",
      "source_chunk_ids": [
        "73a3c3857f5a509736a2bc86f69fbc90"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "REPORTS",
      "source_entity_id": "E4",
      "target_entity_id": "E2",
      "attributes": {
        "outcome": "supports"
      },
      "confidence": 0.7,
      "evidence": "support this hypothesis",
      "source_chunk_ids": [
        "73a3c3857f5a509736a2bc86f69fbc90"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E5",
      "target_entity_id": "E2",
      "attributes": {
        "outcome": "supports"
      },
      "confidence": 0.7,
      "evidence": "support this hypothesis",
      "source_chunk_ids": [
        "73a3c3857f5a509736a2bc86f69fbc90"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E6",
      "target_entity_id": "E2",
      "attributes": {
        "outcome": "supports"
      },
      "confidence": 0.7,
      "evidence": "support this hypothesis",
      "source_chunk_ids": [
        "73a3c3857f5a509736a2bc86f69fbc90"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E7",
      "target_entity_id": "E14",
      "attributes": {
        "outcome": "reports"
      },
      "confidence": 0.7,
      "evidence": "stimulate mitogenesis",
      "source_chunk_ids": [
        "73a3c3857f5a509736a2bc86f69fbc90"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "REPORTS",
      "source_entity_id": "E8",
      "target_entity_id": "E14",
      "attributes": {
        "outcome": "reports"
      },
      "confidence": 0.7,
      "evidence": "stimulate mitogenesis",
      "source_chunk_ids": [
        "73a3c3857f5a509736a2bc86f69fbc90"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "ACTS_ON",
      "source_entity_id": "E9",
      "target_entity_id": "E1",
      "attributes": {
        "action": "agonist"
      },
      "confidence": 0.85,
      "evidence": "potent 5-HT2B receptor agonists",
      "source_chunk_ids": [
        "73a3c3857f5a509736a2bc86f69fbc90"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "ACTS_ON",
      "source_entity_id": "E10",
      "target_entity_id": "E1",
      "attributes": {
        "action": "agonist"
      },
      "confidence": 0.85,
      "evidence": "potent 5-HT2B receptor agonists",
      "source_chunk_ids": [
        "73a3c3857f5a509736a2bc86f69fbc90"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "CAUSES",
      "source_entity_id": "E9",
      "target_entity_id": "E2",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.75,
      "evidence": "increase the risk of VHD",
      "source_chunk_ids": [
        "73a3c3857f5a509736a2bc86f69fbc90"
      ],
      "supporting_study_ids": [
        "E6"
      ],
      "verified": true
    },
    {
      "id": "R10",
      "type": "CAUSES",
      "source_entity_id": "E10",
      "target_entity_id": "E2",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.75,
      "evidence": "increase the risk of VHD",
      "source_chunk_ids": [
        "73a3c3857f5a509736a2bc86f69fbc90"
      ],
      "supporting_study_ids": [
        "E6"
      ],
      "verified": true
    },
    {
      "id": "R11",
      "type": "ACTS_ON",
      "source_entity_id": "E12",
      "target_entity_id": "E1",
      "attributes": {
        "action": "agonist"
      },
      "confidence": 0.85,
      "evidence": "5-HT2B receptor agonists",
      "source_chunk_ids": [
        "73a3c3857f5a509736a2bc86f69fbc90"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "ACTS_ON",
      "source_entity_id": "E13",
      "target_entity_id": "E1",
      "attributes": {
        "action": "agonist"
      },
      "confidence": 0.85,
      "evidence": "5-HT2B receptor agonists",
      "source_chunk_ids": [
        "73a3c3857f5a509736a2bc86f69fbc90"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R13",
      "type": "PRODUCES",
      "source_entity_id": "E12",
      "target_entity_id": "E15",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "stimulate prolonged mitogenic responses",
      "source_chunk_ids": [
        "73a3c3857f5a509736a2bc86f69fbc90"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R14",
      "type": "PRODUCES",
      "source_entity_id": "E13",
      "target_entity_id": "E15",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "stimulate prolonged mitogenic responses",
      "source_chunk_ids": [
        "73a3c3857f5a509736a2bc86f69fbc90"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R15",
      "type": "REPORTS",
      "source_entity_id": "E16",
      "target_entity_id": "E17",
      "attributes": {
        "outcome": "reports"
      },
      "confidence": 0.8,
      "evidence": "higher incidence of valvular regurgitation",
      "source_chunk_ids": [
        "73a3c3857f5a509736a2bc86f69fbc90"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R16",
      "type": "SUGGESTS",
      "source_entity_id": "E12",
      "target_entity_id": "E2",
      "attributes": {
        "mapping_type": "direct"
      },
      "confidence": 0.7,
      "evidence": "link between illicit MDMA use and the risk of developing VHD",
      "source_chunk_ids": [
        "73a3c3857f5a509736a2bc86f69fbc90"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "CAUSES",
      "source_entity_id": "E2",
      "target_entity_id": "E3",
      "attributes": {
        "context": "epidemiological"
      },
      "confidence": 0.85,
      "evidence": "increase the risk of developing IPAH",
      "source_chunk_ids": [
        "d6abe988e1c0db745b99f54e543713ef"
      ],
      "supporting_study_ids": [
        "E4",
        "E5"
      ],
      "verified": true
    },
    {
      "id": "R2",
      "type": "REPORTS",
      "source_entity_id": "E4",
      "target_entity_id": "E3",
      "attributes": {
        "outcome": "increases risk"
      },
      "confidence": 0.7,
      "evidence": "Abenhaim et al., 1996",
      "source_chunk_ids": [
        "d6abe988e1c0db745b99f54e543713ef"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E5",
      "target_entity_id": "E3",
      "attributes": {
        "outcome": "increases risk"
      },
      "confidence": 0.7,
      "evidence": "Fishman, 1999",
      "source_chunk_ids": [
        "d6abe988e1c0db745b99f54e543713ef"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "REPORTS",
      "source_entity_id": "E4",
      "target_entity_id": "E1",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "implicates the involvement of 5-HT and SERT proteins in the pathogenesis of IPAH",
      "source_chunk_ids": [
        "b261139371bea9fdf729ebdbad57e2f5"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "REPORTS",
      "source_entity_id": "E5",
      "target_entity_id": "E1",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "implicates the involvement of 5-HT and SERT proteins in the pathogenesis of IPAH",
      "source_chunk_ids": [
        "b261139371bea9fdf729ebdbad57e2f5"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E6",
      "target_entity_id": "E1",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "implicates the involvement of 5-HT and SERT proteins in the pathogenesis of IPAH",
      "source_chunk_ids": [
        "b261139371bea9fdf729ebdbad57e2f5"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E4",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "evidence from our laboratory",
      "source_chunk_ids": [
        "b261139371bea9fdf729ebdbad57e2f5"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E5",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "evidence from our laboratory",
      "source_chunk_ids": [
        "b261139371bea9fdf729ebdbad57e2f5"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E6",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "evidence from our laboratory",
      "source_chunk_ids": [
        "b261139371bea9fdf729ebdbad57e2f5"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "PRODUCES",
      "source_entity_id": "E8",
      "target_entity_id": "E10",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "leads to severe hypertension",
      "source_chunk_ids": [
        "b261139371bea9fdf729ebdbad57e2f5"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "PRODUCES",
      "source_entity_id": "E9",
      "target_entity_id": "E10",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "leads to severe hypertension",
      "source_chunk_ids": [
        "b261139371bea9fdf729ebdbad57e2f5"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "PRODUCES",
      "source_entity_id": "E11",
      "target_entity_id": "E12",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "would then cause pulmonary dysfunction",
      "source_chunk_ids": [
        "b261139371bea9fdf729ebdbad57e2f5"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "REPORTS",
      "source_entity_id": "E4",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "SERT substrate activity was a common feature of drugs associated with IPAH",
      "source_chunk_ids": [
        "b261139371bea9fdf729ebdbad57e2f5"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "REPORTS",
      "source_entity_id": "E5",
      "target_entity_id": "E13",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "drug-induced activation of 5-HT2B receptors",
      "source_chunk_ids": [
        "b261139371bea9fdf729ebdbad57e2f5"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "REPORTS",
      "source_entity_id": "E5",
      "target_entity_id": "E14",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "explain VHD",
      "source_chunk_ids": [
        "b261139371bea9fdf729ebdbad57e2f5"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "fenfluramine ... produce vasoconstriction",
      "source_chunk_ids": [
        "47b27b75859f62166fd179ee3c1d231f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "fenfluramine ... produce ... mitogenesis",
      "source_chunk_ids": [
        "47b27b75859f62166fd179ee3c1d231f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "CAUSES",
      "source_entity_id": "E2",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "leads to serious side effects",
      "source_chunk_ids": [
        "47b27b75859f62166fd179ee3c1d231f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "CAUSES",
      "source_entity_id": "E2",
      "target_entity_id": "E6",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "fenfluramine-associated IPAH",
      "source_chunk_ids": [
        "47b27b75859f62166fd179ee3c1d231f"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E7",
      "target_entity_id": "E1",
      "attributes": {
        "outcome": "no_effect"
      },
      "confidence": 0.7,
      "evidence": "acute fenfluramine does not increase plasma 5-HT",
      "source_chunk_ids": [
        "47b27b75859f62166fd179ee3c1d231f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "REPORTS",
      "source_entity_id": "E8",
      "target_entity_id": "E1",
      "attributes": {
        "outcome": "no_effect"
      },
      "confidence": 0.7,
      "evidence": "chronic fenfluramine treatment lowers blood 5-HT",
      "source_chunk_ids": [
        "47b27b75859f62166fd179ee3c1d231f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E7",
      "target_entity_id": "E9",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "Studies conducted in the 1990s",
      "source_chunk_ids": [
        "47b27b75859f62166fd179ee3c1d231f"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R8",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E8",
      "target_entity_id": "E9",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "Studies conducted in the 1990s",
      "source_chunk_ids": [
        "47b27b75859f62166fd179ee3c1d231f"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R9",
      "type": "STUDIES",
      "source_entity_id": "E7",
      "target_entity_id": "E2",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.75,
      "evidence": "acute fenfluramine does not increase plasma 5-HT",
      "source_chunk_ids": [
        "47b27b75859f62166fd179ee3c1d231f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "STUDIES",
      "source_entity_id": "E8",
      "target_entity_id": "E2",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.75,
      "evidence": "chronic fenfluramine treatment",
      "source_chunk_ids": [
        "47b27b75859f62166fd179ee3c1d231f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "microdialysis method in rats",
      "source_chunk_ids": [
        "3a483a860877ea40e62005015647f8af"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.8,
      "evidence": "systemic administration of fenfluramine",
      "source_chunk_ids": [
        "3a483a860877ea40e62005015647f8af"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.8,
      "evidence": "systemic administration of MDMA",
      "source_chunk_ids": [
        "3a483a860877ea40e62005015647f8af"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E7",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.7,
      "evidence": "other amphetamines",
      "source_chunk_ids": [
        "3a483a860877ea40e62005015647f8af"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "outcome": "increases"
      },
      "confidence": 0.85,
      "evidence": "evokes transient dose-dependent increases in plasma 5-HT",
      "source_chunk_ids": [
        "3a483a860877ea40e62005015647f8af"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "outcome": "involvement"
      },
      "confidence": 0.75,
      "evidence": "suggesting the involvement of platelet SERT proteins",
      "source_chunk_ids": [
        "3a483a860877ea40e62005015647f8af"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "PRODUCES",
      "source_entity_id": "E5",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "fenfluramine evokes increases in plasma 5-HT",
      "source_chunk_ids": [
        "3a483a860877ea40e62005015647f8af"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "PRODUCES",
      "source_entity_id": "E6",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "MDMA evokes increases in plasma 5-HT",
      "source_chunk_ids": [
        "3a483a860877ea40e62005015647f8af"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "PRODUCES",
      "source_entity_id": "E7",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "other amphetamines evoke increases in plasma 5-HT",
      "source_chunk_ids": [
        "3a483a860877ea40e62005015647f8af"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "chronic administration in rats",
      "source_chunk_ids": [
        "523066717b7900f68422629f96941825"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.9,
      "evidence": "chronic administration of fenfluramine",
      "source_chunk_ids": [
        "523066717b7900f68422629f96941825"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.9,
      "evidence": "chronic administration of fluoxetine",
      "source_chunk_ids": [
        "523066717b7900f68422629f96941825"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "ACTS_ON",
      "source_entity_id": "E4",
      "target_entity_id": "E5",
      "attributes": {
        "action": "blocks"
      },
      "confidence": 0.8,
      "evidence": "5-HT uptake blocker fluoxetine",
      "source_chunk_ids": [
        "523066717b7900f68422629f96941825"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "increases"
      },
      "confidence": 0.85,
      "evidence": "fenfluramine caused increases in baseline dialysate 5-HT levels",
      "source_chunk_ids": [
        "523066717b7900f68422629f96941825"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E7",
      "attributes": {
        "outcome": "reduces"
      },
      "confidence": 0.8,
      "evidence": "chronic exposure reduces the ability to evoke increases",
      "source_chunk_ids": [
        "523066717b7900f68422629f96941825"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "TESTED_AT",
      "source_entity_id": "E1",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "10 mg/kg/day",
      "source_chunk_ids": [
        "523066717b7900f68422629f96941825"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "TESTED_AT",
      "source_entity_id": "E1",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "3 and 10 mg/kg/day",
      "source_chunk_ids": [
        "523066717b7900f68422629f96941825"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "5-HT provokes contraction of human pulmonary arteries",
      "source_chunk_ids": [
        "59ee8d14482b70f5dcf3613901e017c8"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E3",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "Cortijo et al., 1997",
      "source_chunk_ids": [
        "59ee8d14482b70f5dcf3613901e017c8"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "STUDIES",
      "source_entity_id": "E3",
      "target_entity_id": "E1",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.8,
      "evidence": "5-HT provokes contraction",
      "source_chunk_ids": [
        "59ee8d14482b70f5dcf3613901e017c8"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E3",
      "target_entity_id": "E2",
      "attributes": {
        "outcome": "observed"
      },
      "confidence": 0.85,
      "evidence": "provokes contraction of human pulmonary arteries",
      "source_chunk_ids": [
        "59ee8d14482b70f5dcf3613901e017c8"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "stimulate mitogenic responses",
      "source_chunk_ids": [
        "59ee8d14482b70f5dcf3613901e017c8"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "Figure 5: Effects of acute fenfluramine administration",
      "source_chunk_ids": [
        "c928538e18a396a0ebc422b75851d71c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.85,
      "evidence": "Panel A shows 'Chronic Fen' (fenfluramine)",
      "source_chunk_ids": [
        "c928538e18a396a0ebc422b75851d71c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.85,
      "evidence": "Panel B shows 'Chronic Fluox' (fluoxetine)",
      "source_chunk_ids": [
        "c928538e18a396a0ebc422b75851d71c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "measures"
      },
      "confidence": 0.9,
      "evidence": "dialysate 5-HT levels",
      "source_chunk_ids": [
        "c928538e18a396a0ebc422b75851d71c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "observed"
      },
      "confidence": 0.7,
      "evidence": "Effects of acute fenfluramine administration",
      "source_chunk_ids": [
        "c928538e18a396a0ebc422b75851d71c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "TESTED_AT",
      "source_entity_id": "E1",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "3 mg/kg/day",
      "source_chunk_ids": [
        "c928538e18a396a0ebc422b75851d71c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "TESTED_AT",
      "source_entity_id": "E1",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "10 mg/kg/day",
      "source_chunk_ids": [
        "c928538e18a396a0ebc422b75851d71c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "ACTS_ON",
      "source_entity_id": "E3",
      "target_entity_id": "E5",
      "attributes": {
        "action": "affects"
      },
      "confidence": 0.7,
      "evidence": "Effects of acute fenfluramine administration on dialysate 5-HT levels",
      "source_chunk_ids": [
        "c928538e18a396a0ebc422b75851d71c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "ACTS_ON",
      "source_entity_id": "E4",
      "target_entity_id": "E5",
      "attributes": {
        "action": "affects"
      },
      "confidence": 0.7,
      "evidence": "Panel B shows 'Chronic Fluox' (fluoxetine)",
      "source_chunk_ids": [
        "c928538e18a396a0ebc422b75851d71c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "Data taken with permission from Zolkowska et al. (2008)",
      "source_chunk_ids": [
        "da57a52ca3729884f5cb4c5c4779fdcd"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.85,
      "evidence": "Effects of acute fenfluramine administration",
      "source_chunk_ids": [
        "da57a52ca3729884f5cb4c5c4779fdcd"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.85,
      "evidence": "fluoxetine (Panel B)",
      "source_chunk_ids": [
        "da57a52ca3729884f5cb4c5c4779fdcd"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "measured"
      },
      "confidence": 0.8,
      "evidence": "dialysate 5-HT levels measured",
      "source_chunk_ids": [
        "da57a52ca3729884f5cb4c5c4779fdcd"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "observed"
      },
      "confidence": 0.7,
      "evidence": "Effects of acute fenfluramine administration",
      "source_chunk_ids": [
        "da57a52ca3729884f5cb4c5c4779fdcd"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "TESTED_AT",
      "source_entity_id": "E1",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "administered s.c. via osmotic minipumps for 2 weeks",
      "source_chunk_ids": [
        "da57a52ca3729884f5cb4c5c4779fdcd"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "TESTED_AT",
      "source_entity_id": "E1",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "administered i.v. at 0 min",
      "source_chunk_ids": [
        "da57a52ca3729884f5cb4c5c4779fdcd"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "ACTS_ON",
      "source_entity_id": "E3",
      "target_entity_id": "E5",
      "attributes": {
        "action": "affects",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "Effects of acute fenfluramine administration on dialysate 5-HT levels",
      "source_chunk_ids": [
        "da57a52ca3729884f5cb4c5c4779fdcd"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R9",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E6",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.6,
      "evidence": "Effects of acute fenfluramine administration",
      "source_chunk_ids": [
        "da57a52ca3729884f5cb4c5c4779fdcd"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {
        "action": "stimulates",
        "measurement": {
          "value": null,
          "unit": null,
          "measurement_type": "concentration",
          "notes": "much higher concentrations needed"
        }
      },
      "confidence": 0.7,
      "evidence": "5-HT concentrations are needed to stimulate",
      "source_chunk_ids": [
        "175ac8e246ed2c19193e9fb3f3b1f4f7"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "stimulate mitogenic responses",
      "source_chunk_ids": [
        "175ac8e246ed2c19193e9fb3f3b1f4f7"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "CAUSES",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "context": "experimental",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "cause pulmonary side effects",
      "source_chunk_ids": [
        "175ac8e246ed2c19193e9fb3f3b1f4f7"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R4",
      "type": "CAUSES",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "context": "experimental",
        "measurement": {
          "value": 580,
          "unit": "nM",
          "measurement_type": "concentration_range",
          "notes": "580\u2013974 nM required"
        }
      },
      "confidence": 0.8,
      "evidence": "produce VHD in rats exposed to exogenous 5-HT",
      "source_chunk_ids": [
        "175ac8e246ed2c19193e9fb3f3b1f4f7"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "CAUSES",
      "source_entity_id": "E7",
      "target_entity_id": "E6",
      "attributes": {
        "context": "clinical",
        "assertion": "refutes"
      },
      "confidence": 0.85,
      "evidence": "5-HT hypothesis cannot explain fenfluramine-associated IPAH",
      "source_chunk_ids": [
        "175ac8e246ed2c19193e9fb3f3b1f4f7"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "ACTS_ON",
      "source_entity_id": "E7",
      "target_entity_id": "E1",
      "attributes": {
        "action": "elevates",
        "measurement": {
          "value": 5,
          "unit": "nM",
          "measurement_type": "concentration",
          "notes": "less than 5 nM in rats"
        }
      },
      "confidence": 0.9,
      "evidence": "fenfluramine elevates baseline plasma 5-HT to less than 5 nM",
      "source_chunk_ids": [
        "175ac8e246ed2c19193e9fb3f3b1f4f7"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "ACTS_ON",
      "source_entity_id": "E8",
      "target_entity_id": "E1",
      "attributes": {
        "action": "increases",
        "measurement": {
          "value": 2,
          "unit": "fold",
          "measurement_type": "increase",
          "notes": "two- to fourfold increases"
        }
      },
      "confidence": 0.7,
      "evidence": "lithium produces two- to fourfold increases in plasma 5-HT",
      "source_chunk_ids": [
        "175ac8e246ed2c19193e9fb3f3b1f4f7"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "ACTS_ON",
      "source_entity_id": "E9",
      "target_entity_id": "E1",
      "attributes": {
        "action": "increases",
        "measurement": {
          "value": 2,
          "unit": "fold",
          "measurement_type": "increase",
          "notes": "two- to fourfold increases"
        }
      },
      "confidence": 0.7,
      "evidence": "MAO inhibitors produces two- to fourfold increases in plasma 5-HT",
      "source_chunk_ids": [
        "175ac8e246ed2c19193e9fb3f3b1f4f7"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E3",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "hypoxic mouse model",
      "source_chunk_ids": [
        "8d0f8dcb51d6846a717565bc65c4e7cd"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "REPORTS",
      "source_entity_id": "E3",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "critical"
      },
      "confidence": 0.85,
      "evidence": "activation of 5-HT2B receptors is critical",
      "source_chunk_ids": [
        "8d0f8dcb51d6846a717565bc65c4e7cd"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E3",
      "target_entity_id": "E1",
      "attributes": {
        "outcome": "associated"
      },
      "confidence": 0.8,
      "evidence": "development of IPAH",
      "source_chunk_ids": [
        "8d0f8dcb51d6846a717565bc65c4e7cd"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "STUDIES",
      "source_entity_id": "E6",
      "target_entity_id": "E7",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.85,
      "evidence": "stereoisomers of norfenfluramine",
      "source_chunk_ids": [
        "8d0f8dcb51d6846a717565bc65c4e7cd"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "ACTS_ON",
      "source_entity_id": "E7",
      "target_entity_id": "E5",
      "attributes": {
        "action": "agonists"
      },
      "confidence": 0.9,
      "evidence": "potent and selective 5-HT2B agonists",
      "source_chunk_ids": [
        "8d0f8dcb51d6846a717565bc65c4e7cd"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "ACTS_ON",
      "source_entity_id": "E9",
      "target_entity_id": "E5",
      "attributes": {
        "action": "activates"
      },
      "confidence": 0.8,
      "evidence": "activate 5-HT2B receptors",
      "source_chunk_ids": [
        "8d0f8dcb51d6846a717565bc65c4e7cd"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "ACTS_ON",
      "source_entity_id": "E10",
      "target_entity_id": "E5",
      "attributes": {
        "action": "activates"
      },
      "confidence": 0.8,
      "evidence": "activate 5-HT2B receptors",
      "source_chunk_ids": [
        "8d0f8dcb51d6846a717565bc65c4e7cd"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "ACTS_ON",
      "source_entity_id": "E11",
      "target_entity_id": "E5",
      "attributes": {
        "action": "activates"
      },
      "confidence": 0.8,
      "evidence": "activate 5-HT2B receptors",
      "source_chunk_ids": [
        "8d0f8dcb51d6846a717565bc65c4e7cd"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "ACTS_ON",
      "source_entity_id": "E12",
      "target_entity_id": "E5",
      "attributes": {
        "action": "activates"
      },
      "confidence": 0.8,
      "evidence": "activate 5-HT2B receptors",
      "source_chunk_ids": [
        "8d0f8dcb51d6846a717565bc65c4e7cd"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "evidence from our laboratory",
      "source_chunk_ids": [
        "772368d5086ff1bf833427f2648de55a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "outcome": "no_effect"
      },
      "confidence": 0.8,
      "evidence": "disputes a role for 5-HT2B sites",
      "source_chunk_ids": [
        "772368d5086ff1bf833427f2648de55a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "outcome": "no_effect"
      },
      "confidence": 0.75,
      "evidence": "disputes a role in IPAH",
      "source_chunk_ids": [
        "772368d5086ff1bf833427f2648de55a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "ACTS_ON",
      "source_entity_id": "E5",
      "target_entity_id": "E6",
      "attributes": {
        "action": "substrate"
      },
      "confidence": 0.9,
      "evidence": "aminorex is a SERT substrate",
      "source_chunk_ids": [
        "772368d5086ff1bf833427f2648de55a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "CAUSES",
      "source_entity_id": "E5",
      "target_entity_id": "E4",
      "attributes": {
        "context": "epidemic"
      },
      "confidence": 0.85,
      "evidence": "caused an epidemic of IPAH",
      "source_chunk_ids": [
        "772368d5086ff1bf833427f2648de55a"
      ],
      "supporting_study_ids": [
        "E7"
      ],
      "verified": true
    },
    {
      "id": "R6",
      "type": "CAUSES",
      "source_entity_id": "E8",
      "target_entity_id": "E4",
      "attributes": {
        "context": "case reports"
      },
      "confidence": 0.8,
      "evidence": "implicate as a cause of the disease",
      "source_chunk_ids": [
        "772368d5086ff1bf833427f2648de55a"
      ],
      "supporting_study_ids": [
        "E9"
      ],
      "verified": true
    },
    {
      "id": "R7",
      "type": "ACTS_ON",
      "source_entity_id": "E5",
      "target_entity_id": "E3",
      "attributes": {
        "action": "interacts",
        "measurement": {
          "value": 870,
          "unit": "nM",
          "measurement_type": "EC50",
          "notes": "for activation"
        }
      },
      "confidence": 0.85,
      "evidence": "EC50 for 5-HT2B receptor activation (870 nM)",
      "source_chunk_ids": [
        "772368d5086ff1bf833427f2648de55a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "ACTS_ON",
      "source_entity_id": "E5",
      "target_entity_id": "E10",
      "attributes": {
        "action": "releases",
        "measurement": {
          "value": 26.4,
          "unit": "nM",
          "measurement_type": "EC50",
          "notes": "for NE release"
        }
      },
      "confidence": 0.8,
      "evidence": "EC50 for NE release (26.4 nM)",
      "source_chunk_ids": [
        "772368d5086ff1bf833427f2648de55a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "ACTS_ON",
      "source_entity_id": "E11",
      "target_entity_id": "E3",
      "attributes": {
        "action": "more potent"
      },
      "confidence": 0.75,
      "evidence": "activity nearly 50-fold less than D-norfenfluramine",
      "source_chunk_ids": [
        "772368d5086ff1bf833427f2648de55a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "Immunohistochemical studies show (Eddahibi et al., 2006)",
      "source_chunk_ids": [
        "6041a61fba27d3ca51f85f315f4d3b9a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "outcome": "involved"
      },
      "confidence": 0.9,
      "evidence": "5-HT produced locally in the lung as a critical player",
      "source_chunk_ids": [
        "6041a61fba27d3ca51f85f315f4d3b9a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "outcome": "over-expressed"
      },
      "confidence": 0.85,
      "evidence": "over-expression of SERT by the pulmonary artery smooth muscle cells",
      "source_chunk_ids": [
        "6041a61fba27d3ca51f85f315f4d3b9a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "contributes"
      },
      "confidence": 0.9,
      "evidence": "contributes to hyperplasia observed in IPAH",
      "source_chunk_ids": [
        "6041a61fba27d3ca51f85f315f4d3b9a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "observed"
      },
      "confidence": 0.85,
      "evidence": "hyperplasia observed in IPAH",
      "source_chunk_ids": [
        "6041a61fba27d3ca51f85f315f4d3b9a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E7",
      "attributes": {
        "outcome": "no_effect"
      },
      "confidence": 0.8,
      "evidence": "fenfluramine cannot release 5-HT from these cells",
      "source_chunk_ids": [
        "6041a61fba27d3ca51f85f315f4d3b9a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E6",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "dysregulation of 5-HT production contributes to hyperplasia",
      "source_chunk_ids": [
        "6041a61fba27d3ca51f85f315f4d3b9a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "ACTS_ON",
      "source_entity_id": "E8",
      "target_entity_id": "E9",
      "attributes": {
        "action": "bypasses"
      },
      "confidence": 0.8,
      "evidence": "bypasses the rate-limiting enzyme tryptophan hydroxylase",
      "source_chunk_ids": [
        "6041a61fba27d3ca51f85f315f4d3b9a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "PRODUCES",
      "source_entity_id": "E8",
      "target_entity_id": "E13",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "increase 5-HT synthesis in pulmonary endothelial cells",
      "source_chunk_ids": [
        "6041a61fba27d3ca51f85f315f4d3b9a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E10",
      "target_entity_id": "E11",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "well-established history of safety (Das et al., 2004)",
      "source_chunk_ids": [
        "6041a61fba27d3ca51f85f315f4d3b9a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "STUDIES",
      "source_entity_id": "E10",
      "target_entity_id": "E12",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.7,
      "evidence": "5-HTP is a commonly used dietary supplement (Das et al., 2004)",
      "source_chunk_ids": [
        "6041a61fba27d3ca51f85f315f4d3b9a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "REPORTS",
      "source_entity_id": "E10",
      "target_entity_id": "E12",
      "attributes": {
        "outcome": "safe"
      },
      "confidence": 0.75,
      "evidence": "well-established history of safety",
      "source_chunk_ids": [
        "6041a61fba27d3ca51f85f315f4d3b9a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "CAUSES",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "context": "experimental"
      },
      "confidence": 0.85,
      "evidence": "fenfluramine can cause long-term depletion of 5-HT",
      "source_chunk_ids": [
        "c1ffd50c57471cb24d810908cc9c7277"
      ],
      "supporting_study_ids": [
        "E10",
        "E11"
      ],
      "verified": true
    },
    {
      "id": "R2",
      "type": "CAUSES",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {
        "context": "experimental"
      },
      "confidence": 0.85,
      "evidence": "fenfluramine can cause loss of SERT binding sites",
      "source_chunk_ids": [
        "c1ffd50c57471cb24d810908cc9c7277"
      ],
      "supporting_study_ids": [
        "E10",
        "E11"
      ],
      "verified": true
    },
    {
      "id": "R3",
      "type": "CAUSES",
      "source_entity_id": "E2",
      "target_entity_id": "E5",
      "attributes": {
        "context": "experimental"
      },
      "confidence": 0.85,
      "evidence": "\u03b1-fenfluramine can cause long-term depletion of 5-HT",
      "source_chunk_ids": [
        "c1ffd50c57471cb24d810908cc9c7277"
      ],
      "supporting_study_ids": [
        "E10",
        "E11"
      ],
      "verified": true
    },
    {
      "id": "R4",
      "type": "CAUSES",
      "source_entity_id": "E2",
      "target_entity_id": "E6",
      "attributes": {
        "context": "experimental"
      },
      "confidence": 0.85,
      "evidence": "\u03b1-fenfluramine can cause loss of SERT binding sites",
      "source_chunk_ids": [
        "c1ffd50c57471cb24d810908cc9c7277"
      ],
      "supporting_study_ids": [
        "E10",
        "E11"
      ],
      "verified": true
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E5",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "interpreted as evidence for neurotoxicity",
      "source_chunk_ids": [
        "c1ffd50c57471cb24d810908cc9c7277"
      ],
      "supporting_study_ids": [
        "E12",
        "E13"
      ],
      "verified": true
    },
    {
      "id": "R6",
      "type": "ACTS_ON",
      "source_entity_id": "E8",
      "target_entity_id": "E4",
      "attributes": {
        "action": "interacts"
      },
      "confidence": 0.85,
      "evidence": "mCPP interacts with SERT",
      "source_chunk_ids": [
        "c1ffd50c57471cb24d810908cc9c7277"
      ],
      "supporting_study_ids": [
        "E19",
        "E18",
        "E20"
      ],
      "verified": true
    },
    {
      "id": "R7",
      "type": "PRODUCES",
      "source_entity_id": "E8",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "mCPP is equipotent with \u03b1-fenfluramine in releasing 5-HT",
      "source_chunk_ids": [
        "c1ffd50c57471cb24d810908cc9c7277"
      ],
      "supporting_study_ids": [
        "E19",
        "E18",
        "E20"
      ],
      "verified": true
    },
    {
      "id": "R8",
      "type": "INTERACTS_WITH",
      "source_entity_id": "E2",
      "target_entity_id": "E8",
      "attributes": {
        "interaction_type": "equipotent",
        "bidirectional": true
      },
      "confidence": 0.8,
      "evidence": "mCPP is equipotent with \u03b1-fenfluramine",
      "source_chunk_ids": [
        "c1ffd50c57471cb24d810908cc9c7277"
      ],
      "supporting_study_ids": [
        "E19",
        "E18",
        "E20"
      ],
      "verified": true
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E2",
      "target_entity_id": "E3",
      "attributes": {
        "action": "causes",
        "context": "risk"
      },
      "confidence": 0.7,
      "evidence": "5-HT2B agonist activity to prevent the risk of VHD",
      "source_chunk_ids": [
        "b3edff64c00ddb379d6620449284d29c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "CAUSES",
      "source_entity_id": "E7",
      "target_entity_id": "E4",
      "attributes": {
        "context": "neurotoxic",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "amphetamine-like agents have a reduced capacity for causing neurotoxic effects",
      "source_chunk_ids": [
        "b3edff64c00ddb379d6620449284d29c"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R3",
      "type": "CAUSES",
      "source_entity_id": "E7",
      "target_entity_id": "E5",
      "attributes": {
        "context": "pulmonary",
        "verification_needed": true
      },
      "confidence": 0.6,
      "evidence": "possibly IPAH",
      "source_chunk_ids": [
        "b3edff64c00ddb379d6620449284d29c"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {
        "action": "releases"
      },
      "confidence": 0.7,
      "evidence": "would release DA",
      "source_chunk_ids": [
        "79260f2edc2c1282bb4735835b854f8f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "action": "releases"
      },
      "confidence": 0.7,
      "evidence": "would release 5-HT",
      "source_chunk_ids": [
        "79260f2edc2c1282bb4735835b854f8f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "action": "does not affect",
        "outcome": "no_effect",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "without affecting release of NE",
      "source_chunk_ids": [
        "79260f2edc2c1282bb4735835b854f8f"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "Figure 6: Effects of high-dose administration",
      "source_chunk_ids": [
        "d1f0db506dd996e2d849697c53ef564b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.9,
      "evidence": "Panel A shows data for d-FEN",
      "source_chunk_ids": [
        "d1f0db506dd996e2d849697c53ef564b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.9,
      "evidence": "Panel B shows data for mCPP",
      "source_chunk_ids": [
        "d1f0db506dd996e2d849697c53ef564b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "TESTED_AT",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "10 \u03bcmol/kg (light gray bar)",
      "source_chunk_ids": [
        "d1f0db506dd996e2d849697c53ef564b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "TESTED_AT",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "30 \u03bcmol/kg (dark gray bar)",
      "source_chunk_ids": [
        "d1f0db506dd996e2d849697c53ef564b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E7",
      "attributes": {
        "outcome": "increases"
      },
      "confidence": 0.85,
      "evidence": "5-HT levels are significantly higher",
      "source_chunk_ids": [
        "d1f0db506dd996e2d849697c53ef564b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E8",
      "attributes": {
        "outcome": "no_change"
      },
      "confidence": 0.8,
      "evidence": "5-HIAA levels remain relatively stable",
      "source_chunk_ids": [
        "d1f0db506dd996e2d849697c53ef564b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "Data taken with permission from Baumann et al. (2001)",
      "source_chunk_ids": [
        "f3a4c71678d371c8c4c4bf7d78a37e33"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.85,
      "evidence": "Effects of high-dose administration of d-FEN",
      "source_chunk_ids": [
        "f3a4c71678d371c8c4c4bf7d78a37e33"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.85,
      "evidence": "Effects of high-dose administration of mCPP",
      "source_chunk_ids": [
        "f3a4c71678d371c8c4c4bf7d78a37e33"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "TESTED_AT",
      "source_entity_id": "E1",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "doses of 10 or 30 \u03bcmol/kg, every 2 h, for four doses",
      "source_chunk_ids": [
        "f3a4c71678d371c8c4c4bf7d78a37e33"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "measured"
      },
      "confidence": 0.85,
      "evidence": "tissue levels of 5-HT",
      "source_chunk_ids": [
        "f3a4c71678d371c8c4c4bf7d78a37e33"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "measured"
      },
      "confidence": 0.85,
      "evidence": "tissue levels of 5-HIAA",
      "source_chunk_ids": [
        "f3a4c71678d371c8c4c4bf7d78a37e33"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E7",
      "attributes": {
        "outcome": "observed"
      },
      "confidence": 0.8,
      "evidence": "produce equivalent increases in extracellular 5-HT",
      "source_chunk_ids": [
        "f3a4c71678d371c8c4c4bf7d78a37e33"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "d-FEN produce increases in extracellular 5-HT",
      "source_chunk_ids": [
        "f3a4c71678d371c8c4c4bf7d78a37e33"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "PRODUCES",
      "source_entity_id": "E4",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "mCPP produce increases in extracellular 5-HT",
      "source_chunk_ids": [
        "f3a4c71678d371c8c4c4bf7d78a37e33"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "Effects of PAL-287 on neurochemical and locomotor parameters",
      "source_chunk_ids": [
        "be3c1fa204d1fe03e278412a1d79c839"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.85,
      "evidence": "Effects of PAL-287",
      "source_chunk_ids": [
        "be3c1fa204d1fe03e278412a1d79c839"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "outcome": "modulates"
      },
      "confidence": 0.75,
      "evidence": "DA (% baseline) over time",
      "source_chunk_ids": [
        "be3c1fa204d1fe03e278412a1d79c839"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "modulates"
      },
      "confidence": 0.75,
      "evidence": "5-HT (% baseline) over time",
      "source_chunk_ids": [
        "be3c1fa204d1fe03e278412a1d79c839"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "increases"
      },
      "confidence": 0.7,
      "evidence": "Ambulation (cm) over time",
      "source_chunk_ids": [
        "be3c1fa204d1fe03e278412a1d79c839"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E7",
      "attributes": {
        "outcome": "increases"
      },
      "confidence": 0.7,
      "evidence": "Stereotypy (events) over time",
      "source_chunk_ids": [
        "be3c1fa204d1fe03e278412a1d79c839"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "in vivo microdialysis study",
      "source_chunk_ids": [
        "f43712c6ca99d243814087984163e882"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.9,
      "evidence": "Effects of PAL-287",
      "source_chunk_ids": [
        "f43712c6ca99d243814087984163e882"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "TESTED_AT",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "1 mg/kg PAL-287 at time zero",
      "source_chunk_ids": [
        "f43712c6ca99d243814087984163e882"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "TESTED_AT",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "3 mg/kg 60 min later",
      "source_chunk_ids": [
        "f43712c6ca99d243814087984163e882"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "ACTS_ON",
      "source_entity_id": "E3",
      "target_entity_id": "E6",
      "attributes": {
        "action": "modulates"
      },
      "confidence": 0.75,
      "evidence": "Concentrations of DA in dialysate samples",
      "source_chunk_ids": [
        "f43712c6ca99d243814087984163e882"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "ACTS_ON",
      "source_entity_id": "E3",
      "target_entity_id": "E7",
      "attributes": {
        "action": "modulates"
      },
      "confidence": 0.75,
      "evidence": "Concentrations of 5-HT in dialysate samples",
      "source_chunk_ids": [
        "f43712c6ca99d243814087984163e882"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "Effects of PAL-287 on neurochemical parameters",
      "source_chunk_ids": [
        "f43712c6ca99d243814087984163e882"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "Effects of PAL-287 on neurochemical parameters",
      "source_chunk_ids": [
        "f43712c6ca99d243814087984163e882"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E10",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "Effects of PAL-287 on locomotor parameters",
      "source_chunk_ids": [
        "f43712c6ca99d243814087984163e882"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R10",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E11",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "Effects of PAL-287 on locomotor parameters",
      "source_chunk_ids": [
        "f43712c6ca99d243814087984163e882"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R11",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E8",
      "attributes": {
        "outcome": "observed"
      },
      "confidence": 0.75,
      "evidence": "Concentrations of DA expressed as percentage of baseline",
      "source_chunk_ids": [
        "f43712c6ca99d243814087984163e882"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E9",
      "attributes": {
        "outcome": "observed"
      },
      "confidence": 0.75,
      "evidence": "Concentrations of 5-HT expressed as percentage of baseline",
      "source_chunk_ids": [
        "f43712c6ca99d243814087984163e882"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R13",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E10",
      "attributes": {
        "outcome": "observed"
      },
      "confidence": 0.7,
      "evidence": "Locomotor parameters: distance traveled (ambulation)",
      "source_chunk_ids": [
        "f43712c6ca99d243814087984163e882"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R14",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E11",
      "attributes": {
        "outcome": "observed"
      },
      "confidence": 0.7,
      "evidence": "Locomotor parameters: number of repetitive movements (stereotypy)",
      "source_chunk_ids": [
        "f43712c6ca99d243814087984163e882"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {
        "action": "releases",
        "measurement": {
          "value": 12.6,
          "unit": "nM",
          "measurement_type": "potency",
          "notes": "releasing radiolabeled transmitters"
        }
      },
      "confidence": 0.85,
      "evidence": "potency at DAT is 12.6 nM",
      "source_chunk_ids": [
        "6c48e219fa7c33fe1c88a5bc26d0ac6d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "action": "releases",
        "measurement": {
          "value": 11.1,
          "unit": "nM",
          "measurement_type": "potency",
          "notes": "releasing radiolabeled transmitters"
        }
      },
      "confidence": 0.85,
      "evidence": "potency at NET is 11.1 nM",
      "source_chunk_ids": [
        "6c48e219fa7c33fe1c88a5bc26d0ac6d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "action": "releases",
        "measurement": {
          "value": 3.4,
          "unit": "nM",
          "measurement_type": "potency",
          "notes": "releasing radiolabeled transmitters"
        }
      },
      "confidence": 0.85,
      "evidence": "potency at SERT is 3.4 nM",
      "source_chunk_ids": [
        "6c48e219fa7c33fe1c88a5bc26d0ac6d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "action": "agonist",
        "measurement": {
          "value": 40,
          "unit": "nM",
          "measurement_type": "EC50",
          "notes": "full agonist"
        }
      },
      "confidence": 0.8,
      "evidence": "EC50 = 40 nM at 5-HT2B",
      "source_chunk_ids": [
        "6c48e219fa7c33fe1c88a5bc26d0ac6d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {
        "action": "agonist",
        "measurement": {
          "value": 466,
          "unit": "nM",
          "measurement_type": "EC50",
          "notes": "full agonist"
        }
      },
      "confidence": 0.8,
      "evidence": "EC50 = 466 nM at 5-HT2A",
      "source_chunk_ids": [
        "6c48e219fa7c33fe1c88a5bc26d0ac6d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E7",
      "attributes": {
        "action": "agonist",
        "measurement": {
          "value": 2.3,
          "unit": "nM",
          "measurement_type": "EC50",
          "notes": "partial agonist, E_MAX = 20%"
        }
      },
      "confidence": 0.8,
      "evidence": "EC50 = 2.3 nM at 5-HT2C",
      "source_chunk_ids": [
        "6c48e219fa7c33fe1c88a5bc26d0ac6d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "increases extracellular 5-HT",
      "source_chunk_ids": [
        "6c48e219fa7c33fe1c88a5bc26d0ac6d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "increases extracellular DA",
      "source_chunk_ids": [
        "6c48e219fa7c33fe1c88a5bc26d0ac6d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E10",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.6,
      "evidence": "suggests possible anorectic actions",
      "source_chunk_ids": [
        "6c48e219fa7c33fe1c88a5bc26d0ac6d"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R10",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E11",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.6,
      "evidence": "minimal reinforcing properties",
      "source_chunk_ids": [
        "6c48e219fa7c33fe1c88a5bc26d0ac6d"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R11",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E13",
      "target_entity_id": "E12",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "in vitro potency",
      "source_chunk_ids": [
        "6c48e219fa7c33fe1c88a5bc26d0ac6d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "STUDIES",
      "source_entity_id": "E13",
      "target_entity_id": "E1",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.7,
      "evidence": "Rothman et al., 2005",
      "source_chunk_ids": [
        "6c48e219fa7c33fe1c88a5bc26d0ac6d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R13",
      "type": "REPORTS",
      "source_entity_id": "E13",
      "target_entity_id": "E2",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "potency at DAT",
      "source_chunk_ids": [
        "6c48e219fa7c33fe1c88a5bc26d0ac6d"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R14",
      "type": "REPORTS",
      "source_entity_id": "E13",
      "target_entity_id": "E3",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "potency at NET",
      "source_chunk_ids": [
        "6c48e219fa7c33fe1c88a5bc26d0ac6d"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R15",
      "type": "REPORTS",
      "source_entity_id": "E13",
      "target_entity_id": "E4",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "potency at SERT",
      "source_chunk_ids": [
        "6c48e219fa7c33fe1c88a5bc26d0ac6d"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R16",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E14",
      "target_entity_id": "E12",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.6,
      "evidence": "Vickers et al., 1999; Nilsson, 2006",
      "source_chunk_ids": [
        "6c48e219fa7c33fe1c88a5bc26d0ac6d"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R17",
      "type": "STUDIES",
      "source_entity_id": "E14",
      "target_entity_id": "E1",
      "attributes": {
        "role": "intervention",
        "verification_needed": true
      },
      "confidence": 0.6,
      "evidence": "Vickers et al., 1999; Nilsson, 2006",
      "source_chunk_ids": [
        "6c48e219fa7c33fe1c88a5bc26d0ac6d"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R18",
      "type": "REPORTS",
      "source_entity_id": "E14",
      "target_entity_id": "E10",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.55,
      "evidence": "suggests possible anorectic actions",
      "source_chunk_ids": [
        "6c48e219fa7c33fe1c88a5bc26d0ac6d"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R19",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E15",
      "target_entity_id": "E12",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.6,
      "evidence": "Czoty et al., 2002; Higgins and Fletcher, 2003",
      "source_chunk_ids": [
        "6c48e219fa7c33fe1c88a5bc26d0ac6d"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R20",
      "type": "STUDIES",
      "source_entity_id": "E15",
      "target_entity_id": "E1",
      "attributes": {
        "role": "intervention",
        "verification_needed": true
      },
      "confidence": 0.6,
      "evidence": "Czoty et al., 2002; Higgins and Fletcher, 2003",
      "source_chunk_ids": [
        "6c48e219fa7c33fe1c88a5bc26d0ac6d"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R21",
      "type": "REPORTS",
      "source_entity_id": "E15",
      "target_entity_id": "E11",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.55,
      "evidence": "minimal reinforcing properties",
      "source_chunk_ids": [
        "6c48e219fa7c33fe1c88a5bc26d0ac6d"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {
        "outcome": "minimal"
      },
      "confidence": 0.85,
      "evidence": "PAL-287 produces minimal locomotor activation",
      "source_chunk_ids": [
        "0b3ecff2cc2fb09334edabbd47ea1873"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "substantial elevations in extracellular DA",
      "source_chunk_ids": [
        "0b3ecff2cc2fb09334edabbd47ea1873"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "amount of ambulation produced by 3 mg/kg PAL-287",
      "source_chunk_ids": [
        "0b3ecff2cc2fb09334edabbd47ea1873"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E5",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "amount produced by 1 mg/kg D-amphetamine",
      "source_chunk_ids": [
        "0b3ecff2cc2fb09334edabbd47ea1873"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "both drug treatments cause equivalent DA release",
      "source_chunk_ids": [
        "0b3ecff2cc2fb09334edabbd47ea1873"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "PRODUCES",
      "source_entity_id": "E5",
      "target_entity_id": "E6",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "both drug treatments cause equivalent DA release",
      "source_chunk_ids": [
        "0b3ecff2cc2fb09334edabbd47ea1873"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E7",
      "attributes": {
        "action": "releases"
      },
      "confidence": 0.8,
      "evidence": "5-HT-releasing properties of PAL-287",
      "source_chunk_ids": [
        "0b3ecff2cc2fb09334edabbd47ea1873"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "PRODUCES",
      "source_entity_id": "E7",
      "target_entity_id": "E8",
      "attributes": {
        "outcome": "limits"
      },
      "confidence": 0.75,
      "evidence": "5-HT-releasing properties of PAL-287 limit the stimulant effects",
      "source_chunk_ids": [
        "0b3ecff2cc2fb09334edabbd47ea1873"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E10",
      "attributes": {
        "outcome": "no_effect"
      },
      "confidence": 0.8,
      "evidence": "fails to affect brain tissue 5-HT levels",
      "source_chunk_ids": [
        "0b3ecff2cc2fb09334edabbd47ea1873"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "PRODUCES",
      "source_entity_id": "E11",
      "target_entity_id": "E13",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "cause significant 5-HT depletions",
      "source_chunk_ids": [
        "0b3ecff2cc2fb09334edabbd47ea1873"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "PRODUCES",
      "source_entity_id": "E12",
      "target_entity_id": "E13",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "cause significant 5-HT depletions",
      "source_chunk_ids": [
        "0b3ecff2cc2fb09334edabbd47ea1873"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E14",
      "attributes": {
        "outcome": "no_effect"
      },
      "confidence": 0.8,
      "evidence": "does not support self-administration behaviour",
      "source_chunk_ids": [
        "0b3ecff2cc2fb09334edabbd47ea1873"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R13",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E15",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "decreases cocaine self-administration",
      "source_chunk_ids": [
        "0b3ecff2cc2fb09334edabbd47ea1873"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R14",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E17",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "significantly reduces both cocaine- and food-maintained responding",
      "source_chunk_ids": [
        "0b3ecff2cc2fb09334edabbd47ea1873"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R15",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E18",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "reduction in food-maintained responding",
      "source_chunk_ids": [
        "0b3ecff2cc2fb09334edabbd47ea1873"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "monkey self-administration assay",
      "source_chunk_ids": [
        "d141ff97b8e39f3e7bf86dc91db523a4"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.9,
      "evidence": "Effects of PAL-287 in the monkey self-administration assay",
      "source_chunk_ids": [
        "d141ff97b8e39f3e7bf86dc91db523a4"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "role": "comparator"
      },
      "confidence": 0.85,
      "evidence": "Cocaine (0.01 mg/kg/inj) (%)",
      "source_chunk_ids": [
        "d141ff97b8e39f3e7bf86dc91db523a4"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "reduces"
      },
      "confidence": 0.8,
      "evidence": "Effects of PAL-287 in the monkey self-administration assay",
      "source_chunk_ids": [
        "d141ff97b8e39f3e7bf86dc91db523a4"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "reduces"
      },
      "confidence": 0.75,
      "evidence": "Food (1 gm pellets) (%) ~40*",
      "source_chunk_ids": [
        "d141ff97b8e39f3e7bf86dc91db523a4"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "TESTED_AT",
      "source_entity_id": "E1",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "Dose PAL-287 (mg/kg/hr) 0.1, 0.32, 1.0",
      "source_chunk_ids": [
        "d141ff97b8e39f3e7bf86dc91db523a4"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "Effects of PAL-287 in the monkey self-administration assay",
      "source_chunk_ids": [
        "d141ff97b8e39f3e7bf86dc91db523a4"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E6",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "Food (1 gm pellets) (%) ~40*",
      "source_chunk_ids": [
        "d141ff97b8e39f3e7bf86dc91db523a4"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "monkey self-administration assay",
      "source_chunk_ids": [
        "7b2be919fcbd22a9d66fff4c903a6159"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.9,
      "evidence": "Self-administration of PAL-287",
      "source_chunk_ids": [
        "7b2be919fcbd22a9d66fff4c903a6159"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "role": "comparator"
      },
      "confidence": 0.85,
      "evidence": "Self-administration of cocaine",
      "source_chunk_ids": [
        "7b2be919fcbd22a9d66fff4c903a6159"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "observed"
      },
      "confidence": 0.8,
      "evidence": "Self-administration of cocaine and PAL-287",
      "source_chunk_ids": [
        "7b2be919fcbd22a9d66fff4c903a6159"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "reduces"
      },
      "confidence": 0.75,
      "evidence": "Effects of chronic 7-day treatment with PAL-287 on cocaine-maintained responding",
      "source_chunk_ids": [
        "7b2be919fcbd22a9d66fff4c903a6159"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E7",
      "attributes": {
        "outcome": "reduces"
      },
      "confidence": 0.75,
      "evidence": "Effects of chronic 7-day treatment with PAL-287 on food-maintained responding",
      "source_chunk_ids": [
        "7b2be919fcbd22a9d66fff4c903a6159"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "Self-administration of PAL-287",
      "source_chunk_ids": [
        "7b2be919fcbd22a9d66fff4c903a6159"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E6",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "Effects of chronic 7-day treatment with PAL-287 on cocaine-maintained responding",
      "source_chunk_ids": [
        "7b2be919fcbd22a9d66fff4c903a6159"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R9",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E7",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "Effects of chronic 7-day treatment with PAL-287 on food-maintained responding",
      "source_chunk_ids": [
        "7b2be919fcbd22a9d66fff4c903a6159"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {
        "action": "releases"
      },
      "confidence": 0.85,
      "evidence": "SERT will release DA and 5-HT",
      "source_chunk_ids": [
        "9714e3ec9dab0906ab6b538a3d3eb149"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "action": "agonist"
      },
      "confidence": 0.8,
      "evidence": "5-HT2B agonist effects",
      "source_chunk_ids": [
        "9714e3ec9dab0906ab6b538a3d3eb149"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "SERT will release DA and 5-HT",
      "source_chunk_ids": [
        "9714e3ec9dab0906ab6b538a3d3eb149"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "be minimally reinforcing",
      "source_chunk_ids": [
        "9714e3ec9dab0906ab6b538a3d3eb149"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "suppress ongoing cocaine self-administration",
      "source_chunk_ids": [
        "9714e3ec9dab0906ab6b538a3d3eb149"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "minimal locomotor activation",
      "source_chunk_ids": [
        "9714e3ec9dab0906ab6b538a3d3eb149"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "lack of long-term 5-HT neurotoxicity",
      "source_chunk_ids": [
        "9714e3ec9dab0906ab6b538a3d3eb149"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "low abuse potential",
      "source_chunk_ids": [
        "9714e3ec9dab0906ab6b538a3d3eb149"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "TREATS",
      "source_entity_id": "E1",
      "target_entity_id": "E12",
      "attributes": {
        "context": "candidate treatment"
      },
      "confidence": 0.8,
      "evidence": "treatment of stimulant addictions",
      "source_chunk_ids": [
        "9714e3ec9dab0906ab6b538a3d3eb149"
      ],
      "supporting_study_ids": [
        "E15"
      ],
      "verified": true
    },
    {
      "id": "R10",
      "type": "TREATS",
      "source_entity_id": "E1",
      "target_entity_id": "E13",
      "attributes": {
        "context": "experimental"
      },
      "confidence": 0.75,
      "evidence": "eliminated cocaine self-administration",
      "source_chunk_ids": [
        "9714e3ec9dab0906ab6b538a3d3eb149"
      ],
      "supporting_study_ids": [
        "E15"
      ],
      "verified": true
    },
    {
      "id": "R11",
      "type": "CAUSES",
      "source_entity_id": "E1",
      "target_entity_id": "E10",
      "attributes": {
        "context": "potential risk",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "risk of VHD",
      "source_chunk_ids": [
        "9714e3ec9dab0906ab6b538a3d3eb149"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R12",
      "type": "CAUSES",
      "source_entity_id": "E1",
      "target_entity_id": "E11",
      "attributes": {
        "context": "potential risk",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "risk of ... IPAH",
      "source_chunk_ids": [
        "9714e3ec9dab0906ab6b538a3d3eb149"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R13",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E15",
      "target_entity_id": "E16",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "in vivo",
      "source_chunk_ids": [
        "9714e3ec9dab0906ab6b538a3d3eb149"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R14",
      "type": "STUDIES",
      "source_entity_id": "E15",
      "target_entity_id": "E1",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.9,
      "evidence": "PAL-287",
      "source_chunk_ids": [
        "9714e3ec9dab0906ab6b538a3d3eb149"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R15",
      "type": "TESTED_AT",
      "source_entity_id": "E15",
      "target_entity_id": "E14",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "1.0 mg/kg/h ... 7-day treatment",
      "source_chunk_ids": [
        "9714e3ec9dab0906ab6b538a3d3eb149"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R16",
      "type": "REPORTS",
      "source_entity_id": "E15",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.8,
      "evidence": "eliminated cocaine self-administration",
      "source_chunk_ids": [
        "9714e3ec9dab0906ab6b538a3d3eb149"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R17",
      "type": "REPORTS",
      "source_entity_id": "E15",
      "target_entity_id": "E13",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.75,
      "evidence": "cocaine self-administration",
      "source_chunk_ids": [
        "9714e3ec9dab0906ab6b538a3d3eb149"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "action": "releases"
      },
      "confidence": 0.8,
      "evidence": "mixed DA/5-HT-releasing activity",
      "source_chunk_ids": [
        "84b0c5deb9ccfd550d8548bcc03a3b52"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "PAL-287 in monkeys are similar to the suppression of cocaine self-administration",
      "source_chunk_ids": [
        "84b0c5deb9ccfd550d8548bcc03a3b52"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "suppression of cocaine self-administration produced by d-amphetamine",
      "source_chunk_ids": [
        "84b0c5deb9ccfd550d8548bcc03a3b52"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "reducing illicit cocaine use",
      "source_chunk_ids": [
        "84b0c5deb9ccfd550d8548bcc03a3b52"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E6",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "dual DA/5-HT releasers suppress alcohol ingestion",
      "source_chunk_ids": [
        "84b0c5deb9ccfd550d8548bcc03a3b52"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "TREATS",
      "source_entity_id": "E2",
      "target_entity_id": "E7",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.8,
      "evidence": "effective in maintaining cocaine addicts in treatment",
      "source_chunk_ids": [
        "84b0c5deb9ccfd550d8548bcc03a3b52"
      ],
      "supporting_study_ids": [
        "E10"
      ],
      "verified": true
    },
    {
      "id": "R7",
      "type": "SUGGESTS",
      "source_entity_id": "E1",
      "target_entity_id": "E7",
      "attributes": {
        "mapping_type": "direct"
      },
      "confidence": 0.7,
      "evidence": "PAL-287, which have mixed DA/5-HT-releasing activity, will possess the therapeutic effects of amphetamine-type monoamine releasers",
      "source_chunk_ids": [
        "84b0c5deb9ccfd550d8548bcc03a3b52"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "SUGGESTS",
      "source_entity_id": "E1",
      "target_entity_id": "E8",
      "attributes": {
        "mapping_type": "direct"
      },
      "confidence": 0.7,
      "evidence": "PAL-287 or similar agents should be tested as potential treatments for",
      "source_chunk_ids": [
        "84b0c5deb9ccfd550d8548bcc03a3b52"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E9",
      "target_entity_id": "E13",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "findings with PAL-287 in monkeys",
      "source_chunk_ids": [
        "84b0c5deb9ccfd550d8548bcc03a3b52"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E10",
      "target_entity_id": "E13",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "Grabowski et al. (2001, 2004b) showed",
      "source_chunk_ids": [
        "84b0c5deb9ccfd550d8548bcc03a3b52"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E11",
      "target_entity_id": "E13",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "Yu et al., 1997",
      "source_chunk_ids": [
        "84b0c5deb9ccfd550d8548bcc03a3b52"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E12",
      "target_entity_id": "E13",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "Halladay et al., 1999, 2006",
      "source_chunk_ids": [
        "84b0c5deb9ccfd550d8548bcc03a3b52"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R13",
      "type": "STUDIES",
      "source_entity_id": "E9",
      "target_entity_id": "E1",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.75,
      "evidence": "findings with PAL-287 in monkeys",
      "source_chunk_ids": [
        "84b0c5deb9ccfd550d8548bcc03a3b52"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R14",
      "type": "STUDIES",
      "source_entity_id": "E10",
      "target_entity_id": "E2",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.85,
      "evidence": "slow-release formulation of d-amphetamine",
      "source_chunk_ids": [
        "84b0c5deb9ccfd550d8548bcc03a3b52"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R15",
      "type": "STUDIES",
      "source_entity_id": "E11",
      "target_entity_id": "E3",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.8,
      "evidence": "dual DA/5-HT releasers",
      "source_chunk_ids": [
        "84b0c5deb9ccfd550d8548bcc03a3b52"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R16",
      "type": "STUDIES",
      "source_entity_id": "E12",
      "target_entity_id": "E3",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.8,
      "evidence": "dual DA/5-HT releasers",
      "source_chunk_ids": [
        "84b0c5deb9ccfd550d8548bcc03a3b52"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R17",
      "type": "REPORTS",
      "source_entity_id": "E9",
      "target_entity_id": "E4",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.8,
      "evidence": "suppression of cocaine self-administration",
      "source_chunk_ids": [
        "84b0c5deb9ccfd550d8548bcc03a3b52"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R18",
      "type": "REPORTS",
      "source_entity_id": "E10",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.85,
      "evidence": "reducing illicit cocaine use",
      "source_chunk_ids": [
        "84b0c5deb9ccfd550d8548bcc03a3b52"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R19",
      "type": "REPORTS",
      "source_entity_id": "E11",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.8,
      "evidence": "suppress alcohol ingestion",
      "source_chunk_ids": [
        "84b0c5deb9ccfd550d8548bcc03a3b52"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R20",
      "type": "REPORTS",
      "source_entity_id": "E12",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.8,
      "evidence": "suppress alcohol ingestion",
      "source_chunk_ids": [
        "84b0c5deb9ccfd550d8548bcc03a3b52"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E2",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "Yu et al., 1997",
      "source_chunk_ids": [
        "f7a131a0b3f48442c08655d370849fb0"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "STUDIES",
      "source_entity_id": "E2",
      "target_entity_id": "E4",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.8,
      "evidence": "combined treatment with DA",
      "source_chunk_ids": [
        "f7a131a0b3f48442c08655d370849fb0"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "STUDIES",
      "source_entity_id": "E2",
      "target_entity_id": "E5",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.8,
      "evidence": "combined treatment with 5-HT",
      "source_chunk_ids": [
        "f7a131a0b3f48442c08655d370849fb0"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E2",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.85,
      "evidence": "blocks alcohol withdrawal seizures",
      "source_chunk_ids": [
        "f7a131a0b3f48442c08655d370849fb0"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E2",
      "target_entity_id": "E10",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.8,
      "evidence": "blocks alcohol withdrawal seizures",
      "source_chunk_ids": [
        "f7a131a0b3f48442c08655d370849fb0"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "ACTS_ON",
      "source_entity_id": "E7",
      "target_entity_id": "E8",
      "attributes": {
        "action": "reduces potency"
      },
      "confidence": 0.75,
      "evidence": "reduce its potency at 5-HT2B receptors",
      "source_chunk_ids": [
        "f7a131a0b3f48442c08655d370849fb0"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "ACTS_ON",
      "source_entity_id": "E7",
      "target_entity_id": "E9",
      "attributes": {
        "action": "acts as substrates"
      },
      "confidence": 0.8,
      "evidence": "acting as substrates at multiple transporters",
      "source_chunk_ids": [
        "f7a131a0b3f48442c08655d370849fb0"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "PRODUCES",
      "source_entity_id": "E7",
      "target_entity_id": "E11",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "enhance monoamine release",
      "source_chunk_ids": [
        "f7a131a0b3f48442c08655d370849fb0"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "PRODUCES",
      "source_entity_id": "E11",
      "target_entity_id": "E10",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "enhance monoamine release",
      "source_chunk_ids": [
        "f7a131a0b3f48442c08655d370849fb0"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "STUDIES",
      "source_entity_id": "E12",
      "target_entity_id": "E3",
      "attributes": {
        "role": "intervention",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "5-HTP must be co-administered",
      "source_chunk_ids": [
        "24593cf040b711b34d26c5a00eec814d"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R2",
      "type": "STUDIES",
      "source_entity_id": "E13",
      "target_entity_id": "E5",
      "attributes": {
        "role": "intervention",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "phentermine and 5-HTP/carbidopa",
      "source_chunk_ids": [
        "24593cf040b711b34d26c5a00eec814d"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R3",
      "type": "TREATS",
      "source_entity_id": "E2",
      "target_entity_id": "E6",
      "attributes": {
        "context": "suggested",
        "verification_needed": true
      },
      "confidence": 0.6,
      "evidence": "tested by administration for addictive disorders",
      "source_chunk_ids": [
        "24593cf040b711b34d26c5a00eec814d"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R4",
      "type": "TREATS",
      "source_entity_id": "E1",
      "target_entity_id": "E7",
      "attributes": {
        "context": "suggested",
        "verification_needed": true
      },
      "confidence": 0.6,
      "evidence": "provide neurochemical normalization therapy for stimulant addictions",
      "source_chunk_ids": [
        "24593cf040b711b34d26c5a00eec814d"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R5",
      "type": "TREATS",
      "source_entity_id": "E1",
      "target_entity_id": "E8",
      "attributes": {
        "context": "suggested",
        "verification_needed": true
      },
      "confidence": 0.6,
      "evidence": "might also be useful for treating depression",
      "source_chunk_ids": [
        "24593cf040b711b34d26c5a00eec814d"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R6",
      "type": "TREATS",
      "source_entity_id": "E1",
      "target_entity_id": "E9",
      "attributes": {
        "context": "suggested",
        "verification_needed": true
      },
      "confidence": 0.6,
      "evidence": "obsessive compulsive disorder",
      "source_chunk_ids": [
        "24593cf040b711b34d26c5a00eec814d"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R7",
      "type": "TREATS",
      "source_entity_id": "E1",
      "target_entity_id": "E10",
      "attributes": {
        "context": "suggested",
        "verification_needed": true
      },
      "confidence": 0.6,
      "evidence": "attention deficit hyperactivity disorder",
      "source_chunk_ids": [
        "24593cf040b711b34d26c5a00eec814d"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R8",
      "type": "TREATS",
      "source_entity_id": "E1",
      "target_entity_id": "E11",
      "attributes": {
        "context": "suggested",
        "verification_needed": true
      },
      "confidence": 0.6,
      "evidence": "obesity",
      "source_chunk_ids": [
        "24593cf040b711b34d26c5a00eec814d"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R9",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E12",
      "target_entity_id": "E14",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "preclinical arena",
      "source_chunk_ids": [
        "24593cf040b711b34d26c5a00eec814d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E13",
      "target_entity_id": "E15",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "clinical development",
      "source_chunk_ids": [
        "24593cf040b711b34d26c5a00eec814d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "Appetite-suppressant drugs and the risk of primary pulmonary hypertension",
      "source_chunk_ids": [
        "ba24f9acfd0b569d2da6a8bf7cc6be46"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "outcome": "risk"
      },
      "confidence": 0.8,
      "evidence": "risk of primary pulmonary hypertension",
      "source_chunk_ids": [
        "ba24f9acfd0b569d2da6a8bf7cc6be46"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E4",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "Pharmacologic mechanisms of serotonergic regulation",
      "source_chunk_ids": [
        "ba24f9acfd0b569d2da6a8bf7cc6be46"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E6",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "Noradrenergic and dopaminergic effects in baboon",
      "source_chunk_ids": [
        "ba24f9acfd0b569d2da6a8bf7cc6be46"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E8",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "Diethylpropion adjunct therapy for cocaine dependence",
      "source_chunk_ids": [
        "ba24f9acfd0b569d2da6a8bf7cc6be46"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "REPORTS",
      "source_entity_id": "E8",
      "target_entity_id": "E10",
      "attributes": {
        "outcome": "treatment"
      },
      "confidence": 0.8,
      "evidence": "adjunct therapy for cocaine dependence",
      "source_chunk_ids": [
        "ba24f9acfd0b569d2da6a8bf7cc6be46"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E11",
      "target_entity_id": "E12",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "Neurotransmitter transporters: recent progress",
      "source_chunk_ids": [
        "ba24f9acfd0b569d2da6a8bf7cc6be46"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E15",
      "target_entity_id": "E1",
      "attributes": {
        "action": "releases"
      },
      "confidence": 0.8,
      "evidence": "serotonin releaser \u03b4-fenfluramine",
      "source_chunk_ids": [
        "d4fb025eccb3dcf3df18dc15056aad91"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "ACTS_ON",
      "source_entity_id": "E16",
      "target_entity_id": "E2",
      "attributes": {
        "action": "agonist"
      },
      "confidence": 0.85,
      "evidence": "5-HT1A agonist, 8-OH-DPAT",
      "source_chunk_ids": [
        "d4fb025eccb3dcf3df18dc15056aad91"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "ACTS_ON",
      "source_entity_id": "E22",
      "target_entity_id": "E4",
      "attributes": {
        "action": "signals"
      },
      "confidence": 0.7,
      "evidence": "Signaling from G-protein-coupled receptors to mitogen-activated protein (MAP)-kinase cascades",
      "source_chunk_ids": [
        "d4fb025eccb3dcf3df18dc15056aad91"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "TREATS",
      "source_entity_id": "E1",
      "target_entity_id": "E9",
      "attributes": {
        "context": "scientific"
      },
      "confidence": 0.75,
      "evidence": "Serotonin transporter inhibitors protect against hypoxic pulmonary hypertension",
      "source_chunk_ids": [
        "d4fb025eccb3dcf3df18dc15056aad91"
      ],
      "supporting_study_ids": [
        "E26"
      ],
      "verified": true
    },
    {
      "id": "R5",
      "type": "CAUSES",
      "source_entity_id": "E15",
      "target_entity_id": "E14",
      "attributes": {
        "context": "clinical",
        "severity": "severe"
      },
      "confidence": 0.7,
      "evidence": "primary pulmonary hypertension from fenfluramine",
      "source_chunk_ids": [
        "d4fb025eccb3dcf3df18dc15056aad91"
      ],
      "supporting_study_ids": [
        "E27"
      ],
      "verified": true
    },
    {
      "id": "R6",
      "type": "REPORTS",
      "source_entity_id": "E26",
      "target_entity_id": "E9",
      "attributes": {
        "outcome": "protects"
      },
      "confidence": 0.8,
      "evidence": "Serotonin transporter inhibitors protect against hypoxic pulmonary hypertension",
      "source_chunk_ids": [
        "d4fb025eccb3dcf3df18dc15056aad91"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "REPORTS",
      "source_entity_id": "E27",
      "target_entity_id": "E14",
      "attributes": {
        "outcome": "causes"
      },
      "confidence": 0.75,
      "evidence": "primary pulmonary hypertension from fenfluramine",
      "source_chunk_ids": [
        "d4fb025eccb3dcf3df18dc15056aad91"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E27",
      "target_entity_id": "E28",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "systematic review",
      "source_chunk_ids": [
        "d4fb025eccb3dcf3df18dc15056aad91"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "STUDIES",
      "source_entity_id": "E27",
      "target_entity_id": "E15",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.75,
      "evidence": "fenfluramine and dexfenfluramine",
      "source_chunk_ids": [
        "d4fb025eccb3dcf3df18dc15056aad91"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "SUGGESTS",
      "source_entity_id": "E7",
      "target_entity_id": "E13",
      "attributes": {
        "mapping_type": "direct",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "5-HT2C receptor agonists as potential antiobesity agents",
      "source_chunk_ids": [
        "d4fb025eccb3dcf3df18dc15056aad91"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "in vitro study",
      "source_chunk_ids": [
        "f463c7b416f26ce3da280b67c2e85439"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.85,
      "evidence": "Aminorex, fenfluramine, and chlorphenamine",
      "source_chunk_ids": [
        "f463c7b416f26ce3da280b67c2e85439"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.85,
      "evidence": "Aminorex, fenfluramine, and chlorphenamine",
      "source_chunk_ids": [
        "f463c7b416f26ce3da280b67c2e85439"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.85,
      "evidence": "Aminorex, fenfluramine, and chlorphenamine",
      "source_chunk_ids": [
        "f463c7b416f26ce3da280b67c2e85439"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "involves"
      },
      "confidence": 0.8,
      "evidence": "serotonin transporter substrates",
      "source_chunk_ids": [
        "f463c7b416f26ce3da280b67c2e85439"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E7",
      "attributes": {
        "outcome": "implicates"
      },
      "confidence": 0.75,
      "evidence": "implications for primary pulmonary hypertension",
      "source_chunk_ids": [
        "f463c7b416f26ce3da280b67c2e85439"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "ACTS_ON",
      "source_entity_id": "E3",
      "target_entity_id": "E6",
      "attributes": {
        "action": "substrate"
      },
      "confidence": 0.8,
      "evidence": "serotonin transporter substrates",
      "source_chunk_ids": [
        "f463c7b416f26ce3da280b67c2e85439"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "ACTS_ON",
      "source_entity_id": "E4",
      "target_entity_id": "E6",
      "attributes": {
        "action": "substrate"
      },
      "confidence": 0.8,
      "evidence": "serotonin transporter substrates",
      "source_chunk_ids": [
        "f463c7b416f26ce3da280b67c2e85439"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "ACTS_ON",
      "source_entity_id": "E5",
      "target_entity_id": "E6",
      "attributes": {
        "action": "substrate"
      },
      "confidence": 0.8,
      "evidence": "serotonin transporter substrates",
      "source_chunk_ids": [
        "f463c7b416f26ce3da280b67c2e85439"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "SUGGESTS",
      "source_entity_id": "E1",
      "target_entity_id": "E7",
      "attributes": {
        "mapping_type": "direct"
      },
      "confidence": 0.7,
      "evidence": "implications for primary pulmonary hypertension",
      "source_chunk_ids": [
        "f463c7b416f26ce3da280b67c2e85439"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E8",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "in vitro study",
      "source_chunk_ids": [
        "f463c7b416f26ce3da280b67c2e85439"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "STUDIES",
      "source_entity_id": "E8",
      "target_entity_id": "E4",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.85,
      "evidence": "fenfluramine and other serotonergic medications",
      "source_chunk_ids": [
        "f463c7b416f26ce3da280b67c2e85439"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R13",
      "type": "REPORTS",
      "source_entity_id": "E8",
      "target_entity_id": "E9",
      "attributes": {
        "outcome": "involves"
      },
      "confidence": 0.8,
      "evidence": "involvement of 5-HT2B receptors",
      "source_chunk_ids": [
        "f463c7b416f26ce3da280b67c2e85439"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R14",
      "type": "REPORTS",
      "source_entity_id": "E8",
      "target_entity_id": "E10",
      "attributes": {
        "outcome": "associated"
      },
      "confidence": 0.75,
      "evidence": "cardiac valvulopathy associated with fenfluramine",
      "source_chunk_ids": [
        "f463c7b416f26ce3da280b67c2e85439"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R15",
      "type": "ACTS_ON",
      "source_entity_id": "E4",
      "target_entity_id": "E9",
      "attributes": {
        "action": "involves"
      },
      "confidence": 0.75,
      "evidence": "involvement of 5-HT2B receptors",
      "source_chunk_ids": [
        "f463c7b416f26ce3da280b67c2e85439"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R16",
      "type": "CAUSES",
      "source_entity_id": "E4",
      "target_entity_id": "E10",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.7,
      "evidence": "cardiac valvulopathy associated with fenfluramine",
      "source_chunk_ids": [
        "f463c7b416f26ce3da280b67c2e85439"
      ],
      "supporting_study_ids": [
        "E8"
      ],
      "verified": true
    },
    {
      "id": "R17",
      "type": "CAUSES",
      "source_entity_id": "E4",
      "target_entity_id": "E11",
      "attributes": {
        "context": "clinical",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "valvular heart disease",
      "source_chunk_ids": [
        "f463c7b416f26ce3da280b67c2e85439"
      ],
      "supporting_study_ids": [],
      "verified": false
    }
  ]
}